29 49128600'904 - foundationcenter

8

For calendar year 2017 or tax year beginning , 2017, and ending , 20

Name of foundation A Employer identification number

TI-IF WARRV T MANP_ I IDIAN IR FAI IMIIOTIAN 111d(_ 16-1578255

90-PFDepartment of the TreasuryInternal Reven ue Service

CSC,CalG'- 7

QC)

O

Effi I

Effi ]

EXH]

Effi ]

E%H ]

EXH A

M

ffi A

Number and'street (or P.O. box number if mail is not delivered to street address)

3696 NORTH FEDERAL HIGHWAY, SUITE 300

Room/sude B Telephone number (see instructions)

(954) 491-1722

City or town , state or province , country , and ZIP or foreign postal code

FORT LAUDERDALE , FLORIDA 33308-6263

C If exemption application is pending, check here lo- El

G Check all that apply: q Initial return q Initial return of a former public charity

q Final return q Amended return

q Address change q Name change

D 1. Foreign organizations , check here . . . ► q

2. Foreign organizations meeting the 85% test,check here and attach computation • • ► q

H Check type of organization : q Section 501 (c)(3) exempt private foundation Q l,f

El Section 4947 (a) ( 1 ) nonexempt charitable trust El Other taxable private foundation!

E If private foundation status was terminated undersection 507 (b)(1)(A), check here ► q

Fair market value of all assets at

end of year (from Part II, col. (c),

line 16) ► $ 148659923 1

J Accounting method: q Cash q Accrual

q Other (specify)

(Part I, column (d) must be on cash basis.)

F If the foundation is in a 60-month terminationunder section 507(b)(1)(B), check here . ► q

Analysis of Revenue and Expenses (The total ofamounts in columns (b), (c), and (d) may not necessarily equalthe amounts in column (a) (see instructions).)

(a) Revenue andexpenses per

books

(b) Net investmentincome

(c) Adjusted netincome

(d) Disbursementsfor charitablepurposes

(cash basis only

1 Contributions, gifts, grants , etc., received (attach schedule) 0 -2 Check ► q if the foundation is not required to attach Sch. B3 Interest on savings and temporary cash investments 18,285 18,285

3-1 4 Dividends and interest from securities . . . . 3,633,463 3 ,879,920

5a Gross rents . . . . . . . . . . . . . -

b Net rental income or (loss)

6a Net gain or Qoss) from sale of assets not on line 10 3,181 , 459 ' V V Vb Gross sales price for all assets on line 6a 73,981 , 804

7 Capital gain net income (from Part IV, line 2) . 4,015,038 -M 8 Net short-term capital gain . . . . . . . .

9 Income modifications . . . . . . V

10a Gross sales less returns and allowances V

b Less : Cost of goods sold . . . V

c Gross profit or (loss) (attach schedule) . . . .

3-1 11 Other income (attach-schedule)--.- 4, 381 (20 , 507)

12 Total . Add linesli1 thro g 1t1- `T Q\ I ' l .T1 .,

6,837, 588 7,892 736 0

13 Compensation df officers ,-directors,tn.sfees,,etc. 432 , 038 432,038

y 14 Other employee,salaries rid wage to^c^ U I Ii d

15 Pension plans , employee6eneTiiits- . p11 ILh sCFtil) .. . . .16a Legal fees (attac 17,137 17,137

W

.

b Accounting feeS_(atttach^schedule),, 1 , 318 1,318

c Other professional fees (attach s-che-dule)-F.SR B-2 536,118 680 , 326

17 Interest . . . . . . . . . . . . . . 1,664 1,664

!, H 18 Taxes (attach schedule) (see instructions) Elf B-2 128,701 29,696

19 Depreciation (attach schedule) and depletionFOM4 1 ,015Q 20 Occupancy . . . . . . . . . . . 4562 51,007 51,007

21 Travel , conferences, and meetings . . . . . 2 , 940 2 ,940

22 Printing and publications

J o> 23 Other expenses (attach schedule) ESH. R-2 293 , 584 79,16424 Total operating and administrative expenses.

Add lines 13 through 23 . . . . . . . . . 1 431 248 681 ,990 0 579 ,026

O 25 Contributions , gifts, grants paid ffi,. H . . 8 , 130, 260 8 , 130 260

26 Total expenses and disbursements. Add lines 24 and 25 9 , 561 , 508 681 , 990 0 8,709 , 286

27 Subtract line 26 from line 12:

a Excess of revenue over expenses and disbursements (2,723,920)b Net investment income (if negative , enter -0-) 7 , 210,746

c Adjusted net Income (if negative, enter -0-) 0

For Paperwork Reduction Act Notice, see Instructions.

29 49128600'904

Return of Private Foundation OMB No .

or Section 4947(a)(1) Trust Treated as Private Foundation

► Do not enter social security numbers on this form as it may be made public.

► Go to www.irsgov1Form990PF for instructions and the latest information. •

Cat. No. 11289X Form !!!!l)-rr (2017)

Form 990-PF (2017) The Harry T. Mangurian , Jr. Foundation , Inc. EIN : 16-1578255 Page2

Attached schedules and amounts in the descnption column Beginning of year End of yearBalance Sheets (See instructions )ear amounts onlshould be for end-of- (a) Book Value (b) Book Value (c) Fair Market Value.y.y

1 Cash-non-interest-bearing . . . . . . . . . . .

2 Savings and temporary cash investments . EXH. C. . . . 2 , 199,380 1,385,480 1,385 480

3 Accounts receivable ►Less: allowance for doubtful accounts ►

-------------------------------4 Pledges receivable ► ---------------------------------------------------------

Less: allowance for doubtful accounts ► --------------------------------5 Grants receivable . . . . . . . . . . . . . . .6 Receivables due from officers, directors, trustees, and other

disqualified persons (attach schedule) (see instructions) . .

7 Other notes and loans receivable (attach schedule) ► _______________________

Less: allowance for doubtful accounts ►--------------------------------------8 Inventories for sale or use . . . .

cc 9 Prepaid expenses and deferred chargesPPd Ins/Deposit 6 , 919 8 , 332 8 , 332

a 10a Investments-U.S. and state government obligations (attach schedule)

b Investments-corporate stock (attach schedule) E$H C . . 50,660,727 53,640,065 59,985,190

c Investments-corporate bonds (attach schedule) E$H C . . 43,053,988 42,336,971 43,017,284

11 Investments-land, buildings, and equipment: basis ►------------------------Less: accumulated depreciation (attach schedule) ► ----------------------------

12 Investments-mortgage loans .

13 Investments-other (attach schedule) . . . .ffi .C • • 35,374, 158 31 ,201,419 44,261,741

14 Land, buildings, and equipment: basis ► .................... 33.546

31,650Less: accumulated depreciation (attach schedule) ► 2,911 1,896 1,896________________

15 Other assets (describe ► )-----------------------------------------------

16 Total assets (to be completed by all filers-see theinstructions. Also, see page 1, item I) . . . . . . . . 131 , 298 , 083 128 , 574, 163 148 659 923

17 Accounts payable and accrued expenses . . . . . . .

18 Grants payable . . . . . . . . . . . . . . . .

19 Deferred revenue . . . . . . . . . . . . . . .

20 Loans from officers, directors, trustees, and other disqualified persons

.Lv 21 Mortgages and other notes payable (attach schedule) . . .

J 22 Other liabilities (describe ► ------------------------------------------23 Total liabilities (add lines 17 through 22) o 0

Foundations that follow SFAS 117, check here . . ► q0 and complete lines 24 through 26, and lines 30 and 31.

C 24 Unrestricted . .M

m 25 Temporarily restricted . . . . . . . . . . . . .

26 Permanently restricted . . . . . . . . . . . . .ca

2 Foundations that do not follow WAS 117, check here ► El

LLand complete lines 27 through 31.

0 27 Capital stock, trust principal, or current funds . . . . . .U)

28 Paid-in or capital surplus, or land, bldg., and equipment fund

29 Retained earnings, accumulated income, endowment, or other funds 131,298 ,083 128 , 574,163

30 Total net assets or fund balances (see instructions) . . . 131,298 ,083 128,574,163

31 Total liabilities and net assets/fund balances (seeZ instructions) . . . . . . . . . . . . . . . . . 131 , 298 ,083 128 574 163

• Analysis of Changes in Net Assets or Fund Balances1 Total net assets or fund balances at beginning of year-Part II, column (a), line 30 (must agree with

end-of-year figure reported on prior year's return) . . . . . . . . . . . . . . . . . 1 131, 298,083

2 Enter amount from Part I, line 27a . . . . . . . . . . . . . . . . . . . . . . 2 2,723,920

3 Other increases not included in line 2 (itemize) ► 3 0----------------------------------------------------------------------

4 Add lines 1, 2, and 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 128,574,163

5 Decreases not included in line 2 (itemize) ► 5 0_-

__------------------------------------------------0------ --

.---

line 5)-Part II, column (b), line--36 Total net assets or fund balances at end of year pine-4minus-- 6 28 , 574 , 163Form 990-PF (2017)

Form 990-PF (2017) The Harry T. Mangurian, Jr. Foundation, Inc. EIN: 16-1578255

' Capital Gains and Losses for Tax on Investment Income(a) List and describe the kind(s) of property sold (for example , real estate ,

2-story brick warehouse; or common stock, 200 shs. MLC Co.)

(b) How acquiredP-PurchaseD-Donation

(c) Date acquired(mo., day, yr.)

(d) Date sold(mo., day, yr.)

1a PUBLICLY TRADED SECURITIES - SEE EXHIBIT D P VARIOUS 2017

bC SCHEDULES K-1 - SEE EXHIBIT 0 P VARIOUS 2017

de GOLDMAN SACHS VINTAGE V VI & VII FUNDS - SEE EXHIBIT D P VARIOUS 2017

(a) Gross sales price(f) Depreciation allowed

(or allowable)(9) Cost or other basisplus expense of sale

(h) Gain or poss)((e) plus (t) minus (q))

a 73, 981 ,804 0 70,714 679 3,267 125

bC (22,224)

de 770.137

Complete only for assets showing gain in column (h) and owned by the foundation on 12/31/69. (q Gains (Col. (h) gain minus

(i) FMV as of 12/31/69(^j Adjusted basisas of 12/31/69

(k) Excess of col 0iover col. (I), if any

col. (k), but not less than -0-) orLosses (from col. (h))

abcde

2 Capital gain net income or (net capital loss)1

If gain, also enter in Part I, line 7If (loss), enter -0- in Part 1, line 7 1 2 4,015,038

3 Net short-term capital gain or (loss) as defined in sections 1222(5) and (6):If gain, also enter in Part I, line 8, column (c). See instructions. If (loss), enter -0- inPart 1, line 8 . . . . . . . . . . . . . . . . . . . . . . . . 3

• Qualification Under Section 4940(e) for Reduced Tax on Net Investment Income(For optional use by domestic private foundations subject to the section 4940(a) tax on net investment income.)

If section 4940(d)(2) applies, leave this part blank.

Was the foundation liable for the section 4942 tax on the distributable amount of any year in the base period? q Yes NoIf "Yes," the foundation doesn't qualify under section 4940(e). Do not complete this part.

I Enter the appropriate amount in each column for each year, see the instructions before making any entries.

(a)Base period years

Calendar year (or tax year beginning in) Adjusted qualifying distributions Net value of nonc(chantable-use assets (col.Distribution(b)

dividividratiodivided by col. (c))

2016 7,120,105 138, 871 ,888 0.051271

2015 7, 184, 616 145,110 119 0.049511

2014 6,519,234 147 291, 528 0.044261

2013 6,578,600 138,538,041 0.047486

2012 6, 248 ,678 129 , 241 ,625 0.048349

2 Total of line 1, column (d) . . . . . . . . . . . . . . . . . . . . . . 2 0.2408783 Average distribution ratio for the 5-year base period-divide the total on line 2 by 5.0, or by

the number of years the foundation has been in existence if less than 5 years . . . . . 3 0.0481756

4 Enter the net value of noncharitable-use assets for 2017 from Part X, line 5 . . . . . . 4 144 ,649 ,486

5 Multiply line 4 by line 3 . . . . . . . . . . . . . . . . . . . . . . . 5 6,968 576

8 Enter 1 % of net investment income (1 % of Part I, line 27b) . . . . . . . . . . . 6 72,107

7 Add lines 5 and 6 . . . . . . . . . . . . . . . . . . . . . . . . . 7 7 , 040, 683

8 Enter qualifying distributions from Part XII, line 4 . . . . . . . . . . . . . . . 8 8.709,286If line 8 is equal to or greater than line 7, check the box in Part VI, line 1 b, and complete that part using a 1 % tax rate. See thePart VI instructions.

Form 990-PF (2017)

Form 9s0-PF(2otn The Harry T. Mangurian, Jr. Foundation, Inc. / EIN: 16-1578255 Page4

UU&IM Excise Tax Based on Investment Income (Section 4940(a), 4940(b), 4940(e), or 49

1 a Exempt operating foundations described in section 4940(d)(2), check here ► q and enter "N/A" on line 1.Date of ruling or determination letter. (attach copy of letter if necessary-see instructions)

--------------------b Domestic foundations that meet the section 4940(e) requirements in Part V, check

48-

1

see instructio

2107

ns)

here ► 21 and enter 1 % of Part I, line 27b . . . . . . . . . . . . . . . . .

c All other domestic foundations enter 2% of line 27b. Exempt foreign organizations, enter 4% ofPart I, line 12, col. (b).

2 Tax under section 511 (domestic section 4947(a)(1) trusts and taxable foundations only, others, enter -0-) 2 03 Add lines 1 and 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 72,107

4 Subtitle A (income) tax (domestic section 4947(a)(1) trusts and taxable foundations only; others, enter -0-) 4 0

5 Tax based on investment income. Subtract line 4 from line 3. If zero or less, enter -0- . . . 5 72,107

6 Credits/Payments:

a 2017 estimated tax payments and 2016 overpayment credited to 2017 6a 85,000b Exempt foreign organizations-tax withheld at source . . . . . 6b

c Tax paid with application for extension of time to file (Form 8868) . 6c 15 ,000d Backup withholding erroneously withheld . . . . . . . . . 6d

7 Total credits and payments. Add lines 6a through 6d . . . . . . . . . . . . . . . 7 100,000

8 Enter any penalty for underpayment of estimated tax. Check here q if Form 2220 is attached 8 0

9 Tax due. If the total of lines 5 and 8 is more than line 7, enter amount owed . . . . . . ► 9 0

10 Overpayment . If line 7 is more than the total of lines 5 and 8, enter the amount overpaid . . ► 10 27,89311 Enter the amount of line 10 to be: Credited to 2018 estimated tax ► 15.000) Refunded ► 11 12,893MBM Statements Regarding Activitiesis

b

cd

e

2

3

4a

b5

6

78a

b

9

10

During the tax year, did the foundation attempt to influence any national, state , or local legislation or did itparticipate or intervene in any political campaign? . . . . . . . . . . . . . . . . . . .

Did it spend more than $100 during the year (either directly or indirectly) for political purposes? See theinstructions for the definition . . . . . . . . . . . . . . . . . . . . . . . . . .

If the answer is "Yes" to 1 a or 1 b, attach a detailed description of the activities and copies of any materialspublished or distributed by the foundation in connection with the activities.

Did the foundation file Form 1120-POL for this year? . . . . . . . . . . . . . . . . . .

Enter the amount (if any) of tax on political expenditures (section 4955) imposed during the year:(1) On the foundation . ► $ N / A (2) On foundation managers. ► $ N/A

Enter the reimbursement (if any) paid by the foundation during the year for political expenditure tax imposedon foundation managers. ► $ N/A

Has the foundation engaged in any activities that have not previously been reported to the IRS? . . . .

If "Yes," attach a detailed description of the activities.Has the foundation made any changes , not previously reported to the IRS, in its governing instrument , articles ofincorporation , or bylaws , or other similar instruments ? If "Yes ," attach a conformed copy of the changes . .

Did the foundation have unrelated business gross income of $1 ,000 or more during the year? . . . . .

If "Yes," has it filed a tax return on Form 990-T for this year? . . . . . . . . . . . . . . . .

Was there a liquidation , termination , dissolution, or substantial contraction during the year? . . . . .

If "Yes," attach the statement required by General Instruction T.

Are the requirements of section 508(e) (relating to sections 4941 through 4945) satisfied either:

• By language in the governing instrument, or• By state legislation that effectively amends the governing instrument so that no mandatory directions thatconflict with the state law remain in the governing instrument ? . . . . . . . . . . . . . . .

Did the foundation have at least $5,000 in assets at any time during the year? If "Yes," complete Part II, col. (c), and Part XV

Enter the states to which the foundation reports or with which it is registered . See instructions. ►- - NEW YORK

- °° °- - - - -----

-------------°----------------------------------------------------------------------If the answer is "Yes" to line 7,

-has----the foundation furnished a copy of Form 990-PF to the Attorney General

(or designate) of each state as required by General Instruction G? If "No," attach explanation . . . . .

Is the foundation claiming status as a private operating foundation within the meaning of section 49426)(3) or4942Q)(5) for calendar year 2017 or the tax year beginning in 2017? See the instructions for Part XIV . If "Yes,"complete Part XIV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Did any persons become substantial contributors during the tax year? If "Yes," attach a schedule listing theirnames and addresses . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes No

1a 3

1b 3

1c F-T 3

0-'A

7 3

8b 3

9 3 2,-1101 1 3

Form 990-PF (2oi 7)

Form99O-PF(20i7) The Harry T. Mangurian, Jr. Foundation, Inc. EIN: 16-1578255 Page5

111111 Statements Regarding Activities (continued)Yes No

11 At any time during the year, did the foundation, directly or indirectly, own a controlled entity within the

meaning of section 512(b)(13)? If "Yes," attach schedule. See instructions . . . . . . . . . . . 11 3

12 Did the foundation make a distribution to a donor advised fund over which the foundation or a disqualifiedperson had advisory privileges? If "Yes," attach statement. See instructions . . . . . . . . . . . 12 3

13 Did the foundation comply with the public inspection requirements for its annual returns and exemption application? 13 3

Website address ► N / A-----------------------------------------------------------------------------------------------------------------------------------------------

14 The books are in care of ► STEPEHN G. MEHALLIS & BETH P. PIANA Telephone no. Op- (954) 491-1722---------------------------------- - - - - - - - ----------------------------------

Located at ► 3696 NORTH FEDERAL HIGHWAY, SUITE 300, FORT LAUDERDALE, FLORIDA ZIP+4 ► 33308-6263

15 Section 4947(a)(1) nonexempt charitable trusts filing Form 990-PF in lieu of Form 1041-check here . . . . . ► q

and enter the amount of tax-exempt interest received or accrued during the year . . . . . ► 15 N I A16 At any time during calendar year 2017, did the foundation have an interest in or a signature or other authority Yes No

over a bank, securities, or other financial account in a foreign country?. . . . 16 3See the instructions for exceptions and filing requirements for FinCEN Form 114. If "Yes,' enter the name ofthe foreign country ► N/A

' Statements Regarding Activities for Which Form 4720 May Be RequiredFile Form 4720 if any item is checked In the "Yes" column, unless an exception applies. Yes No

I a During the year, did the foundation (either directly or indirectly):(1) Engage in the sale or exchange, or leasing of property with a disqualified person? . . q Yes [D No(2) Borrow money from, lend money to, or otherwise extend credit to (or accept it from) a

disqualified person? . . . . . . . . . . . . . . . . . . . . . . . q Yes 2] No(3) Furnish goods, services, or facilities to (or accept them from) a disqualified person? . . q Yes No(4) Pay compensation to, or pay or reimburse the expenses of, a disqualified person? . . q Yes 0 No(5) Transfer any income or assets to a disqualified person (or make any of either available for

the benefit or use of a disqualified person)? . . . . . . . . . . . . . . . q Yes 2] No

(6) Agree to pay money or property to a government official? (Exception . Check "No" if thefoundation agreed to make a grant to or to employ the official for a period aftertermination of government service, if terminating within 90 days.) . . . . . . . . q Yes No

b If any answer is "Yes" to 1 a(1)--(6), did any of the acts fail to qualify under the exceptions described in Regulationssection 53.4941 (d)-3 or in a current notice regarding disaster assistance? See instructions . . . . . . . 1 b N A

Organizations relying on a current notice regarding disaster assistance, check here . . . . . . ► q

c Did the foundation engage in a prior year in any of the acts described in 1 a, other than excepted acts, thatwere not corrected before the first day of the tax year beginning in 2017? . . . . . . . . . . . I c 3

2 Taxes on failure to distribute income (section 4942) (does not apply for years the foundation was a privateoperating foundation defined in section 49426)(3) or 49420)(5)):

a At the end of tax year 2017, did the foundation have any undistributed income (lines 6d and6e, Part XIII) for tax year(s) beginning before 2017? . . . . . . . . . . . . . . 21 NoIf "Yes," list the years ► 20 , 20 , 20 , 20

----- ---- ------ ------b Are there any years listed in 2a for which the foundation is not applying the provisions of section 4942(a)(2)

(relating to incorrect valuation of assets) to the year's undistributed income? (If applying section 4942(a)(2) toall years listed, answer "No" and attach statement-see instructions.) . . . . . . . . . . . . . 2b N/A

c If the provisions of section 4942(a)(2) are being applied to any of the years listed in 2a, list the years here.► 20 , 20 , 20 , 20

----- ----- ------3a Did the foundation hold more than a 2% direct or indirect interest in any business enterprise

at any time during the year? . . . . . . . . . . . . . . . . . . . . . . q Yes Q No

b If "Yes," did it have excess business holdings in 2017 as a result of (1) any purchase by the foundation ordisqualified persons after May 26, 1969; (2) the lapse of the 5-year period (or longer period approved by theCommissioner under section 4943(c)(7)) to dispose of holdings acquired by gift or bequest; or (3) the lapse ofthe 10-, 15-, or 20-year first phase holding period? (Use Schedule C, Form 4720, to determine if thefoundation had excess business holdings in 2017.) . . . . . . . . . . . . . . . . . 3b N/A

4a Did the foundation invest during the year any amount in a manner that would jeopardize its charitable purposes? 4a 3

b Did the foundation make any investment in a prior year (but after December 31, 1969) that could jeopardize itscharitable purpose that had not been removed from jeopardy before the first day of the tax year beginning in 2017? 4b 3

Form 990-PF (2017)

Form 990-PF (2017) The Harry T. Mangurian , Jr. Foundation, Inc. MEN: 16-1578255

' Statements Regarding Activities for Which Form 4720 May Be Required (continued)

Page6

5a During the year, did the foundation pay or incur any amount to: Yes No

(1) Carry on propaganda, or otherwise attempt to influence legislation (section 4945(e))? q Yes 0 No

(2) Influence the outcome of any specific public election (see section 4955); or to carry on,directly or indirectly, any voter registration drive? . . . . . . . . . . . . . q Yes No

(3) Provide a grant to an individual for travel, study, or other similar purposes? . . . . . q Yes [D No(4) Provide a grant to an organization other than a charitable, etc., organization described in

section 4945(d)(4)(A)? See instructions . . $E IBIT K , , , , . . . . Yes q No(5) Provide for any purpose other than religious, charitable, scientific, literary, or educational

purposes, or for the prevention of cruelty to children or animals? . . . . . . . . Nob If any answer is "Yes" to 5a(1}{5), did any of the transactions fail to qualify under the exceptions described in

Regulations section 53.4945 or in a current notice regarding disaster assistance? See instructions . . . . . 5b 3

Organizations relying on a current notice regarding disaster assistance, check here . . . . . . ► q

c If the answer is "Yes" to question 5a(4), does the foundation claim exemption from the taxbecause it maintained expenditure responsibility for the grant? . . SEE. EH.IRIT K . Yes q No

If "Yes," attach the statement required by Regulations section 53.4945-5(d).6a Did the foundation, during the year, receive any funds, directly or indirectly, to pay premiums

on a personal benefit contract? . . . . . . . . . . . . . . . . . . . . q Yes No

b Did the foundation, during the year, pay premiums, directly or indirectly, on a personal benefit contract? . 6b 3

If "Yes" to 6b, file Form 8870.7a At any time during the tax year, was the foundation a party to a prohibited tax shelter transaction? q Yes 0 No

b If "Yes," did the foundation receive any proceeds or have any net income attributable to the transaction? . 7b N/A

and Contractors1 List all officers , directors, trustees , and foundation managers and their compensation . See instructions.

(a) Name and address(b) Title, and average

hours per weekdevoted to position

(c) Compensation(If not paid,enter -0-)

(d) Contributions toemployee benefit plans

and deferred compensation

(e) Expense account,other allowances

SEE EXHIBIT E----------------------------------------------------------------

-------------------------------------------------------------------------

-------------------------------------------------------------------------

-------------------------------------------------------------------------

2 Compensation of five highest-paid employees (other than those included on line 1-see instructions). If none, enter"NONE."

(a) Name and address of each employee paid more than $50,000(b) Title, and average

hours per weekdevoted to position

(c) Compensation

(d) Contributions toemployee benefitPlans and deferredcompensation

(e) Expense account,other allowances

-------------------- NONE---- --------------------------------------------------

-----------------------------------------------------------------------------------

-----------------------------------------------------------------------------------

-----------------------------------------------------------------------------------

-----------------------------------------------------------------------------------

Total number of other employees paid over $50,000 ► 0Form 9WPF (2017)

Form 990-PF (2017) The Harry T. Mangurian, Jr. Foundation, Inc. EIN: 16-1578255

' Information About Officers , Directors, Trustees, Foundation Managers , Highly Paid Employees,

and Contractors (continued)3 Five highest-paid independent contractors for professional services. See instructions. If none, enter "NONE."

(a) Name and address of each person paid more than $50,000 (b) Type of service (c) Compensation

NONE------------------------------------------------

-----------------------------------------------------------------------------------------------------------

-----------------------------------------------------------------------------------------------------------

-----------------------------------------------------------------------------------------------------------

-----------------------------------------------------------------------------------------------------------

Total number of others receiving over $50,000 for professional services . P o

' • Summary of Direct Charitable Activities

list the foundation's four largest direct charitable activities during the tax year. Include relevant statistical information such as the number of

I

n

organizations and other beneficiaries served, conferences convened, research papers produced, etc.

1 NONE

2

3

4

(see instructions)Describe the two largest program-related investments made by the foundation during the tax year on lines 1 and 2 . Amount

NONE---°-----------------------------

-----------------------------------------------------------------------------------------------------------------------------------------------------

2 ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

All other program -related investments . See instructions.

3NONE

- - ° - - - ---- ° -

----------------------------------------------------------------------------------------------------------------------------------------------------

Total . Add lines 1 through 3 ► 0Form 990-PF (2017)

Fon„ 99o-PF (2017) The Harry T. Mangurian, Jr. Foundation, Inc. EIN: 16-1578255

• Minimum Investment Return (All domestic foundations must complete this part. Foreign foundations,see instructions.)

1 Fair market value of assets not used (or held for use) directly in carrying out charitable, etc.,purposes:

a Average monthly fair market value of securities . . . . . ffiIBIT F . _ . . , . . 1a 144,698,440

b Average of monthly cash balances . . . . . . . . . X IBBI,T G . . . . . . . 1b 2,143,602

c Fair market value of all other assets (see instructions) . . . SEE BELOW . . . . . . . 1c 10,228d Total (add lines 1a, b, and c) . . . . . . . . . . . . . . . . . . . . . 1d 146,852,270e Reduction claimed for blockage or other factors reported on lines 1 a and

1c (attach detailed explanation). . . . . . . . . . . . . 1e 02 Acquisition indebtedness applicable to line 1 assets . . . . . . . . . . . . . . . . 2 03 Subtract line 2 from line 1d . . . . . . . . . . . . . . . . . . . . . . . . 3 146,852,2704 Cash deemed held for charitable activities. Enter 1 V2% of line 3 (for greater amount, see

instructions) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 2,202,784

5 Net value of noncharitable-use assets. Subtract line 4 from line 3. Enter here and on Part V, line 4 5 144 ,649 ,4866 Minimum investment return . Enter 5% of line 5 . 6 7 , 232 , 474

• Distributable Amount (see instructions) (Section 4942(1)(3) and (I)(5) private operating foundationsand certain foreign organizations, check here ► q and do not complete this part.)

1 Minimum investment return from Part X, line 6 . . . . . . . . . . . . . 1 7,232,474

2a Tax on investment income for 2017 from Part VI, line 5 . . . . . . . 2a 72,107

b Income tax for 2017. (This does not include the tax from Part VI.) . . . 2b 0c Add lines 2a and 2b . . . . . . . . . . . . . . . . . . . . . . . . . . 2c 72 , 107

3 Distributable amount before adjustments. Subtract line 2c from line 1 . . . . . . . . . . 3 7.160;3674 Recoveries of amounts treated as qualifying distributions . . . . . . . . . . . . . . 4 0

5 Add lines 3 and 4 . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 7,160,367

6 Deduction from distributable amount (see instructions) . . . . . . . . . . . . . . . 6 07 Distributable amount as adjusted. Subtract line 6 from line 5. Enter here and on Part XIII,

line 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 7 , 160, 367

Qualifying Distributions (see instructions)

1 Amounts paid (including administrative expenses) to accomplish charitable, etc., purposes:

a Expenses, contributions, gifts, etc.-total from Part I, column (d), line 26 . . . . . . . . . 1a 8,709,286

b Program-related investments-total from Part IX-B . . . . . . . . . . . . . . lb 02 Amounts paid to acquire assets used (or held for use) directly in carrying out charitable, etc.,

purposes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 0

3 Amounts set aside for specific charitable projects that satisfy the:

a Suitability test (prior IRS approval required) . . . . . . . . . . . . . . . . . . . 3a 0

b Cash distribution test (attach the required schedule) . . . . . . . . . . . . . . . . 3b 04 Qualifying distributions . Add lines 1 a through 3b. Enter here and on Part V, line 8; and Part All, line 4 4 8, 709,2865 Foundations that qualify under section 4940(e) for the reduced rate of tax on net investment income.

Enter 1 % of Part I, line 27b. See instructions . . . . . . . . . . . . . . . . . . 5 72,107

6 Adjusted qualifying distributions . Subtract line 5 from line 4 . . . . . . . . . . . . 6 8 , 637 , 179

Note: The amount on line 6 will be used in Part V, column (b), in subsequent years when calculating whether the foundationqualifies for the section 4940(e) reduction of tax in those years.

Form 990-PF (2ol 7)PART X, LINE 1(c):

From Part II - Balance Sheet:

Prepaid Insurance 2,926Deposits 5,406

Other Assets 8,332

Land, Buildings & Equipment 33,546Less: Accum. Depreciation (31,650)

Net Land, Bldgs. & Equip. 1,896

Fair Market Value - All Other Assets 10,228

Form 990-PF(2017) The Harry T . Mangurian , Jr. Foundation, Inc.

1 Distributable amount for 2017 from Part XI,line 7 . . . . . . . . . . . . .

2 Undistributed income, if any, as of the end of 2017:

a Enter amount for 2016 only . . . . . .b Total for prior years: 20 15 ,20 14 ,20 13

3 Excess distributions carryover, if any, to 2017:

a From 2012 . . . . . .

b From 2013 . . . .c From 2014 . . . . .

d From 2015 . . . . .e From 2016 . . . . . .

f Total of lines 3a through e . . . . . .4 Qualifying distributions for 2017 from Part XII,

line 4:110- $ 8, 709,286

a Applied to 2016, but not more than line 2ab Applied to undistributed income of prior years

(Election required-see instructions) . . .

c Treated as distributions out of corpus (Electionrequired-see instructions) . . . . . .

d Applied to 2017 distributable amount . .e Remaining amount distributed out of corpus

5 Excess distributions carryover applied to 2017(If an amount appears in column (d), the sameamount must be shown in column (a).)

8 Enter the net total of each column asindicated below:

a Corpus. Add lines 3f, 4c, and 4e. Subtract line 5b Prior years' undistributed income. Subtract

line 4b from line 2b . . . . . . . .

c Enter the amount of prior years' undistributedincome for which a notice of deficiency hasbeen issued, or on which the section 4942(a)tax has been previously assessed . . . .

d Subtract line 6c from line 6b. Taxableamount-see instructions . . . . . .

e Undistributed income for 2016. Subtract line4a from line 2a. Taxable amount-seeinstructions . . . . . . . . . . .

f Undistributed income for 2017. Subtract lines4d and 5 from line 1. This amount must be

• distributed in 2018 . . . . . . . . .

7 Amounts treated as distributions out of corpusto satisfy requirements imposed by section170(b)(1)(F) or 4942(g)(3) (Election may berequired-see instructions) . . . . . .

8 Excess distributions carryover from 2012 notapplied on line 5 or line 7 (see instructions) .

9 Excess distributions carryover to 2018.Subtract lines 7 and 8 from line 6a . . .

10 Analysis of line 9:

a Excess from 2013 .

b Excess from 2014 .

c Excess from 2015 .d Excess from 2016 .e Excess from 2017 .

EIN: 16-1578255 Page9

(a) (b) I (c) I (d)Corpus Years pnor to 2016 2016 2017

6,518,731

0

0

2.190,555

0

0 0

0

0

0

Form 9,'A)-11`11- (2017)

Form 990-PF(2017) The Harry T. Mangurian , Jr. Foundation , Inc. EIN : 16-1578255

LZEM Private Operating Foundations (see instructions and Part VII-A, question 9)

1 a If the foundation has received a ruling or determination letter that it is a private operating

I Afoundation , and the ruling is effective for 2017, enter the date of the ruling N I A

b Check box to indicate whether the foundation is a private operating foundation described in section q 49420)(3) pr q 4942(j)(5)

2a Enter the lesser of the adjusted netincome from Part I or the minimuminvestment return from Part X foreach year listed . . . . . . .

b 85% of line 2a . . . . . . .

c Qualifying distributions from Part XII,

line 4 for each year listed . . . .

d Amounts included in line 2c not used directly

for active conduct of exempt actmties . .

e Qualifying distributions made directly

for active conduct of exempt activities.

Subtract line 2d from line 2c . . .

3 Complete 3a, b, or c for the

alternative test relied upon:

a "Assets" alternative test-enter.

(1) Value of all assets . . . . .

(2) Value of assets qualifying under

section 49420)(3)(B)(i) . . . .b "Endowment" alternative test-enter 2/3

of minimum investment return shown inPart X, line 6 for each year listed . . .

c "Support" alternative test-enter:

(1) Total support other than grossinvestment income (interest,dividends, rents, payments onsecurities loans (section512(a)(5)), or royalties) . . . .

(2) Support from general publicand 5 or more exemptorganizations as provided insection 4942(j)(3)(B)(iii) . . . .

(3) Largest amount of support froman exempt organization . . .

(4) Gross investment income .' Supplementary Information (Complete this part only if the foundation had $5,000 or more in assets at

any time during the year-see instructions.)1 Information Regarding Foundation Managers:a List any managers of the foundation who have contributed more than 2% of the total contributions received by the foundation

before the close of any tax year (but only if they have contributed more than $5,000). (See section 507(d)(2).)

HARRY T. MANGURIAN, JR. (DECEASED 1011912008

b List any managers of the foundation who own 10% or more of the stock of a corporation (or an equally large portion of theownership of a partnership or other entity) of which the foundation has a 10% or greater interest.

NONE

2 Information Regarding Contribution , Grant , Gift, Loan , Scholarship, etc., Programs:

Check here ► q if the foundation only makes contributions to preselected charitable organizations and does not acceptunsolicited requests for funds. If the foundation makes gifts, grants, etc., to individuals or organizations under other conditions,complete items 2a, b, c, and d. See instructions.

a The name, address, and telephone number or email address of the person to whom applications should be addressed:

GORDON W. LATZ, VICE PRESIDENT-GRANTS, 3696 NORTH FEDERAL HIGHWAY, SUITE 300, FORT LAUDERDALE, FLORIDA 33308-6263(954) 491-1722

b The form in which applications should be submitted and information and materials they should include:

SEE EXHIBIT L - GRANT GUIDELINES 1 GRANT APPLICATION

c Any submission deadlines:

SEE EXHIBIT L - GRANT GUIDELINESd Any restrictions or limitations on awards, such as by geographical areas, charitable fields, kinds of institutions, or other

factors:

SEE EXHIBIT L - GRANT GUIDELINES

Tax year Prior 3 years(e) Total

(a) 2017 (b) 2016 (c) 2015 (d) 2014

1

Form 990-PF (2017)

Form 990-PF (2017) The Harry T. Mangurian , Jr. Foundation , Inc. EIN: 16-1578255 Page11

3 Grants and Contributions Paid During the Year or Anoroved for Future Payment

Recipient recipient is an individual.show any relationship to

Foundationofm

us ofPurpose of grant or

Amount

Name and address (home or business)any foundation manageror substantial contributor

r^ contribution

a Paid during the year

SEE EXHIBIT H

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Total ► 3a 8 , 130 ,260

b Approved for future payment

SEE EXHIBIT J

Total P, 3101 12 , 405,000Form 990-PF (2017)

Form 990-PF (2017) The Harry T. Mangurian, Jr. Foundation, Inc. EIN: 16-1578255 page 12

Analysis of Income-Producing ActivitiesEnter gross amounts unless otherwise indicated. Unrelated business income Excluded by section 512, 513, or 514 (e)

Related or exempt(a) (b) (c) (d) function income

Business code Amount Exclusion code Amount (See instructions.)1 Program service revenue:

abCdef

g Fees and contracts from government agencies

2 Membership dues and assessments . . . .3 Interest on savings and temporary cash investments 18,2854 Dividends and interest from securities . . . . 3,633,4635 Net rental income or (loss) from real estate:

a Debt-financed property . . . . . . .

b Not debt-financed property . . . . . .

6 Net rental income or (loss) from personal property

7 Other investment income . . . . . . . .

8 Gain or (loss) from sales of assets other than inventory 3,181,459

9 Net income or (loss) from special events . . .10 Gross profit or (loss) from sales of inventory11 Other revenue : a Miscellaneous income 411

b Class Action Settlement income 3,970

C

de

12 Subtotal. Add columns (b), (d), and (e) . . 0 0 6,837 588

13 Total. Add line 12, columns (b), (d), and (e) . . . . . . . . . . . . . . . . . . 13 6,837,588See worksheet in line 13 instructions to verify calculation

Relationship of Activities to the A

s.)

ccomplishment of Exempt Purposesline No.

♦Explain below how each activity for which income is reported in column (e) of Part XVI-A contributed importantly to theaccomplishment of the foundation s exempt purposes (other than by providing funds for such purposes). (See instructions.)

8&11 ALLOW IT TO ADDRESS THE NEEDS OF VARIOUS QUALIFYING I.R.C. SECTION 501 (c)(3) CHARITABLE ORGANIZATIONS

VIA CONTRIBUTIONS / GRANTS / GIFTS.

Form 9W-F1- (2017)

Form 990-Kpow) The Harry T. Mangurian, Jr. Foundation, Inc. EIN: 16-1578255 ' Information Regarding Transfers to and Transactions and Relationships With Noncharitable Exempt

1 Did the organization directly or indirectly engage in any of the following with any other organization describedin section 501(c) (other than section 501(c)(3) organizations) or in section 527, relating to politicalorganizations?

a Transfers from the reporting foundation to a noncharitable exempt organization of:(1) Cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . la(1) 3

(2) Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . la(2) 3

b Other transactions:(1) Sales of assets to a noncharitable exempt organization . . . . . . . . . . . . . . . . 1b(1) 3

(2) Purchases of assets from a noncharitable exempt organization . . . . . . . . . . . . . . lb(2) 3

(3) Rental of facilities, equipment, or other assets . . . . . . . . . . . . . . . . . . . lb(3) 3

(4) Reimbursement arrangements . . . . . . . . . . . . . . . . . . . . . . . . . lb(4) 3

(5) Loans or loan guarantees . . . . . . . . . . . . . . . . . . . . . . . . . . lb(5) 3

(6) Performance of services or membership or fundraising solicitations . . . . . . . . . . . . I b(6)6 3

c Sharing of facilities, equipment, mailing lists, other assets, or paid employees . . . . . . . . . . 1c 3

d If the answer to any of the above is "Yes," complete the following schedule. Column (b) should always show the fair marketvalue of the goods, other assets, or services given by the reporting foundation. If the foundation received less than fair marketvalue in any transaction or sharing arrangement, show in column (d) the value of the goods, other assets, or services received.

(a) Name of organization (b) Type of organization (c) Description of relationship

NIA N/A N/A

Under et le of pequry I declare that I^Conn, rid late. of r (^Sign

t fHere

officer or stee S. C.

PaidPnnt/Type pr rs name

Prc nary r

ined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is true,r than taxpayer) is ased o 1 i lion of which preparer has any knowledge.

D the IRS d^sousa this return

I Date

Preparer's sgnatur

described in section 501(c) (other than section 501 (c)(3)) or in section 527? . . . . . . . . . . . q Yes ® Nob If "Yes," complete the following schedule.

THE HARRY T. MANGURIAN, JR. FOUNDATION, INC.FEDERAL TAX I.D. # 16-1578255FORM 990-PF - PART I, LINES 16a , 16c, 18 and 23OPERATING & ADMINISTRATIVE EXPENSES - COLUMN (a)FOR THE YEAR ENDED DECEMBER 31, 2017

LINE DESCRIPTION

16a Legal Fees : Louis C . Anderson , L.L.C.Legal Fees: McConville , Considine, Cooman & Morin, P.C.Legal Fees: Reimbursement by Philadelphia Insurance Co,

TOTAL

16b Accounting Fees: Ruderman & Company

TOTAL

16c Other Professional Fees:- Goldman Sachs - Gov't/Corp. F.I. Acct - Invest . Mgmt. Fees- Goldman Sachs - Enh. Div . Tax Ex. Acct - Invest. Mgmt. Fees- Goldman Sachs - Adv. All Acct - Invest. Mgmt. Fees- Goldman Sachs - Spec . Inv. Acct - Invest. Mgmt. Fees- Goldman Sachs - H. Y. Corp. F.I. Acct - Invest. Mgmt. Fees- Goldman Sachs - Delaware Acct - Invest. Mgmt. Fees

- Goldman Sachs - Lazard Acct - Invest . Mgmt. Fees- Goldman Sachs - Invesco Acct - Invest Mgmt. Fees

TOTAL

18 Taxes:- Federal Excise Tax - 2016- Federal Excise Tax Refund - 2016- Federal Excise Tax - 2017- Payroll Taxes

TOTAL

23 Other Expenses:- Dues , Subscriptions & Memberships- New York State Filing Fee- Office Supplies / Office Expense- Postage Expense- Computer Processing- Property / Liability Insurance Expense- Group Health Insurance Expense- Worker's Comp. Insurance Expense- Meals & Entertainment Expense

**SEE ATTACHMENT - Amortizatidh of Bond Premiums - H.Y. Corp . F.I. Acct`

TO EXHIBIT A** - Amortization of Bond Premiums - Govt/Corp. F.I. Acct'*

TOTAL

EXHIBIT A

EXHIBIT A

AMOUNT

5,50911,460(34,106)

(17,137)

1,318

1,318

116,361120,74589,45525,09839,21876,96543,02425,252

536,118

23,000(995)

77,00029,696

128,701

12,8111,5006,237728

2,4895,049

42,4111,4546,48518,764

195,656

293,584

THE HARRY T. MANGURIAN, JR. FOUNDATION, INC. - TAX ID # 16-1578255AMORTIZATION OF BOND PREMIUMS - GOV/CORP F.I. ACCOUNT2017 FORM 990-PF, PAGE 1, LINE 23, COLUMN A - OTHER EXPENSES

Total Accumulated Amortization as of 12/31/2017

LESS:

Amortization Expense F/Y/EAmortization Expense F/Y/EAmortization Expense F/Y/EAmortization Expense F/Y/EAmortization Expense F/Y/EAmortization Expense F/Y/EAmortization Expense F/Y/EAmortization Expense F/Y/E

12/31/201612/31/201512/31/201412/31/201312/31/201212/31/201112/31/201012/31/2009

(680,881) *

222,128260,452379,522460,223437,228388,434202,153209,631

PLUS:

Amortization Exp. on Bonds bought in 2009, 2013 & 2015 and sold in 2017Amortization Exp. on Bonds bought in 2009 through 2016 & sold in 2016Amortization Exp. on Bonds bought in 2009 through 2014 & sold in 2015Amortization Exp. on Bonds bought in 2009 through 2013 & sold in 2014

Amortization Exp. on Bonds bought in 2009 through 2013 & sold in 2013



(190,363) **(272,885)(398,727)(461,501)(234,865)(335,921)( 180,284)

TOTAL AMORTIZATION EXPENSE FOR THE YEAR ENDED 12/31/2017 (19

* See Attachment to Exhibit A, Page 6 of 21

** See Attachment to Exhibit A, Page 7 of 21

ATTACHMENT TO EXHIBITAPage 1 of 21

THE HARRY T. MANGURIAN , JR. FOUNDATION , INC. - EIN : 16-1578255

AMORTIZATION OF BOND PREMIUMS - GOV/CORP F.I. ACCOUNT

2017 FORM 990-PF, PAGE 1, LINE 23, COLUMN A - OTHER EXPENSES

'gyn. i ', e+^' }:^"'G• ti 'tn' ` ``' S_"S,; ,w `tea ^•-^ ^S +axN.y

.o.f^.;i;,..,,^.,err

,'_e^^.- da:r+w^b^^^'''^^a^^;^*^4!1'.7.^1'ils:4'^{^^`^^..<'.,:^h`;^f3.^v^'^y^.`F^ .^'^'oi .,'<<;:'-.^_?.`'^•,,

ax Lots

2009 - 2017

TOTAL

ACCUMULATEDAMORTIZATION

:G > +^X{:+OtS `•['(, .b;r;iktit •x fir.. l ,, ^ .^, , . # ^^ z ,, r= ;;,,' Sepatatt:.Account} trqtegy

k,,. rs ;t+ x^ '<<4, -Qoverll>IrrientlCorpo^altA,;FlAed,Income,'''BAae:Cdrrency 'IISD

Description Symbol Trade Date Qty Latest Price Mkt Val (Base) Original Cost with Original Cost Unrlzd Gain/Loss Unit Cost Accretion /Amortization

(Base ) OID(Base ) (Base ) ( Base ) ( Base) (Base)

EXXON MOBIL 4RHFY6 2015-06-17 1,500,000 99 8400 1,497,600 00 1,503,420 000 1,503.420 000 -3,533 02 100 0755 -2,28698

CORPORATION 1 819%03/152019 USD SR LIEN

KEYBANK NATIONAL 3V97Y0 2013-01-29 1,400,000 99 9740 1,399,636 00 1,398,656 000 1,398,656 000 980 00 99 9040 0 00

ASSOCIATION 1 65%02/012018 SER BKNT SRLIEN

BANK OF AMERICA 4RLA22 2015-04-16 1,300,000 100 5680 1,307,384 00 1,328,860 000 1,328,860 000 -2,01371 100 7229 -19,46229

CORPORATION MTN2 65% 04/01/2019 USD SERL SR LIEN

CBS CORP 2 3% 6VAJ12 2014-08-12 1,300,000 99.9300 1,299,090 00 1,296,048 000 1,296,048 000 3,042 00 99 6960 0 00

08/15/2019 USD SR LIEN

AMERICA MOVIL SAB DE 3JHQW9 2012-09-19 1,100,000 104 5200 1,149,720 00 1,283,414 000 1,283,414 000 222 95 104 4997 -133,916 95

CV 5 0% 10/16/2019 USDSER B SR LIEN

HOST HOTELS & 11-19WL0 2014-07-02 1,000,000 109 9290 1,099,290 00 1,151,360 000 1,151,360 000 15,913 30 108 3377 -67,983 30

RESORTS, L P 6 0%10/01/2021 USD SER Z SRLIEN

ONTARIO (PROVINCE OF) 3JYRU5 2012-07-18 975,000 103 1110 1,005,332 25 1,119,329 250 1,119,329 250 -6,787 55 103 8072 -107,20945

4 0% 10107/2019 USD SRLIEN

CNA FINANCIAL 3JHE51 2016-01-20 1,000,000 1081670 1,081,670 00 1,118,380.000 1,118,380 000 11,484 05 107 0206 -48,174 05

CORPORATION 5 875%08/152020 USD SR LIEN

AGILENT TECHNOLOGIES, 3JGZJ0 2013-12-19 1,000.000 106 1840 1,061,840 00 1,083,060 000 1,083,060 000 27,353 15 103 4487 -48,573 15

INC 5 0% 07115/2020 USDSR LIEN

ATTACHMENT TO EXHIBIT A

Page 2 of 21

THE HARRY T. MANGURIAN, JR. FOUNDATION, INC. - EIN: 16-1578255


2017 FORM 990-PF, Page 1, Line 23, Column A - OTHER EXPENSES

2009 - 2017

TOTALACCUMULATEDAMORTIZATION

Description Symbol Trade Date City Latest Price Mkt Val ( Base ) Original Cost with Original Cost Unrizd Gain/Loss Unit Cost Accretion/Amortization

(Base ) OID (Base) (Base ) (Base ) ( Base ) ( Base)

I HE BOEING COMPANY 5VHSJ7 2017-05-23 1,000,000 100 9500 1,009,500 00 1,012,610 000 1,012,610 000 -2,193 35 101 1693 -916 65

2.85% 1 0130/2024 USD SRIEN

SYNCHRONY FINANCIAL 4XY4MO 2014-08-13 1,000,000 102 5410 1,025,410 00 1,009,090 000 1,009,090 000 20,410 27 100 5000 -4,09027

3 75% 08115/2021 USD SRIEN

ERIZON 6VY215 2015-03-18 1,000,000 101 1180 1,011,18000 1,007,710 000 1,007,710000 6,51878 1004661 -3,04878

OMMUNICATIONS INC0% 11/0112021 USD SRIEN

WELLS FARGO & 2000L4 2016-02-26 1,000,000 99 9540 999,540 00 999,770 000 999,770 000 -230 00 99 9770 0 00

OMPANY25%3/04/2021 USD SR LIEN

MANITOBA (PROVINCE 11L656 2013-03-21 1,000,000 99 7520 997.520 00 999,000 000 999,000 000 -1,48000 99 9000 0 00

^OF) 1 125% 06/01/2018 SRLIEN

'US TREASURY NOTE TN13720 2013-12-24 1.050,000 98 7190 1,036,549 50 995,818 360 1,185,498 050 7,81245 97 9750 32.918 69

1 375000% 05/31/2020 MNON THE RUN

MERCK SHARP & DOHME 906SW8 2015-03-17 1,000,000 99 8660 998,660 00 988,670 000 988,670 000 9,99000 98 8670 0 00

CORP 2 35% 02/10/2022USD SR LIEN

U S TREASURY NOTE TN16252J 2016-11-09 1,000,000 96 5430 965,430 00 986,640 620 986,640 620 -21,21062 98 6641 0 00

1 625000% 10/31/2023 AOON THE RUN

U S. TREASURY NOTE TN2524 2016-12-15 950,000 101 1290 960,725 50 951,855 460 951,855 460 9,101 86 100 1709 -231 82

2 500000% 05/15/2024 MNOFF THE RUN

TARGET CORPORATION 4XJTH7 2017-03-03 925,000 104 2560 964,368 00 951,399 500 951,399 500 15,589 91 102 5706 -2,621 41

3 5% 07/01/2024 USD SRLIEN

FEDERAL HOME LOAN 44JNR3 2017-07-25 900,000 102 8010 925,209 00 933,399 000 933,399 000 -6,26441 103 4970 -1,925 59

BANK SYSTEM 2.875%06/14/2024 SER RK-2024SR LIEN

XILINX INC 2 95% ABOMC9 2017-05-24 925,000 99 3760 919,228 00 923,954 750 923,954 750 -4,726 75 99 8870 0 00


2


Page 3 of 21

THE HARRY T. MANGURIAN , JR. FOUNDATION, INC. - EIN: 16-1578255



2009 - 2017

TOTAL


Description Symbol Trade Date Qty Latest Price Mkt Val (Base ) Original Cost with Original Cost Unrizd Gain/Loss Unit Cost Accretion/Amortization

(Base ) OID(Base ) ( Base) (Base ) ( Base) (Base)

CAPITAL ONE, NATIONAL 4X2ME8 2014-07-21 925,000 100 5960 930,513 00 922,391 500 922.391 500 8,121 50 99 7180 0 00

ASSOCIAT 2 95%072312021 USD SER BNKTSR LIEN

WAL-MART STORES. INC 3JE6F5 2009-03-23 750,000 100 4420 753,315 00 824,175 000 824,175 000 2,06782 100 1663 -72,92782

5 8% 02/152018 SR LIEN

US TREASURY NOTE TN18722H 2016-02-26 800,000 98 5940 788,752.00 818,093 600 818,093 600 -24,404 77 101 6446 -4,93683

1 875000% 08/312022 FAOFF THE RUN

AT&T INC 3 8% 03/15/2022 2DTRS9 2016-03-21 775,000 103 3490 800,954 75 789,585 500 789,585 500 11,369 25 101 8820 0 00

USD SER WI SR LIEN

FORD MOTOR CREDIT 5MW633 2013-11-06 700,000 101 0180 707,126 00 775.558 000 775,558 000 56560 100 9372 -68,99760

COMPANY LLC 5 0%05115/2018 SR LIEN

UNITED PARCEL 3JUGC5 2009-03-23 750,000 103 7180 777,885 00 753,022 500 753,022 500 27,418 61 100 0622 -2,556 11

SERVICE, INC 5 125%04/01/2019 USD SR LIEN

CITIGROUP INC 2 7% 2DU683 2016-03-22 750.000 100 3040 752,280 00 748,920 000 748,920 000 3,36000 99 8560 0 00


CAPITAL ONE BANK 111189 2016-03-23 750,000 100 9870 757,402 50 748,792 500 748,792 500 8,61000 99 8390 0 00

(USA), NATION 3 375%02/15/2023 USD SUB LIEN

DR PEPPER SNAPPLE 3VIJE1 2016-01-19 750,000 99 2180 744,135 00 736,320 000 736,320 000 1.31463 99 0427 6,50037

GRP INC 2 0% 01/15/2020USD SR LIEN

LYONDELLBASELL 4USOG3 2013-05-21 622,000 102 6730 638,826 06 704,999 680 1,418,800 000 -2,58927 103 0893 -63,784 35

INDUSTRIES N V. 5 0%04/15/2019 USD SER B SRLIEN

PNC BANK, NATIONAL 2RNKS4 2015-10-29 675,000 100 1500 676,012 50 674,554 500 674,554 500 1,45800 999340 0 00

ASSOCIATION 2 45%11/05/2020 USD SER BKNTSR LIEN

AMAZON COM INC 3 3% 9WMTY3 2014-12-03 675,000 103 2690 697,065 75 674,163 000 674,163 000 22,902 75 99.8760 0.00

12/052021 USD SR LIEN


Page 4 of 21

THE HARRY T. MANGLJRIAN, JR. FOUNDATION, INC. - EIN: 16-1578255

AMORTIZATION OF BOND PREMIUMS - COV/CORP F.I. ACCOUNT


2009 - 2017


Description Symbol Trade Date Qty Latest Price Mkt Val ( Base ) Original Cost with Original Cost Unrizd Gain/Loss Unit Cost Accretion /Amortization

(Base ) OID(Base ) (Base ) ( Base ) ( Base ) ( Base)

ROYAL BANK OF CANADA 901ME5 2015-01-29 650,000 99 1710 644,611 50 649,909 000 649,909 000 -5,297 50 99 9860 0 00

1 875% 02/05/2020 SERCB18 SR LIEN

JPMORGAN CHASE 8 CO 91341.11,14 2015-01-16 650,000 99.9330 649,564 50 644,735 000 644,735 000 4,829 50 99 1900 0 00

2 25% 01232020 USO SRLIEN

PMORGAN CHASE & CO 904UU4 2015-01-16 600,000 99 9330 599,598 00 600,000 000 600,000 000 -402 00 100 0000 0 00

2.25% 0123/2020 USD SRLIEN

FHLB 2 875% 09/11/2020 2OJRM2 2014-05-16 550,000 102 1810 561,995 50 576,389 000 576,389 000 313 22 102 1241 -14,70672

^ER QL-2020 SR LIEN

UTONATION, INC 6 75% 3G44T2 2016-01-20 500,000 101 2440 506,220 00 543,220 000 543,220 000 475 10 101 1490 -37,475 10

64/152018 SR LIEN

AUTOZONE, INC. 3 7% 4D22F9 2015-01-23 500,000 103 1660 515,830 00 525,960 000 525,960 000 -253 92 103 2168 -9.87608

9411512022 USD SR LIEN

U S TREASURY NOTE TN18722H 2016-09-08 500,000 98 5940 492,970 00 514,570 500 514,570 500 -18,501 22 102 2942 -3,09928

875000% 08/312022 FAFF THE RUN

U S BANCORP MTN 2 35% 40WO136 2016-01-26 500,000 100 0170 500,085 00 499,930 000 499,930 000 155 00 999860 0 00

W29/20211 USD SR LIEN

BBOTT LABORATORIES 4JFUB2 2016-11-17 450,000 101 7300 457,785 00 447,880 500 447,880 500 9,90450 99 5290 0 00

3 4% 11/30/2023 USD SRLIEN

RACLE CORPORATION 90E9U6 2015-10-16 350,000 100 1580 350,553 00 347,959 500 347,959 500 2,59350 99 4170 0 00

5% 05/152022 USD SRLIEN

ING BANK N V HYBRID 30FW13 2016-01-26 325,000 101 1530 328,747 12 329,875 000 329,875 000 -58 87 101 1711 -1,069 01

MTN 11/212023 USD PVT!2EGS SUB LIEN CPN11/21/13- 1 MOM 8 4 125%

LABORATORY CORP OF 905F46 2015-01-21 325,000 101 9540 331,350 50 324,736 750 324,736 750 6,61375 99 9190 0 00

AMER 3 2% 02/012022IJSD SR LIEN

ABBOTT LABORATORIES 4JFUB2 2016-11-16 300,000 101.7300 305,190.00 299,217.000 299,217 000 5,97300 99.7390 0 00

4% 11/30/2023 USD SRIEN


Page 5 of 21


AMORTIZATION OF BOND PREMIUMS - GOV/CORD F.I. ACCOUNT


2009 - 2017


Description Symbol Trade Date Qty Latest Price Mkt Val (Base) Original Cost with Original Cost Unrizd Gain/Loss Unit Cost Accretion/Amortization

(Base ) DID (Base) (Base ) (Base) ( Base) (Base)

KINDER MORGAN 01CB76 2016-01-07 200,000 103 2020 206,404 00 177,200 000 177,200 000 23,344 26 91 5299 5,85974ENERGY PARTN 3 95%09/01/2022 USD SR LIEN

UNITED PARCEL 3JUGC5 2010-02-24 100,000 103 7180 103.718 00 107,465 000 107,465 000 2,521 34 101 1967 -6,26834SERVICE, INC 5 125%04/01/2019 USD SR LIEN

NITED TECHNOLOGIES ABOKVY 2017-05-23 50,000 99 2620 49,631 00 50,283 500 50,283 500 -630 60 100 5232 -21 90bORPORATIO 2 8%65104/2024 USD SR LIEN

TOTAL 38,343 , 202.93 38,852 ,351470 39 , 753,831.480 171 , 732.51 -680,881.05

* TO ATTACHMENT TO EXHIBIT A,PAGE 1 OF 21


k

Page 6 of 21

THE HARRY T. MANGORIAN, JR. FOUNDATION, INC. - BIN: 16-1578255



REALIZED BROWSER CRITERIA

Account Id 020518916 Doc HTM, JR FOUNDATION GOV/CORP From 01/01/±017 Super Asset Class NONE

Product Id Doc To 12/31/2017 ISGAssetClass NONE

Currency Id Currency Desc Period YTD ISG Sub Asset Class NONE

Ton Id RepNumber 6047 NEW BUSINESS - TEAM 047 Period Type STMT Strategy NONE

Pit Closing method FIFO BaseCurrency USD

REALIZED BROWSER FILTER

Operations ALL Operations Gain Type ALL Ta,dot Qty

REALIZED BROWSER BALANCES

Start Balanra -15868 6 End Balance 0

AMORTIZATION EXPENSE

ON BONDS SOLD IN 2017Kit- UnVYR>[ r.--

020518916 THE HARRY T MANGURIAN , JR. 370334859 GENERAL MILLS, INC FEB 15201757 Maturity 750000 02/12/2009 02/15/2017 786 , 75000 750,00000 36,75000

020518916 THE HARRY T MANGURIAN , JR 552081AG6 LYONDELLBASELL INDUSTRIES N V APR 15 20 Partial Call 2000 05/21/2013 03/24/2017 2,26688 2,129 20 31 31 ( 16899 )

020518916 THE HARRY T MANGURIAN , JR. 552081006 LYONDELLBASELL INDUSTRIES N V APR 15 20 Partial Call 614000 05 121/2013 03/24/2017 695 932 16 653,664 40 9 611 23 ( 51,87899)

020518916 THE HARRYT MANGURIAN , JR. 552081AG6 LYONDELLBASELL INDUSTRIES N V APR 15 20 Partial Call 12000 05/21/2013 03/24/2017 13, 601 28 12,775 20 18784 1,013 92

020518916 THE HARRY T MANGUI8AN , IR 3133 06056 FHLB MAY 17 2017 4 875 Mature 500000 02 / 17/2009 05/17/2017 551,75000 500,00000 51,75000

020518916 THE HARRYT MANGURIAN, JR 31330KQX6 FHLB MAY 17 2017 4 875 Matunty 500000 04 / 13/2009 05/ 17/2017 548 , 60000 500 , 00000 4860000

020S18916 THE HARRY T MANGURIAN , JR 22546QAL1 CREDIT SUISSE AG NEW YORK BRAN MAY 26 Maturity 725000 08/ 27/2015 05/26/2017 723,745 75 725, 000 00 1,254 25

020518916 THE HARRYT MANGURIAN , JR 042735BD1 ARROW ELECTRONICS, INC APR 1202235 Sale 225000 02/26/2015 06/01/2017 225 , 69975 230 , 28300 4 , 78397 (20072*

** TO ATTACHMENT TO EXHIBIT A,

PAGE 1 OF 21


Page 7 of 21

THE HARRY T. MANGURIAN, JR. FOUNDATION, INC. - TAX ID # 16-1578255

AMORTIZATION OF BOND PREMIUMS - H.Y. CORP. F.I. ACCOUNT


Total Accumulated Amortization as of 12/31/2017 (57,472)*

LESS:

PLUS:

Amortization Expense F/Y/E 12/31/2016 33,377Amortization Expense F/Y/E 12/31/2015 41,211

Amortization Expense F/Y/E 12/31/2014 43,006Amortization Expense F/Y/E 12/31/2013 59,897Amortization Expense F/Y/E 12/31/2012 30,953

Amortization Exp. on Bonds bought in 2012 through 2017 & sold in 2017 (37,228)**

Amortization Exp. on Bonds bought in 2012 through 2016 & sold in 2016 (79,939)Amortization Exp. on Bonds bought in 2012 through 2014 & sold in 2015 (14,432)Amortization Exp. on Bonds bought in 2012 and 2013 & sold in 2014 (22,658)

Amortization Exp. on Bonds bought in 2012 and 2013 & sold in 2013 (12,997)

Amortization Exp. on Bonds bought in 2012 & sold in 2012 (2,482)

1! 8.7641TOTAL AMORTIZATION EXPENSE FOR THE YEAR ENDED 12/31/2017

* See Attachment to Exhibit A, Page 20 of 21ATTACHMENT TO EXHIBIT A

** See Attachment to Exhibit A, Page 21 of 21 Page 8 of 21

THE HARRY T. MANGURIAN, JR._FOUNDATION , INC. - EIN : 16-1578255


2017 FORM 990-PF , PAGE 1, LINE 23, COLUMN A - OTHER EXPENSES

Wi

r

HT.̂+

`

A'.,.•<^'+^'^4.;

Tax Lots

2012 - 2017TOTALACCUMULATEDAMORTIZATION

TaxLots;,f• r g==a^ S" r te'Acc' h- rat C ore ou t : t e' A or at

Fixed. In ome;,(High Y.leld)^ 5'•;,,,'^, ' , r' • Base•Currency,:USD `, :,

Description Symbol Trade Date Qty Latest Price Mkt Val (Base ) Original Cost with Original Cost Unrizd GalnlLoss Unit Cost Accretion /Amortization

(Base) DID (Base ) ( Base ) ( Base ) ( Base) (Base)

CALPINE CORPORATION 20SG77 2015-01-05 135,000 103 0000 139,050 00 143,100 000 143,100 000 -951 00 103 7044 -3,099006 0% 01/15/2022 USD PVTREGS SR LIEN

NV ENERGY, INC 6.25% 5M01 R5 2012-05-18 125,000 109 8240 137,280 00 138,437 500 138,437 500 7,124 11 104 1247 -8,281 6111/15/2020 USD SR LIEN

HCA INC 6 5% 02/15/2020 2R7QYO 2012-04-10 115,000 106 0000 121,900 00 119,312 500 129,687 500 5,52796 101 1931 -2,94046USD SR LIEN

PUGET ENERGY, INC 2R9UGO 2012-04-16 105,000 110 6340 116,165 70 112,218 750 112,218 750 7,930 14 103 0815 -3,983 196 0% 0910112021 USD SERB SR LIEN

LAMAR MEDIA CORP 9HGDQ7 2016-10-05 95,000 106 7500 101,412 50 103,075 000 103,075 000 -790 99 107 5826 -871 515 75% 02/01/2026 USD SERWI SR LIEN

VIDEOTRON LTEE 5 0% 4U8ZU8 2012-04-16 90,000 105 2500 94,725 00 87,975 000 87,975 000 6,75000 97 7500 0 0007/15/2022 USD SER B SRLIEN

FRESENIUS MEDICAL 5M9L11 2012-04-11 85,000 108 1920 91,963 20 86,593 750 86,593 750 6,307 83 100 7710 -938 38CARE US FINA 5 75%02/15/2021 USD PVT 144APVT SR LIEN

L BRANDS, INC 6 625% 5MRP74 2012-04-05 80,000 109 5000 87,600 00 86,000 000 86,000 000 5,08045 103 1494 -3,4804504/01/2021 USD SR LIEN

SPRINT NEXTEL 01ADD5 2012-04-11 85,000 107 0000 90,950 00 85,425 000 105,525 000 5,80664 100 1687 -281 64CORPORATION 7 0%03/01/2020 USD PVT 144APVT SR LIENLEVEL 3 FINANCING. INC ABOIPT 2016-03-08 85,000 98 1550 83,431 75 85,000 000 85,000 000 -1,56825 100 0000 0 005 25% 03/1 512026 USD SERWI SR LIEN


Page 9 of 21

THE HARRY T . MANGURIAN , JR. FOUNDATION, INC. - EIN: 16-1578255



2012 - 2017


Description Symbol Trade Date Qty Latest Price Mkt Val ( Base) Original Cost with Original Cost Unrizd Gain/Loss Unit Cost Accretion/Amortization

( Base) OID(Base) (Base ) ( Base) (Base ) (Base)

SPECTRUM BRANDS, INC 4R59Z6 2015-07-08 75,000 103 5000 77,625 00 79,968 750 79,968 750 -894 36 104 6925 -1,44939

625% 11/15/2022 USDSER B SR LIEN

MICHAELS STORES, INC 302FH3 2015-08-03 70,000 101 3750 70,962 50 73,587 500 73,587 500 -1,13079 102 9904 -1.49421

5 875% 12/15/2020 USDPVT 144A PVT SUB LIEN

CROWN CASTLE 112CE2 2013-02-26 65,000 109 4950 71,171 75 66,706 250 66,706 250 5,201 06 101 4934 -735 56

INTERNATIONAL COR5 25% 01115/2023 USD SERB SR LIEN

NBCUNIVERSAL MEDIA, 2REKQ8 2012-04-16 60,000 105 9880 63,592 80 65,404 200 65,404 200 1,45055 103 5704 -3,261 95

LLC 4 375% 04/01/2021USD SER B SR LIEN

CENTENE CORP 4 75% 4JCYK5 2016-10-26 65,000 101 7500 66,137 50 65,000 000 65,000 000 1,137 50 100 0000 0 00


BALL CORPORATION 5 0% 019XW4 2012-04-11 65,000 106 7500 69,387 50 64,350 000 64,350 000 5,03750 99 0000 0 00


W R GRACE & CO-CONN 6VFLK3 2014-10-28 60,000 105 1250 63,075 00 62,850 000 62,850 000 1,423 75 102 7521 -1,198 75

5 125% 10/012021 USDPVT 144A PVT SR LIEN

SILGAN HOLDINGS INC 9FOBP8 2013-11-04 61,000 100 5000 61,305 00 60,923 750 109,862 500 381 25 99 8750 0 00

5 0% 04/012020 SER B SRLIEN

ALCOA INC 615% 3JH6N1 2016-06-29 55,000 107 5100 59,130.50 59,812 500 59,812.500 970 93 105 7447 -1.65293


ALLY FINANCIAL INC 90BI65 2015-03-25 60,000 102 0000 61,200 00 59,332 800 59,332 800 1,867 20 98 8880 0 00

4 125% 03/302020 USD SRLIEN

CROWN CASTLE 112CE2 2013-02-27 55,000 1094950 60,222 25 56,650 000 56,650 000 4.28348 101 7069 -711 23

INTERNATIONAL COR5 25% 01/15/2023 USD SERB SR LIEN

DAVITA HEALTHCARE 90D367 2016-08-18 55,000 99 9700 54,983 50 56,512 500 56,512 500 -1,48374 102 6677 -45 26

PARTNERS INC 5 0%05/01/2025 USD SR LIEN

2


Page 10 of 21



2017 FORM 990-}F, PAGE 1, LINE 23, COLUMN A - OTHER EXPENSES

2012 - 2017TOTALACCUMULATEDAMORTIZATION


(Base ) OID(Base) (Base) (Base) (Base) (Base)

UNIVERSAL HEALTH 4XWFEO 2014-07-29 55,000 101 6250 55,893 75 55,000 000 55,000 000 893 75 100 0000 0 00SERVICES, INC 3 75%08/01/2019 USD PVT 144APVT SR LIEN

CONSTELLATION 4D1 U60 2012-04-19 50,000 112 3930 56,196 50 52,250 000 52,250 000 5.07506 102 2429 -1,12856BRANDS, INC 6 0%05/0112022 SR LIEN

TARGA RESOURCES 4ROG48 2016-12-15 50,000 102 2500 51,125 00 50,625 000 50,625 000 562 31 101 1254 -62 31PARTNERS LP 5 25%05/01/2023 USD SER B SRLIEN

W R GRACE & CO-CONN 6VFLK3 2014-09-11 50,000 105 1250 52,562 50 50,000 000 50,000 000 2,562 50 100 0000 0 005 125% 10/01/2021 USDPVT 144A PVT SR LIEN

UNIVISION 9074G7 2015-02-10 50,000 97 3750 48,687 50 50,000 000 50,000 000 -1,31250 100 0000 0 00COMMUNICATIONS INC5 125% 02/15/2025 USDPVT 144A PVT SR LIEN

GOODYEAR TIRE & 2WHNM1 2016-05-10 50,000 103 1100 51,555 00 50,000 000 50,000 000 1,555 00 100 0000 0 00RUBBER 5 0% 05/31/2026USD SR LIEN

GRAPHIC PACKAGING 1IM6R6 2014-01-30 50,000 104 5000 52,250 00 49,625 000 49,625 000 2,62500 99 2500 0 00INTL INC 4 75% 04/15/2021USD SR LIEN

21ST CENTURY FOX 907CV5 2012-04-16 45,000 105 6920 47,561 40 48,750 750 48,750 750 1,10326 103 2403 -2,29261AMERICA, INC 4 5%02/15/2021 USD SER C SRLIEN

AT&T INC 4 6% 02/1512021 20P9U2 2016-03-21 45,000 105 2470 47,361 15 47,860 650 47,860 650 537 62 104 0523 -1,037 12USD SER WI SR LIEN

DOLLAR TREE STORES, 9H00S2 2016-05-10 45,000 104 7500 47,137 50 47,583 900 47,583 900 -68 94 104 9032 -377 46INC 5 75% 03/0112023 SERWI SR LIEN

NCR CORPORATION 5 0% 2D7MS2 2016-02-19 50,000 101 7500 50,875 00 46,625 000 46,625 000 3,40450 94 9410 845500711 5/2022 USD SER B SRLIEN

- _ it ', ' _ 1• n4 ` r r ^ -r'J5 ^ i


Page 11 of 21



2017 FORM 990-PF , PAGE 1, LINE 23, COLUMN A - OTHER EXPENSES

2012 - 2017

TOTAL



(Base) OID(Base ) ( Base) (Base) (Base) (Base)

DISH DBS CORPORATION 3JYVT3 2012-04-10 40,000 107 0000 42,800 00 46,539 620 45,950 000 1,24681 103 8830 -4,98643

7 875% 091012019 USDSER B SR LIEN

IAMAR MEDIA CORP. 6VOAE2 2016-02-24 45,000 104 5000 47,025 00 46,237 500 46,237 500 803 75 102 7139 -16 25

5 375% 01/15/2024 USDSER B SR LIEN

CEQUEL COMMN 3V2UM5 2014-09-08 44,000 101 5000 44,660 00 45,870 000 57,337 500 -581 64 102 8219 -628 36

ESCROW I, LLC 6 375%09/1 51202 0 PVT REGS SRLIEN

POST HOLDINGS, INC 9HJEI8 2016-07-25 45,000 98 3750 44,268 75 45,000 000 45,000 000 -731 25 100 0000 0 00

^ 0% 08/15/2026 USD PVT144A PVT SR LIEN

ACADIA HEALTHCARE CO 90P1Z8 2016-12-05 45,000 101 5000 45,675 00 44,550 000 44,550 000 1,12500 99 0000 0 00

INC 5 625% 0211 5/2023IJSD SER B SR LIEN

SUBSID OF CABLEVISION 2619L3 2012-04-11 40,000 102 2500 40,900 00 44,300 000 44,300 000 466 71 101 0832 -3,866 71

SYS CRP CVC 7 62507/15/2018 SR LIEN

LTRIA GROUP, INC 5MWFRO 2012-04-16 40,000 107 2380 42,895 20 43,980 800 43,980 800 1,27741 104 0445 -2.36301

4 75% 05105/2021 USD SRLIEN

ONTINENTAL 9FQLR6 2013-01-02 40,000 101 5000 40,600 00 43,350 000 108,375 000 -1,18581 104 4645 -1,56419

ESOURCES, INC 50%b9115/2022 USD SER B SRLIEN

PAVITA HEALTHCARE 9FSVNO 2013-01-03 40,000 102 8750 41,150 00 42,500 000 42,500 000 -200 35 103 3759 -1,14965

PARTNERS INC 5 75%8/15/2022 USD SR LIEN

ALVOLINE INC 5 5% AB1025 2016-10-25 40,000 106 2500 42,500 00 42,380 000 42,380 000 261 57 105 5961 -141 57

7/152024 USD

NIELSEN FINANCE LLC 4R4PW8 2016-08-17 40,000 102 8750 41,150 00 41,400 000 41,400 000 55 40 102 7365 -305 40

0% 04/152022 USD PVT

11 44A PVT SR LIEN


Page 12 of 21

THE HARRY T. MANGIIRIAN, JR. FOUNDATION, INC. - EIN: 16-1578255



2012 - 2017

TOTAL


Description Symbol Trade Date Qty Latest Price Mkt Val ( Base) Original Cost with Original Cost Unrlzd Gain/Loss Unit Cost Accretion/Amortization

(Base ) OID (Base ) ( Base) (Base) (Base) (Base)

EYNOLDS GROUP 2WPNE 1 2016-06-13 40,000 103 5000 41,400 00 40,000 000 40,000 000 1,40000 100 0000 0 00

SSUER INC. 5 125%07/15/2023 USD PVT 144APVT SR LIEN

SABINE PASS ABOLGR 2016-06-08 40,000 112 3470 44,938 80 40,000 000 40,000 000 4,93880 1000000 0 00

LIQUEFACTION, LLC5 875% 06/30/2026 USDSER WI SR LIEN

REGENCY ENERGY 2DT5K0 2013-09-05 40,000 106 4290 42,571 60 39,400 000 39,400 000 3,171 60 98 5000 0 00

PARTNERS LP 5 75%09101/2020 USD SR LIEN

NCR CORPORATION 5 0% 2D7MS2 2016-02-22 40,000 101 7500 40,700 00 37,600 000 37,600 000 2,497 26 95 5069 602 74

07/1 51202 2 USD SER B SRLIEN

ENERGY TRANSFER 5MXDP4 2012-04-16 35,000 104 9660 36,738 10 36,316 000 46,692 000 1,18577 101 5781 -763 67

PARTNERS, L P 4 65%06/01 /2021 USD SR LIEN

GRAPHIC PACKAGING t IM6R6 2013-03-25 35,000 104 5000 36,575 00 35,000 000 35,000 000 1.57500 100 0000 0 00

INTL INC 4 75% 04/15/2021USD SR LIEN

RANGE RESOURCES ABOU4B 2012-04-11 35,000 995000 34,825 00 34,125 000 34,125 000 662 41 97 6074 37 59

CORPORATION 5 0%08/1 512022 USD SER WISR LIEN RATE DETAILS23914467

MGM RESORTS 2D2776 2016-10-13 30.000 108 0000 32,400 00 33,861 000 33,861 000 -337 37 109 1246 -1,12363

INTERNATIONAL 8 75%10/01 /2020 USD SER B SRLIEN

CONSTELLATION 4D1U60 2016-05-26 29.000 112 3930 32,593 97 32,842 500 32,842 500 141 86 111 9038 -390 39

BRANDS, INC 6 0%05101/2022 SR LIEN

MEDNAX INC 5 25% 70TXH9 2015-12-03 30,000 101 7500 30,525 00 30,000 000 30,000000 525 00 100 0000 0 00

12/01/2023 USD PVT 144APVT SR LIEN

WMG ACQUISITION CORP 9H1582 2016-07-21 30,000 103 5000 31,050 00 30,000 000 30,000 000 1,05000 100 0000 0 00

5 0% 08/0112023 USD PVT144A PVT SR LIEN , ,

t<` r 5


Page 13 of 21




2012 - 2017

TOTALACCUMULATED

AMORTIZATION

Description Symbol Trade Date Qty Latest Price Mkt Val (Base ) Original Cost with Original Cost Unrlzd Gain/Loss Unit Cost Accretion/Amortization

(Base ) OID (Base) (Base ) (Base ) (Base) (Base)

QORVO, INC 6 75% 4J31 U9 2015-11-13 30,000 107 5000 32,250 00 30,000 000 30,000 000 2,25000 100 0000 0 00

12/01/2023 USD SER WISR LIEN

WMG ACQUISITION CORP 4JBM87 2016-10-13 30,000 103 0000 30,900 00 30,000 000 30,000 000 90000 100 0000 0 00

4875% 11/012024 USDPVT 144A PVT SR LIEN

P, RONTIER 3JYIN1 2014-11-26 25,000 99 6150 24,903 75 28,343 750 28,343 750 -793 80 102 7902 -2.64620

COMMUNICATIONS CORP8 125% 10/0112018 SR LIEN

CENTURYLINK INC 6 45% 2R1AQ7 2016-09-28 25,000 101 0000 25,250 00 26,875 000 26,875 000 -1,16900 105 6760 -456 00

06/15/2021 USD SER S SRLIEN

INTELSAT JACKSON 015065 2012-04-16 25,000 91.0000 22,750 00 25,843 750 41,350 000 -2,76984 102 0794 -323 91

OLDINGS S A 7 5%/01/2021 USD SER B SR

LIEN

ORVO, INC 6 75% 4J31U9 2016-01-05 25,000 107 5000 26,875 00 25,625 000 25,625 000 1,30925 102 2630 -59 25

2/01/2023 USD SER WIR LIENP

1011778 BC / NEW RED 90FRIO 2015-05-14 25,000 102 3750 25,593 75 25,000 000 25,000.000 593 75 100 0000 0 00

IN 4 625% 01/15/2022SD PVT 144A PVT SRIEN

MGM GROWTH ABOH64 2016-04-06 25,000 106 5000 26,625 00 25,000 000 25,000 000 1,62500 100 0000 0 00

PROPERTIES OPERATIN5.625% 05/01/2024 USDSER WI SR LIEN

NAVIENT CORPORATION 5VMXT8 2014-11-03 25,000 101 3750 25,343 75 24,841 250 24,841 250 502 50 993650 0 00

5.0% 101262020 USD SRLIEN

CENTURYLINK INC 6 45% 2131 AQ7 2016-10-05 20,000 101 0000 20,200 00 21,500 000 21,500 000 -939 91 105 6996 -360 09


SEALED AIR 1IIJY3 2016-10-05 20,000 106 5000 21,300 00 21,362 400 21,362 400 168 60 105 6570 -231 00

CORPORATION 5 25%04/01/2023 USD PVT 144APVT SR LIEN

t t S 6


Page 14 of 21




2012 - 2017TOTAL

ACCUMULATED

AMORTIZATION

Description Symbol Trade Date Qty Latest Price Mkt Val (Base) Original Cost with Original Cost Unrlzd Gain/Loss Unit Cost Accretion/Amortization

( Base) DID (Base ) (Base) (Base) (Base ) (Base)

VALVOLINE INC. 5 5% AB1025 2016-10-11 20,000 106 2500 21,250 00 21,148 000 21,148 000 170 28 105 3986 -68 28

07/15/2024 USD

CINEMARK USA, INC. 2D8GB8 2016-08-17 20,000 102 2500 20,450 00 20,962 400 20,962 400 -327 37 103 8869 -185 03

5.125% 12115/2022 USDSER B SR LIEN

CLEAN HARBORS INC 2D2VYO 2017-02-23 20,000 101 0000 20,200 00 20,525 000 20,525 000 -230 03 102 1502 -94 97

5.125% 06/01/2021 USDSER B SR LIEN

bUTFRONT MEDIA 9023S3 2016-02-24 20,000 102 5000 20,500 00 20,400 000 20,400 000 181 42 101.5929 -81 42

OAPITAL LLC/ CO 5 25%02115/2022 USD SER B SRLIEN

ALLY HOLDINGS LLC 22UHT7 2015-11-18 20.000 99 5000 19.900 00 20,000 000 20,000 000 -100 00

"'00000

0 00

5 625% 12/01/2025 USD SR1LIEN

S&C TECHNOLOGIES 2W9P62 2015-06-29 20,000 105 5000 21,100 00 20,000 000 20,000 000 1,10000 100 0000 0 00

OLDINGS, IN 5 875%7/15/2023 SER WI SR

LIEN

EREIT OPERATING 2WIZ04 2016-05-18 20,000 105 8290 21,165 80 20,000 000 20,000 000 1,16580 100 0000 0 00

PARTNER 4 875%06101/2026 USD SR LIEN

MGM GROWTH ABOFZS 2016-08-09 20,000 99 5000 19,900 00 20,000 000 20.000 000 -100 00 100.0000 0 00

PROPERTIES OPERATIN4 5% 09/01/2026 USD SER^VI SR LIEN

DISH DBS CORPORATION 3V3ZY2 2016-04-15 20,000 100 5000 20,100 00 19,500 000 19,500 000 100 00 100 0000 500 00

5.875% 0 7/1 512022 USDER B SR LIEN

ISH DBS CORPORATION 3V3ZY2 2016-06-16 20,000 100 5000 20,100 00 19,250 000 19,250 000 100 00 100 0000 750 00

875% 07/15/2022 USDERR B SR LIEN

SHKOSH CORPORATION 90JWB1 2016-10-05 17,000 106 1250 18,041 25 17,892 500 17,892 500 257 94 104 6077 -109 19

375% 03/01/2025 USDER B SR LIENR


Page 15 of 21




2012 - 2017

TOTALACCUMULATED

AMORTIZATION

Description Symbol Trade Date City Latest Price Mkt Val ( Base ) Original Cost with Original Cost Unrizd Gain/Loss Unit Cost Accretion/Amortization

(Base) DID (Base) (Base) (Base ) ( Base ) (Base)

MGM RESORTS 202776 2016-08-17 15,000 108 0000 16,200 00 16.795 350 16,795 350 -30 59 108 2039 -564 76INTERNATIONAL 6.75%10/0112020 USD SER B SRLIEN

FRESENIUS MED CARE 5JIEE2 2017-02-22 15,000 110 0840 16,512 60 16,340 630 16,340 630 38304 107 5304 -211 07^i 875% 01/3112022 PVT44A PVT SR LIEN

EALED AIR 1 I 1 JY3 2016-08-18 15,000 106 5000 15,975 00 16,125 000 16,125 000 57 78 106 1148 -207 78ORPORATION 5 25%/01/2023 USD PVT 144AVT SR LIEN

YUMI BRANDS, INC 5 3% 3JXZ38 2016-02-19 15,000 104 0000 15,600 00 15,525 000 15,525 000 338 74 101 7418 -263 749/1512019 USD SR LIEN

INEMARK USA, INC 206688 2016-10-05 15,000 102 2500 15,337 50 15,447 000 15,447 000 -43 90 102 5427 -65 6015 125% 12/15/2022 USDSER B SR LIEN

OUTFRONT MEDIA 9023S3 2016-05-17 15,000 102 5000 15,375 00 15,375 000 15,375 000 95 15 101 8656 -95 15CAPITAL LLC/ CO 5 25%0211 512022 USD SER B SRLIEN

GLP CAPITAL, L P 4 375% 4XWKA2 2016-03-02 15,000 100 7500 15,112 50 15,300 000 15,300 000 14 91 100 6506 -202 4111/0112018 SERB SR LIEN

AMC ENTERTAINMENT 903526 2016-09-26 15,000 98 8750 14,831 25 15,225 000 15,225 000 -379 17 101 4028 -14 58HOLDINGS INC 5 75%06/15/2025 USD SER BSRSUB LIEN

SPRINT CAP CORP 6 9% 64B6H6 2016-01-26 20,000 104 6250 20,925 00 15,200 000 15,200 000 3.18908 88 6796 2,5359205/01/2019 USD SR LIEN

AMC ENTERTAINMENT ABOOV3 2016-10-28 15,000 985000 14,775 00 15.116 250 15,116 250 -335 41 100 7360 -5 84HOLDINGS, IN 5 875%11/1512026 USD SRSUBLIEN

GLP CAPITAL, L P 1375% 2DWBY6 2016-04-11 15,000 107 2500 16,087 50 15,000 000 15,000 000 1,087 50 100 0000 0 0004/15/2026 USD SR LIEN

8

Page 16 of 21





2012 - 2017

TOTAL

ACCUMULATED

AMORTIZATION

Description Symbol Trade Date Qty Latest Price Mkt Val (Base ) Original Cost with Original Cost Unrizd Gain/Loss Unit Cost Accretion /Amortization

( Base ) DID (Base) (Base ) ( Base) (Base) (Base)

SYMANTEC ABOFPN 2017-02-07 15,000 104 0000 15,600 00 15.000 000 15,000 000 60000 100 0000 0 00

CORPORATION 5 0%04/15/2025 USD PVT 144APVT SR LIEN

AMC ENTERTAINMENT ABOOV3 2016-10-28 15,000 98 5000 14,775 00 15,000 000 15,000 000 -225 00 100 0000 0 00

HOLDINGS, IN 5 875%11/1512026 USD SRSUBLIEN

CIT GROUP INC 5 0% 4U92P3 2016-10-12 13,000 106 0000 13,780 00 14,040 000 16,200 000 -62 47 108 4805 -197 53


SPRINT CAP CORP 6 9% 64B6H6 2016-01-26 15,000 104 6250 15,693 75 11,475 000 11,475 000 2,35334 88 9361 1,86541


MGM RESORTS 202778 2017-02-27 10,000 108 0000 10,800 00 11,037 500 11,037 500 -8 62 108 0862 -228 88

INTERNATIONAL 6 75%10/01/2020 USD SER B SRLIEN

MGM RESORTS 2D2776 2016-06-01 10,000 108 0000 10,800 00 10,906 200 10,906 200 203 17 105 9683 -309 37

INTERNATIONAL 6 75%10/0112020 USD SER 8 SRLIEN

CONSTELLATION 4D1U60 2012-07-05 10,000 112 3930 11,239 30 10,850 000 10,850 000 813 96 104 2534 -424 66

BRANDS, INC 6 0%05/01/2022 SR LIEN

1 CENTENE CORPORATION 2WEFPO 2016-10-20 10,000 105 7500 10,575 00 10,814 500 10,814 500 -126 82 107 0182 -112 68

6 125% 02/15/2024 USDSER WI SR LIEN

MPT OPER 2DLYD1 2016-05-26 10,000 105 7500 10,575 00 10,806 200 10,806 200 -91 82 106 6682 -139 38

PARTNERSP/FINL 6 375%03/01/2024 USD SR LIEN

CENTURYLINK INC 8 45% 2R1AQ7 2016-10-13 10,000 101 0000 10,100 00 10,725 000 10,725 000 -453 17 105 5317 -171.83


SEALED AIR 111JY3 2016-06-01 10,000 106 5000 10,650 00 10,468 700 10,468 700 27663 103 7337 -95 33

CORPORATION 5.25%04/01/2023 USD PVT 144APVT SR LIEN


Page 17 of 21




2012 - 2017TOTAL



( Base) OID (Base) ( Base) ( Base) (Base ) ( Base)

MPT OPERATING 4RPUU9 2014-04-10 10.000 103 5000 10,350 00 10,000 000 10,000 000 350 00 100 0000 cooIIARTNERSHIP 5 5%05/01/2024 USD SR LIEN

HD SUPPLY INC 5.75% 2DU180 2016-03-28 10,000 106 2500 10,625 00 10,000 000 10,000 000 625 00 100 0000 0 00

04/1 512024 USD PVT 144APVT SR LIEN

FC HOLDING CO. 5 0% 2WMIZ7 2016-06-02 10,000 103 1250 10,312 50 10,000 000 10,000 000 312 50 100 0000 0 00

06/01/2024 USD PVT 144AVT SR LIEN PIZZA HUT

HOLDINGS LLCITACO BE

FC HOLDING CO. 5 25% 2WMJ11 2016-06-02 10,000 105 2500 10,525 00 10,000 000 10,000 000 525 00 100 0000 0 00

6/0112028 USD PVT 144AVT SR LIEN PIZZAUT/TACO BELL

PRINT CAP CORP 6 9% 641361-16 2016-01-26 10,000 104 6250 10,462 50 7,650 000 7,650 000 1,56889 88 9361 1,24361


NBCUNIVERSAL MEDIA, 2REKQ8 2012-05-01 5,000 105 9880 5,29940 5,481 400 5,481 400 108 19 103 8243 -290 19

LLC 4 375% 04101/2021USD SER B SR LIEN

SUBSID OF CABLEVISION 2619L3 2012-05-22 5,000 102 2500 5,11250 5,462 500 5,462 500 64 91 100 9519 -414 91

SYS CRP CVC 7 62507/15/2018 SR LI EN

FRESENIUS MED CARE 5J1 EE2 2017-02-22 5,000 110 0840 5,50420 5,446 880 5,446 880 127 68 107 5304 -70 38

5 875% 01/31/2022 PVT144A PVT SR LIEN

L BRANDS, INC. 8 625% 5MRP74 2012-05-02 5,000 109 5000 5,47500 5,425 000 5,425 000 295 95 103 5810 -245 95

04/01/2021 USD SR LIENHCA INC 6 5% 02/15/2020 2R70Y0 2012-05-01 5,000 106 0000 5,30000 5.368 750 5,368 750 183 79 102 3243 -252.54USD SR LIEN

PUGET ENERGY, INC 2R9UGO 2012-05-01 5,000 110 6340 5,531 70 5,328 500 5,328 500 383 77 102 9585 -180 57

60%09/01/2021 USDSERB SR LIEN

DOLLAR TREE STORES, 9H00S2 2016-06-01 5,000 104 7500 5,23750 5.299 500 5,299 500 -13 54 105 0208 -48 46

INC 5 75% 03/01/2023 SERWI SR LIEN

L BRANDS, INC 5 625% 3D6E05 2017-01-10 5,000 107 8750 5,39375 5,287 500 5,287 500 141 87 105 0376 -35 62


v 10,


Page 18 of 21

THE HARRY T. MANCURIAN, JR. FOUNDATION, INC. - EIN: 16-1578255



2012 - 2017


Description Symbol Trade Date Qty Latest Price Mkt Val (Base) Original Cost with Original Cost Unrlzd Gain/Loss Unit Cost Accretion/Amortization

(Base ) DID (Base ) (Base) (Base) (Base) (Base)

EQUINIX, INC 5 375% 1IDAX8 2016-10-11 5,000 103 4000 5,17000 5,285 000 5,285 000 -67 37 104 7475 -47 62

04101 /2023 USD SR LIEN

INTELSAT JACKSON 015065 2012-05-10 5,000 91 0000 4,55000 5,225 000 5,225 000 -675 00 104 5000 0 00

HOLDINGS S.A 7 5%04101/2021 USD SER B SRLIEN

HCA INC 6 5% 02/152020 2R7QYO 2012-05-21 5,000 1060000 5,30000 5,200 000 5,200 000 235 69 101 2863 -135 69

USD SR LIEN

iCINEMARK USA, INC 2D8GB8 2016-09-28 5,000 102 2500 5,112 50 5,149 000 5,149 000 -14 63 102 5427 -21 87

125% 12/152022 USDUSER B SR LIEN

1011778 BC / NEW RED 90FR1O 2018-05-10 5,000 102 3750 5,118 75 5,125 000 5,125 000 0 29 102 3692 -6 54

FIN 4 625% 01/15/2022USD PVT 144A PVT SRLIEN

1011778 BC / NEW RED 90FRIO 2016-06-01 5,000 102 3750 5,118 75 5,121 850 5,121 850 1 19 102 3512 -4 29

FIN 4 625% 01115/2022USD PVT 144A PVT SRLIEN

HCA INC 5 0% 03/15/2024 4RDK86 2015-09-24 5,000 104 0000 5.20000 5,087 500 5,087 500 132 49 101 3503 -19 99

IJSD SR LIEN

CINEMARK USA, INC 2D6GB8 2016-02-24 5,000 102 2500 5,11250 5,050 000 5,050 000 65 66 100 9368 -3 16

5 125% 1 211 512022 USDSER B SR LIEN

SABINE PASS ABOLGR 2016-06-08 5,000 112 3470 5,61735 5,031 250 5,031 250 588 19 100 5832 -2 09

LIQUEFACTION, LLC5 875% 08/302026 USDSER WI SR LIEN

CCO HOLDINGS, LLC/ 2DW424 2016-04-14 5,000 102 5000 5,12500 5,018 750 5,018 750 108 66 100 3268 -2 41

CAPITAL COR 5 5%05/012026 USD PVT 144APVT SR LIEN

1011778 BC / NEW RED 90FRIO 2015-06-03 5,000 102.3750 5,118 75 5,000 000 5,000.000 118.75 100 0000 0 00

FIN 4 625% 01/1512022USD PVT 144A PVT SRLIEN


Page 19 of 21

THE HARRY T. MANG[TRIAN, JR. FOUNDATION, INC. - EIN: 16-1578255



2012 - 2017TOTALACCUMULATED

AMORTIZATION


(Base) OID(Base ) ( Base ) ( Base ) ( Base) (Base)

GLP CAPITAL L P 4 375% 2DWDN8 2016-04-11 5,000 102 7500 5,13750 5,000.000 5,000 000 137 50 100 0000 0 00,P1512021 USD SR LIEN

PERFORMANCE FOOD 2W161-0 2016-05-12 5,000 103 2500 5,16250 5,000 000 5,000 000 162 50 100 0000 0 00

GROUP 15 5% 08/01/2024USD PVT 144A PVT SRLIEN

R GRACE & CO-CONN 6VFLK3 2016-01-26 5,000 105 1250 5,25625 4,943 750 4,943 750 312 50 98.8750 0 00

5 125% 10/01/2021 USDPVT 144A PVT SR LIEN

SPRINT CAP CORP 6 9% 641361-16 2016-01-26 5,000 104 6250 5,231 25 3,725 000 3,725 000 836 05 87 9040 670 20


CONSTELLATION I IUOO3 2013-04-30 3,000 105 7860 3,17358 3,060 000 3,060 000 138 56 101 1673 -24 98

BRANDS, INC 4 25%05/01/2023 USD SR LIEN

FRONTIER 3JHIK4 2014-09-08 2,000 83 0000 1,66000 2,300 000 5,750 000 -473 51 106 6756 -166 49

COMMUNICATIONSCORPOR 8 5% 04/15/2020USD SER B SR LIEN

CONSTELLATION 1I0003 2013-04-30 2,000 105 7860 2,11572 2,000 000 2,000 000 115 72 100 0000 0 00

BRANDS. INC 4 25%05/01/2023 USD SR LIEN

TOTAL 4,277, 845.32 4,221,521.980 4 ,408,330 .860 113 ,794.87 -57,471.53

* TO ATTACHMENT TO EXHIBIT A,

PAGE 8 OF 21

12'


Page 20 of 21

k


AMORTIZATION OF BOND PREMIUMS - B.Y. CORP. F.I. ACCOUNT


REALIZED BROWSER CRITERIA

Account Id 021944350 Oesc HTM, JR FOUNDATION HY CORP From 01/01/2017 Super Asset Class NONE

Product Id Deft To 12/30017 ISG Asset Class NONE

Currency Id Currency Desc Period YTD ISG Sub Asset Class NONE

Tao Id RepNumber 6047 NEW BUSINESS - TEAM 047 Period Type STMT Strategy NONE

Psi Closing method FIFO BaseCurrency USD

REALIZED BROWSER FILTER

Operations ALL Operations Gain Type ALL Tordot Qty

REALIZED BROWSER BALANCES

Start Balance - 20614 77 End Balance 0

AMORTIZATION EXPENSE

ON BONDS SOLD IN 2017

021944350 THE HARRY T MANGURIAN , JR 23331ABEB 0 R HORTON, INC SEP 15 2022 4 375 Sale 10000 09/12/2012 01/03/2017 10,000 00 10,203 10 203 10

02 1944 3 50 THE HARRY T MANGURIAN, IR 526057805 LENNAR CORPORATION JUN 12018 6 95 Sale 50000 05/13/2014 01/03/2017 56,625 00 52,815 00 415 81 (4,22531 )

021944350 THE HARRY T MANGURIAN, JR 345370B07 FORD MOTOR COMPANY DEBS AUG 12018 6 Sale 120000 04/16/2012 01/03/2017 133,200 00 128,190 00 4,53763 9547 63

021944350 THE HARRY T MANGURIAN, JR 23331ASEB D R HORTON, INC SEP 15 2022 4 375 Sale 70000 09/11/2012 01/03/2017 70,000 00 71,421 70 1,421 70 -

021944360 THE HARRY T MANGURIAN, JR 723787AJ6 PIONEER NATURAL RESOURCES JAN 15 2020 Sale 90000 04/10/2012 01/03/2017 109,687 50 102,264 30 3,82707 11,250 27

021944350 THE HARRY T MANGURIAN, JR 150890.5C8 CELANESE US HOLDINGS LLC JUN 15 20215 R Sale 45000 04/11/2012 01/03/2017 47,587 50 49,604 81 3,201 23 1,183 88

021944350 THE HARRY T MANGURIAN, JR. I24BEPAOO CCO HOLDINGS LLC/CAP CORP JAN 31 2022 Full Call 5000 09/08/2014 02/16/2017 5,356 25 5,1656S (9883 ) (101 77 )

021944350 THE HARRY T MANGURIAN, JR. 878742BA2 10CR RESOURCES LIMITED JUN 120218 Tender Offer 5000 01/13/2017 03/08/2017 5,517 50 5,57500 76 89 ( 1439 )

021944350 THE HARRY T MANGURIAN, JR. 92912EAC7 VPII ESCROW CORP AUG 15 2018 6 75 Tender Offer 56000 12/15/2015 03/21/2017 55,30000 57,627 36 2,327 36 523 11

021944350 THE HARRY T MANGURIAN, JR 827048AP4 SILIIAN HOLDINGS INC APR 12020 5 Partial Call 49000 11/04/2013 04/01/2017 48,938 75 49,612 50 673 75

021944350 THE HARRY T MANGURIAN. JR

_

87264AAKI T-MOBILE USA, INC APR 120216 25 all Call 25000 03/08/2013 04/01/2017 25,000 00 25,781 25 78125 -

021944350 _THE HARRY T MANGURIAN, JR 12543DAR1

_

CHS/COMMUNITY HLTH 515, INC AUG 15 20 Full Call 22000 11/26/2012 04/03/2017 23,017 50 22,282 82 15 06 750 74

021944350 THE HARRY T MANGURIAN, JR U1568TAA3 CEQUEL COMMN ESCROW I, LLC SEP 15 2020 Partial Call 11000 09/08/2014 04/14/2017 11,46750 11,350 68 46 47 ( 16329 )

021944350 THE HARRY T MANGURIAN, JR 125581GL6

_

CIT GROUP INC MAR 15 2018 S 25 Full Call 70000 02/09/2016 05/04/2017 70,17500 72,209 90 2,13398 9908

021944350 THE HARRY T MANGURIAN, JR 35906AAH1 FRONTIER COMMUNICATIONS CORPOR APR Tender Offer 3000 09/08/2014 06/26/2017 3,45000 3,18000 6211) 20789

_

021944350 THE HARRY T MANGURIAN, JR 1844964.16 CLEAN HARBORS, INC AUG 12020 5 25 Tender Offer 5000 11/29/2012 06/30/2017 5,14900 5,07875 2460) (4565 )

021944350 THE HARRY T MANGURIAN, JR 1844963.16 CLEAN HARBORS, INC AUG 12020 5 25 Tender Offer 25000 11/29/2012 06/30/2017 25 , 68750 25,393 75 ( 12298) ( 17077 )

021944350 THE HARRY T MANGURIAN, JR 00434NAA3 WILLIAMS PARTNERS LP MAY 15 2023 4 875 Full Call 50000 03/20/2014 07/03/2017 50,125 00 51,915 50 1,827 12 (3662 )

021944350 THE HARRY T MANGURIAN, JR 7954633.15 SALLY HOLDINGS LLC JUN 12022 575 Full Call 75000 08/09/2012 0710612011 81,375 00 77 , 15625 ( 1 , 39688) 2,821 87)

021944350 THE HARRY T MANGURIAN, JR 251S91AY9 DEVELOPERS DIVERSIFIED REALTY APR 15 20 Full call 25000 04/19/2032 07/10/2017 26,018 50 25,610 50 466 52 ( 874 52

021944350 THE HARRY T MANGURIAN, JR 88033GBP4 TENET HEALTHCARE CORPORATION NOV 12( Full Call 30000 04/25/2013 07/14/2017 33,637 50 31,72980 803 04 2,710 74)

021944350 THE HARRY T MANGURIAN, JR 92912EAC7 VPII ESCROW CORP AUG 15 2018 6 75 Full Call 4000 12/15/2015 08/15/2017 3,95000 4,00000 50 00 50 00

001944350 THE HARRY T MANGURIAN, JR 92912EAC7 VPII ESCROW CORP AUG 15 2018 6 75 Full Call 20000 10/07/2016 08/IS/2017 20,152 00 20,000 00 (84 73) (6727)

021944350 THE HARRY T MANGURIAN, JR U4047C4H0 HD SUPPLY INC DEC 15 20215 25 Full Call 85000 1 01114/2015 09/01/2017 87,125 00 89,189 61 2,56995 ( 50534 )

0219"350 THE HARRY T MANGURIAN, JR 682450AA7 1011776 BC ULC / NEW RED FINAN APR 1 20 Partial Call 3000 10/18/2016 09/07/2017 3,172 50

_

3 098 34 (4923 ) 24 93

0219"350 THE HARRY T MANGURWN, JR 55342UA06 MPT OPERATING PARTNERSHIP FEB 15 2022 Full Call 25000 06/19/2013

_

30/10/2017 26,968 75 25,79700 ( 30366) 868 09

021944350 THE HARRYT MANGURIAN, JR 682450467 1011778 BC ULC / NEW RED FINAN APR 1 20 Full Call 2000 10/18/2016 10/18/2017 2,115 00 2,06000 ( 36 18 ( 1882 )

021944350 THE HARRY T MANGUI0AN, JR

_

_

97381WAN4

_

WINDSTREAM SERVICES, LLC OCT 15 2020 7 Sale 5000 1 06121/2016

_

_

10/19/2017 4,900 00 4,58125 (318 75 27 27

021944350

_

THE HARRY T MANGURIAN, JR

_

_

97381WAN4

_

WINDSTRFAM SERVICES, LLC OCT 15 2020 7 Sale 15000 1 09/30/2016

_

10/19/2017 15,375 00 13,743 75 (1,543 70) (87 55

021944350

_

THE HARRY T MANGURIAN, JR

_

9738IWAN4

_

WINDS TREAM SERVICES, LLC OCT 1520207 Sale 5000 06/21/2016

_

10/19/2017 4,90000 4,58125 31675) 2727

021944350 THE HARRY T MANGURIAN, JR 75886AAF5 REGENCY ENERGY PARTNERS LP JUL 15 2021 Full Call 65000 04/05/2012 10/20/2017 68,900 00 66,40955 (412 76) 2,078 69

41 20,614 77 (37,227 96) **

** TO ATTACHMENT TO EXHIBIT A,

PAGE 8 OF 21


Page 21 of 21

THE HARRY T. MANGURIAN, JR. FOUNDATION, INC.FEDERAL TAX I.D. # 16-1578255FORM 990-PF - PART I, LINES 4 and 11REVENUE - COLUMN (b)FOR THE YEAR ENDED DECEMBER 31, 2017

LINE DESCRIPTION

4 Dividends and Interest from securities:- Sch. K-1: U.S. Real Property Income Fund, L.P.

F.E.I. Number: 80-0699417

- Sch. K-1: West Street Energy Partners, L.P.

F.E.I. Number: 45-5302489

- Sch. K- 1: West Street Energy Partners AIV-1, L.P.F.E.I. Number : 45-5499354

- Sch. K-1: West Street Capital Partners VII Parallel, L.P

F E.1 Number: 81-4370542

- Sch. K-1: Broad St Real Estate Credit Ptnrs III Offshore, LPF.E.I. Number. 98-1360807

- Sch. K-1: Vintage VII AIV Offshore, SCSpF.E.I. Number: 98-1351727

- Sch. K-1: Cadre Access Offshore, L.P.

F.E.I. Number: 98-0331317DIVIDENDS & INTEREST PER SCHEDULES K-1

- Goldman Sachs Vintage Fund V Offshore, L.P.

- Goldman Sachs Vintage Fund VI Offshore, L.P.

- Goldman Sachs Vintage Fund VII Offshore, L.P.

- Dividends and Interest from Part I, Column (a), Line 4:

Gross dividends and interest from securities

**SEE ATTACHMENT LESS: Accrued interest paid at purchase*

TO EXHIBIT B-1** DIVIDENDS AND INTEREST PER BOOKS

EXHIBIT B-1(Page 1 of 2)

AMOUNT

72,700

83,580

15,100

6,077

71

19

985

178,532

33,51319,2803,057

3,645,392(11,929)

3,633,463

- Dividends and interest earned per 2017 Forms 1099 3,645,538

SEE DETAIL BELOW - Less : Dividends and interest earned per books (3,633,463)

ADJUSTMENT TO AGREE BOOKS TO FORMS 1099 12,075

TOTAL 3,879,920

Detail for Dividends and Interest Earned Per 2017 Forms 1099:

- Interest Income 1,473,030

- Dividend Income 2,268,255

- Foreign Tax Withheld (47,540)

- Accrued Interest Paid (11,929)

- Reclaimable Tax (25,436)

- ADR Fees Paid (10,842)

Dividends and Interest Earned Per 2017 Forms 1099 3,645,538


THE HARRY T. MANGURIAN, JR. FOUNDATION, INC.FEDERAL TAX I.D. # 16-1578255FORM 990-PF - PART I, LINES 4 and 11REVENUE - COLUMN (b)FOR THE YEAR ENDED DECEMBER 31, 2017

LINE DESCRIPTION

11 Other Income from Part 1, Column (a), Line 11:

- Class Actions - Settlement Income- Miscellaneous Income

Other income per books

Other Income from Schedules K-1 and Forms 1099:

- Goldman Sachs - Enh. Div. Tax Ex. Acct

Account # 046-62922-6 - Deferred Income

- Sch. K-1: West Street Energy Partners, L.PF.E.I. Number: 45-5302489 - Section 988 Loss

- Sch. K-1: West Street Capital Partners VII Parallel, L.P.

F.E.I. Number: 81-4370542 - Section 988 Loss

- Guaranteed Payment

- Sch. K-1: Broad St Real Estate Credit Ptnrs III Offshore, LP

F.E.I. Number: 98-1360807 - Section 988 Loss- Guaranteed Payment

Other income per Schedules K-1 and Forms 1099

Total Other Income from Part 1, Column (b), Line 11


3,970

2,032

(15,768)

(12,515)1,748

(389)


AMOUNT

4,381

(24,888)

(20,507)

The Harry T. Mangurian, Jr. Foundation, Inc. - EIN: 16-1578255

Accrued Interest Paid at Purchase - GOV/CORD F.I. ACCOUNT

2017 Form 990-PF, Page 1, Line 4, Columns A & B

Statement Detail

HTM, JR . FOUNDATION GOV/CORP FITax Details (Continued)

Period Ended December 31, 2017

NON-REPORTABLE ITEMS

Date Quantity Gross Amount

ACCRUED INTEREST PAID AT PURCHASEINTEREST PAID ON OTHER SECURITIES

TARGET CORPORATION 3.5% 07/01/2024 USD SR UEN Mar 0817 925,000 (6,025 35)

THE BOEING COMPANY 2.85% 10/30/2024 USD SR LIEN May 2617 1,000,000 (2,058 33)UNITED TECHNOLOGIES CORPORATIO 2.8% 05/04/2024 USO SR LIEN May 2617 50,000 (85 56)FEDERAL HOME LOAN BANK SYSTEM 2 675% 06/14/2024 SER RK-2024 SR LIEN

Jul 2617 900,000 (3,018.75)

TOTAL INTEREST PAID ON OTHER SECURITIES ( 11,187,99)

TOTAL ACCRUED INTEREST PAID AT PURCHASE (11,187.99)

TOTAL NON-REPORTABLE ITEMS (11,187.99)

*** From Attachment to Exhibit B-1, Page 2 of 2 (741.03)

TOTAL ACCRUED INTEREST PAID AT PURCHASE 511:929_022**

** To Exhibit B-1, Page 1 of 2

Portfolio No, XXX-M91-6 Page 105 of 349

ATTACHPIENT TO EXHIBIT B-1

Page 1 of 2


Accrued Interest Paid at Purchase - H.Y. CORP. F.I. ACCOUNTStatement Detail

2017 Form 990-PF, Page 1, Line 4 , Columns A & B HTM GSAM: CORPORATE HIGH YIELD FITax Details (Continued)


NON-REPORTABLE ITEMS

Date Quantity Gross Amount

ACCRUED INTEREST PAID AT PURCHASEINTEREST PAID ON OTHER SECURITIES

L BRANDS, INC. 5.625% 10/15/2023 USD SR LIEN Jan 13 17 5,000 (68.75)TECK RESOURCES LIMITED 8 0% 06/01/2021 PVT 144A PVT SR LIEN Jan 19 17 5,000 (53 33)FRESENIUS MED CARE 5 875% 01/31/2022 PVT 144A PVT SR LIEN

FRESENIUS MED CARE 5 875% 01/31/2022 PVT 144A PVT SR LIENFeb 27 17Feb 27 17

5,00015,000

(22 03)(66.09)

CLEAN HARBORS INC. 5 125% 06/01/2021 USD SER B SR LIEN Feb 2817 20,000 (247.71 )MGM RESORTS INTERNATIONAL 6.75% 10/01/2020 USD SER B SR

LIEN

Mar 02 17 10,000 (2133 12)

TOTAL INTEREST PAID ON OTHER SECURITIES (741.03)

TOTAL ACCRUED INTEREST PAID AT PURCHASE (741.03)

TOTAL NON-REPORTABLE ITEMS *** (741.03)

*** TO ATTACHMENT TO EXHIBIT B-1, Page 1 of 2

Portfolio No: XXX-XX435-0 Page 136 of 349

ATTACHMENT TO EXHIBIT B-1

Page 2 of 2

THE HARRY T. MANGURIAN, JR. FOUNDATION, INC.FEDERAL TAX I.D. # 16-1578255FORM 990-PF - PART 1. LINES 16c, 18 and 23OPERATING & ADMINISTRATIVE EXPENSES - COLUMNS ( b) & (d)

FOR THE YEAR ENDED DECEMBER 31. 2017

LINE DESCRIPTION

16c - Column (b) Other Professional Fees.- Investment Management / Advisory Fees:

- Sch. K-1: U.S. Real Property Income Fund, L.P.

F.E.I. Number: 80-0699417

- Sch. K-1: West Street Energy Partners, L P.

F.E.I. Number: 45-5302489

- Sch. K- 1: West Street Energy Partners AIV-1, L.P.

F.E.I. Number: 45-5499354

- Sch. K-1: West Street Capital Partners VII Parallel, L.P.

F E.I. Number. 81-4370542


- Sch. K-1: Broad St Real Estate Credit Ptnrs III Offshore, L.P.

F.E.I. Number: 98-1360807

- Sch K-1: BPG Investors, L.P.F.E.I. Number: 82-2493810

- Sch K-1: Vintage VII AIV Offshore, SCSpF.E.I. Number: 98-1351727

- Sch. K-1: Cadre Access Offshore, L.P.

F E.I. Number: 98-0331317

- Goldman Sachs Vintage Fund V Offshore, L.P.

- Goldman Sachs Vintage Fund VI Offshore, L.P.

- Goldman Sachs Vintage Fund VII Offshore, L.P.

- Investment Management / Advisory Fees from Part I,

Column (a), Line 16c relating to investment income

TOTAL

18 - Column (d) Taxes:- Taxes from Part I, Column (a), Line 18

(expenses per books)

- Reductions to expenses per books to arrive at

disbursements for charitable purposes:

- Federal Excise Taxes (2016 taxes paid with extension,

2016 refund, and 2017 estimated taxes paid)

TOTAL


AMOUNT

25,067

6,060

6,217

40,177

1,016

1,017

78

1,412

27,84121,84413,479

536,118

680,326

128,701

(99,005)

29,696

THE HARRY T. MANGURIAN, JR. FOUNDATION, INC.

FEDERAL TAX I.D. # 16-1578255FORM 990-PF - PART I, LINES 16c, 18 and 23

OPERATING & ADMINISTRATIVE EXPENSES - COLUMNS (b) & (d)

FOR THE YEAR ENDED DECEMBER 31, 2017

LINE DESCRIPTION

23 - Column (d) Other Expenses.

- Other expenses from Part I, Column (a),

Line 23 (expenses per books)

- Reductions to expenses per books to arrive atdisbursements for charitable purposes.

**SEE ATTACHMENT - Amortization of bond premiums - Govt/Corp. F.I. Acct**

TO EXHIBIT A** - Amortization of bond premiums - H.Y. Corp. F.I. Acct**

TOTAL



AMOUNT

293,584

(195,656)(18,764)

79,164

THE HARRY T. MANGURIAN . JR. FOUNDATION, INC.FEDERAL TAX I.D. # 16-1578255FORM 990-PF - PART II, LINES 2 . 10b. 10c and 13 EXHIBIT CSCHEDULE OF BALANCE SHEET ASSETS (Page 1 of 2)FOR THE YEAR ENDED DECEMBER 31. 2017 SEE ATTACHED

Part II - Balance Sheets (Form 990-PF. Pane 2):

12131/2017Line 2 12/31/2017 12/31/2017 12131/2017 12/31/2017 12/31/2017 12/31/2017 EXHIBIT C

BOOK & FMV Line 10b - BOOK Line 10b - FMV Line 10c - BOOK Line 10c - FMV Line 13 - BOOK Line 13 - FMV AttachmentFinancial Institution Temp Cash Inv Corp Stocks Corp Stocks Corp Bonds Corp Bonds Other Invest Other Invest Location

Goldman Sachs & Co }Payment Services Account $83,625 $0 $0 $0 $0 $0 $0 } Page 1 of 40# 020 - 46666 - 0 }

Goldman Sachs & Co }Adv All Account 22,327 0 0 0 0 19,190,899 25,997,313 } Pgs 2-3 of 40# 020 - 46700 - 7 }

Goldman Sachs & Co }Stocks Account 18,270 0 0 0 0 4,000,000 6,362,391 } Page 4 of 40#020-46612-4 }

Goldman Sachs & Co }Lazard Account 246,057 3,507,766 3,988,044 0 0 0 0 } Pgs 5-6 of 40#051-60049-2 }

Goldman Sachs & Co }Spec Invest Account 276,465 0 0 0 0 8,010,520 11,902,037 } Pgs 7-9 of 40# 020 - 49965 - 3 }

Goldman Sachs & Co. }Delaware Account 193,702 8,374,680 8,672,257 0 0 0 0 } Pgs.10-12 of 40# 046 - 53800 -5 }

THE HARRY T. MANGURIAN . JR. FOUNDATION, INC.FEDERAL TAX I.D. # 16-1578255FORM 990-PF - PART II, LINES 2. 10b. 10c and 13 EXHIBIT CSCHEDULE OF BALANCE SHEET ASSETS (Page 2 of 2)FOR THE YEAR ENDED DECEMBER 31. 2017 SEE ATTACHED

Part li - Balance Sheets (Form 990-PF , Pam 2):

12/31/2017Line 2 12/31/2017 12/31/2017 12/31/2017 12/31/2017 12/31/2017 12131/2017 EXHIBIT C

BOOK & FMV Line 10b - BOOK Line 10b - FMV Line 10c - BOOK Line 10c - FMV Line 13 - BOOK Line 13 - FMV AttachmentFinancial Institution Temp Cash Inv Corp Stocks Corp Stocks Corp Bonds Corp Bonds Other Invest Other Invest Location

Goldman Sachs & Co }Invesco Account 319,462 3,465,689 3,686,415 0 0 0 0 } Pgs 13-16 of 40# 051 - 60050 - 0 }

Goldman Sachs & Co. }Gov't / Corp F.I. Account 60,894 0 0 38,172,820 38,673,101 0 0 } Pgs. 17-20 of 40#020-51891-6 }

Goldman Sachs & Co }H Y. Corp F I Account 82,700 0 0 4,164,151 4,344,183 0 0 } Pgs 21-28 of 40# 021 - 94435 - 0 }

Goldman Sachs & Co }Enh Div Tax Ex Account 81,978 38,291,930 43,638,474 0 0 0 0 } Pgs. 29-40 of 40#046-62922-6 }

TOTALS $1,385,480 $53,640,065 $59,985,190 $42,336,971 $43,017,284 $31,201,419 $44,261,741

Line 2 Line 10b Line 10b Line 10c Line 10c Line 13 Line 13

The Harry T. Mangurian, Jr. Foundation, Inc. - EIN: 16-1578255Statement Detail

Schedule of Balance Sheet Assets HTM, JR . FOUNDATION - PYMT. SERV. A/C2017 Form 990-PF - PART II, Balance Sheets Holdings


CASH, DEPOSITS & MONEY MARKET FUNDSMarket Value / Adjusted Cost/ Unrealized Yield to Maturity / Estimated

Quantity Market Price Accrued Income Unit Cost Original Cost Gain (Loss) Current Yield Annual Income

DEPOSITS & MONEY MARKET FUNDS

GOLDMAN SACHS BANK USA DEPOSIT (BDA)14 91,666.54 1.0000 91,666.54 1.0000 91,666.54 0 00 1.1654 1,068 33

Adjusted Cost /' Unrealized Estimated_Market Value Ori ginal Cost Gain (Loss ) Annual Income

TOTAL PORTFOLIO 91,666.54 91 ,666.54 0.00 1,068.33

LESS: OUTSTANDING CHECKS AT 12/31/2017 (8,041.70) (8,041.70)

ADJUSTED TOTAL PORTFOLIO AT 12/31/2017 83,624.84 83,624.84

OUTSTANDING CHECKS AT 12/31/2017:

#2965 $1,250.00 Charles Glenn Leonard (Director's Fee)

#2975 5,000.00 Pink Ribbon Foundation

#2976 76.30 Florida Blue (GWL MediRx Insurance)

#2977 335.40 Blue Cross & Blue Shield of FL (GWL MediSupp Insurance)

#2978 1,380.00 The Hartford (Workers' Compensation Insurance-2018)

$8,041 .70 T 0 T A L

6 Original Cost is price paid by purchaser adjusted for annual ori ginal issue discount inclusions and/or return of capital adjustments , if applicable Adjusted Cost reflects adjustments to Original Cost for market discount accretion and/or premiumamortization Adjusted cost for GMS Portfolios and Altemauvelnvestments are determined by inception to date contributions minus inception to date distributions

14This represents a bank deposit of an affiliated bank reflected here for your convenience and is not cash held in your brokerage or custody account Please see the enclosed Bank Statement page(s) for specific information related to your bank deposit

Not a Deposit Not FDIC Insured May Lose Value (Excluding Goldman Sachs Bank Deposit Account, Term Deposits and Certificates of Deposit)

Brokerage and securities services provided by Goldman. Sachs & Co Bank Deposit Account, Certificates of Deposit and Term Deposits offered by Goldman Sachs Bank USA. Member FDIC ATTACHMENT TO EXHIBIT C

Portfolio No XXX-XX666-OPage 1 of 40

Page 28 of 349

00()1623-0028.1i35 0-0142388 ---0151-29

The Harry T. Mangurian, Jr. Foundation, Inc. - EIN: 16-1578255Statement Detail

Schedule of Balance Sheet Assets HTM, JR. FOUNDATION ADV ALL

2017 Form 990-PF - PART II, Balance Sheets Holdings


CASH, DEPOSITS & MONEY MARKET FUNDS

Quantity Market PriceMarket Value /

Accrued Income Unit CostAdjusted Cost /Original Cost

UnrealizedGain (Loss)

Yield to Maturity /Current Yield

EstimatedAnnual Income


DEPOSITSGOLDMAN SACHS BANK USA DEPOSIT (BDA) 14 22,326.77 1.0000 22,326.77 1.0000 22,326 77 0 00 1 1707 261.38

FIXED INCOME

Quantity /Current Face Market Price

Market Value /Accrued Income Unit Cost

Adjusted Cost /Original Cost

Unrealized /Economic

Gain (Loss)Yield to Maturity

in PercentageEstimated

Annual Income

OTHER FIXED INCOME

GS HIGH YIELD FLOATING RATE FUND

GS HIGH YIELD FLOATING RATE FUND INSTITUTIONAL

SHARES

280,873.440 9.6800 2,718,854 90 98874 2,777,114.79 (58,259.89)

220,769 21

103,923.17

PUBLIC EQUITYMarket Value / Unrealized Dividend Estimated

Quantity Market Price Accrued Income Unit Cost Cost Basis Gain (Loss ) Yield Annual Income

NON-US EQUITY

MSCI EAFE 100% HEDGED TO USD INDEX FUND (ISHARES)

(SHARES TRUST-ISHARES CURRENCY HEDGED MSCI EAFE 203,000.00 29.6850 6,026,055.00 27.1417 5,509,771.75 516,283.25 2.5470 153,482.41

ETF (HEFA) 62,944.82

FTSE EMERGING MARKETS INDEX FUND (VANGUARD)

VANGUARD FTSE EMERGING MKTS ETF (VWO) 66,840.00 45.9100 3,068,624 40 41.3840 2,766,107.17 302,517.23 2.3047 70,723.40

" This represents a bank deposit of an affiliated bank reflected here for your convenience and is not cash held in your brokerage or custody account Please see the enclosed Bank Statement page ( s) for specific information related to your bank deposit

Not a Deposit Not FDIC Insured May Lose Value ( Excluding Goldman Sachs Bank Deposit Account. Term Deposits and Certificates of Deposit)

Brokerage and securities services provided by Goldman, Sachs & Co Bank Deposit Account, Certificates of Deposit and Term Deposits offered by Goldman Sachs Bank USA, Member FDIC ATTACHMENT TO EXHIBIT C

Portfolio No XXX•XX700- 7 Page 2 of 40Page 56 of 349


Schedule of Balance Sheet Assets

2017 Form 990-PF - PART II, Balance Sheets

Holdings (Continued)


PUBLIC EQUITY ( Continued)Contributions/

Market Value/ Distributions Net Contribution Economic

Quantity Market Price Accrued Income To Date To Date Gain (Loss)

NON-US EQUITY

ARTISAN. DYNAMIC EQUITY (NON-US EQUITY) [SERIES]

ARTISAN' DYNAMIC EQUITY(NON-US EQUITY) OFFSHORE L.P. 34,875.24 303.8180 10,595,728.18 5,583,333.00 6,162,395 18

(GMSAA2AC) 1,150,000.00

Market Value/ Unrealized Dividend Estimated

Quantity Market Price Accrued Income Unit Cost Cost Basis Gain ( Loss) Yield Annual Income

TOTAL NON-US EQUITY 19,690,407.58 12,709,211.92 6,981,195.66 2.4652 224,205.82

62,944.82

OTHER INVESTMENTSMarket Value / Adjusted Cost / Unrealized Yield to Maturity/ Estimated

Quantity Market Price Accrued Income Unit Cost Original Cost Gain (Loss ) Current Yield Annual Income

ASSET ALLOCATION INVESTMENTS

GS TACTICAL TILT OVERLAY FUND

GS TACTICAL TILT OVERLAY MUTUAL FUND ITTIFX) 359,337.980 9.8100 3,525,105.58 10.3094 3,704,572.04 (179,466.46)Adjusted Cost / I Unrealized Estimated

Market Value Original Cost Gain (Loss) Annual Income

TOTAL PORTFOLIO 26,019,639.65 19,213,225.52 6,743,469.31 328,390.37

20,363,225.52

Generally, the values noted above are based on information provided by the fund administrator For purchases made on the secondary market, the information shown in Total Contributions/Distributions reflects your purchase price and your contributions

only This information does not reflect contributions/distributions made or received by the seller from whom you purchased the position

ATTACHMENT TO EXHIBIT C

Page 3 of 40

6 Original Cost is puce paid by purchaser adjusted for annual onginal issue discount inclusions and/or return of capital adjustments , if applicable Adjusted Cost reflects adjustments to Original Cost for market discount accretion and/or prem ium

amortization Adjusted cost for GMS Portfolios and Alternative Investments are determined by inception to date contributions minus inception to date distributions

Portfolio No XXX-XX700-7 Page 57 of 349

Statement Detail

HTM, JR. FOUNDATION ADV ALL

The Harry T. Mangurlan, Jr. Foundation, Inc. - EIN: 16-1578255 Statement Detail

Schedule of Balance Sheet Assets HTM, JR. FOUNDATION - STOCKS2017 Form 990-PF - PART II, Balance Sheets Holdings


CASH, DEPOSITS & MONEY MARKET FUNDSMarket Value / Adjusted Cost / Unrealized Yield to Maturity / Estimated

Quantity Market Price Accrued Income Unit Cost Original Cost Gain (Loss) Curreet Yield Annual Income


DEPOSITS

GOLDMAN SACHS BANK USA DEPOSIT

FIXED INCOME

18,270 .43 1.0000 18,270.43 1.0000 18,270 . 43 0 00 1.0807 197.45

Quantity / Market Value / Adjusted Cost / Unrealized Yield to Maturity Estimated

Current Face Market Price Accrued Income Unit Cost Original Cost Gain (Loss) in Percentage Annual Income

OTHER FIXED INCOME

CORPORATE CREDIT INVESTMENT STRATEGIES LLC

CORPORATE CREDIT INVESTMENT FUND CLASS A ACCUM 37,247 36 170.8145 6,362,391.00 4,000,000.00

SERIES ACCUMULATING Not RatedAdjusted Cost /' Unrealized Estimated

Market Value Original Cost Gain (Loss) Annual Income

TOTAL PORTFOLIO 6,380,661.43 4,018,270.43 0.00 197.45

6 Original CostUlusted

paid by purchaser adjusted for annual original issue discount inclusions and/or return of capital adjustments" if applicable Adjusted Cost reflects adjustments to Original Cost for market discount accretion and/or premiumamortization Adjusted cost for GMS Portfolios and Alternative, investments are determined by inception to data contributions minus inception to date distributions

14This represents a bank deposit of an affiliated bank reflected here for your convenience and is not cash held in your brokerage or custody account Please see the enclosed Bank Statement pagels) for specific information related to your bank deposit

Not a Deposit Not FDIC Insured May Lose Value (Excluding Goldman Sachs Bank Deposit Account" Term Deposits and Certificates of Deposit)

Brokerage and securities services provided by Goldman, Sachs & Co Bank Deposit Account, Certificates of Deposit and Term Deposits offered by Goldman Sachs Bank USA" Member FDIC ATTACHMENT TO EXHIBIT C

Portfolio No" XXX-XX612-4 Page 4 of 40 Page 14 of 349

wv,I a'11m tnxn-n1.f1»I-.---Mc -'fu

The Harry T. Mangurian , Jr. Foundation, Inc. - EIN: 16-1578255 Statement Detail

Schedule of Balance Sheet Assets HTNI, JR . FOUNDATION LAZARD2017 Form 990-PF - PART II, Balance Sheets Holdings

PUBLIC EQUITYPeriod Ended December 31, 2017


Accrued Income Unit CostAdjusted Cost /

Original CostUnrealizedGain (Loss)

Yield to Maturity /Current Yield


US EQUITY

LAZARD: DYNAMIC EQUITY

GOLDMAN SACHS BANK USA DEPOSIT (BDA) ("BDANOW)14 246,057.40 1.0000 246,057.40 1.0000 246,057.40 1.2124 2,98312

Quantity Market PriceMarket Value

Accrued Income Unit Cost Cost BasisUnrealizedGain (Loss)

DividendYield


ALPHABET INC. CMN CLASS A (GOOGL) 264.00 1,053.4000 278,097.60 663.2674 175,102.60 102,995 00

• APTIV PLC CMN (APTV) 1,48600 84.8300 126,057.38 78.7271 116,988.42 9,068.96

AT&T INC CMN (T) 4,406.00 38 8800 171,305.28 37 2701 164,212.06 7,093.22 5.1440 8,B1 2.00

AUTOZONE, INC. CMN (AZO) 173.00 711 3700 123,067.01 521.9278 90,293.51 32,773 50

CARTER'S, INC. CMN (CRI) 552 00 117 4900 64,854.48 88 0615 48,609 95 16,244.53 12597 816 96

CISCO SYSTEMS, INC. CMN (CSCO) 10,166 00 38.3000 389,357.80 31.1084 316,247 90 73,109 90 30287 11,792 56

COCA-COLA COMPANY (THE) CMN (KO) 7,829.00 45 8800 359,194 52 41.8668 327,774.79 31,419.73 3.2258 11,586.92

CROWN HOLDINGS INC CMN (CCK) 2,759.00 56 2500 155,193 75 54.3294 149,894.93 5,298.82

DXC TECHNOLOGY COMPANY CMN (DXC) 2, 582.00 94 9000 245,031.80 75 4157 194,723 44 50, 308.36 0.7587 1,85904464 76

EBAY INC . CMN (EBAY) 7 ,99000 37.7400 301 ,542 60 28.3495 226,512.67 75,029 93

KELLOGG COMPANY CMN (K) 649 00 67 9800 44 , 119 02 72 0965 46,790 . 64 (2,671 . 62) 3.1774 1,401.84

MOLSON COORS BREWING CO CMN CLASS B (TAP) 4, 288.00 82 . 0700 351 , 916.16 92 . 5595 396 , 89511 (44 , 978.95 ) 1.9983 7,032.32

MOTOROLA SOLUTIONS INC CMN (MSI) 2,890 . 00 90 . 3400 261 ,082.60 82 5645 238,611 . 46 22,471 14

1,502.80

SCHLUMBERGER LTD CMN (SLB) 1,107.00 67.3900 74,600 73 631867 69,947 71 4,653.02 2.9678 2,214.00

553.50

SKYWORKS SOLUTIONS INC CMN (SWKS) 1,751.00 94 9500 166,257 45 80.9234 141,696 88 24,560 57 13481 2,241.28STEEL DYNAMICS, INC. CMN (STLD) 2,020.00 43.1300 87,122.60 34.8972 70,49234 16,630.26 1.4375 1,252 40

313.10

UNITED PARCEL SERVICE, INC CLASS B COMMON STOCK 2,208.00 119.1500 263,083.20 1081976 238,900.37 24,182.83 2.7864 7,33056(UPS)

(' This represents a bank deposit of an affiliated bank reflected here for your convenience and is not cash held in your brokerage or custody account Please see the enclosed Bank Statement page(s) for specific information related to your bank deposit



Portfolio No XXX-XX049.2 Page 5 of 40 Page 302 of 349

(MMI 1 (21-0i02-I1.1S0.01.12662----- It I S 1-29

The Harry T. Mangurian, Jr. Foundation, Inc. - EIN: 16-1578255 Statement Detail

Schedule of Balance Sheet AssetsHTM, JR . FOUNDATION LAZARD

2017 Form 990-PF - PART II, Balance SheetsHoldings (Continued)


PUBLIC EQUITY ( Continued)Market Value/ Unrealized Dividend Estimated

Quantity Market Price Accrued Income Unit Cost Cost Basis Gain (Loss) Yield Annual Income

US EQUITY

LAZARD DYNAMIC EQUITY

WABTEC CORP CMN (WAB) 1,40500 81.4300 114,40915 77.0084 108,196 80 6,212.35 0.5895 674 40

MEDTRONIC PUBLIC LIMITED COMPA CMN (MDT) 5,041.00 80.7500 407,060 75 76 5472 385,874.20 21,186.55

1,855.09

TOTAL LAZARD: DYNAMIC EQUITY 4,229,411 28 3,753,823.18 475,58810 2.3279 59,997 40

4,689.25Adjusted Cost /i Unrealized Estimated

Market Value Original Cost Gain ( Loss) Annual Income

TOTAL PORTFOLIO 4,234, 100.53 3,753,823.18 475,588.10 59,997.40


Page 6 of 40

6 Original Cost is puce paid by purchaser adjusted for annual original issue discount inclusinns and/or return of capital adjustments, if applicable Adjusted Cost reflects adjustments to Original Cost for market discount accretion and/or premiumamortization Adjusted cost for GMS Portfolios and Alternative Investments are determined by inception to date contributions minus inception to date distributions

Portfolio No- XXX-XX049-2 Page 303 of 349

The Harry T. Mangurian , Jr. Foundation, Inc. - EIN: 16-1578255 Statement Detail

Schedule of Balance Sheet Assets HTM, JR. FOUNDATION - SPECIAL INVESTMENT2017 Form 990-PF - PART II , Balance - Sheets Holdings


CASH, DEPOSITS & MONEY MARKET FUNDS


Accrued Income Unit CostAdjusted Cost/


Yield to Maturity/Current Yield



DEPOSITS

GOLDMAN SACHS BANK USA DEPOSIT (BOA)" 276,464 89 1.0000 276,464 89 1.0000 276,464 89 0 00 1.1639 3,21771

ALTERNATIVE INVESTMENTS

Market ValueContributions

To DateDistributions

To Date

EconomicGain (Loss)

HEDGE FUNDS

HEDGE FUND SELECT CORSAIR CAPITAL INVESTORS FLAGSHIP FUND 1,403,928.00 1,250,000 00 0.00 153,928 00

GLOBAL OPPORTUNITIES OFFSHORE LTD 2,437,942 53 2,500,000.00 0 00 (62,057.47)

TOTAL HEDGE FUNDS 3,841,870 .53 3,750 ,000.00 0.00 91,870.53

ommitment

TotalContributions/

Distributions

Remaining

Commitment

Net Contributions/( Distributions )

Since Inception

Latest CapStatement Value/

Statement Date

Net Contributions/(Distributions)Since Lest Cap

Statement

Computed

Market Value

Economic

Gain (Loss)

PRIVATE EQUITY

VINTAGE V GMBH & CO KGClosing Date:Jun,2008'Q2'

5,000,000 00 4,085,038.76

5,781,984.00

1,528,412 24 (1,696,945 24) 1,044,829.00

Sep 30, 2017

(215,405.00) 829,424.00 2,526,369.24

VINTAGE VI 1P712' 2,000,000.00 1,580,622.90

1,124,739.03

758,196.45 455,883.87 1,143,831.00

Sep 30, 2017

(188,691.02) 955,139.98 499,25611

10Contrlbutions may include fees Distributions may be net of fees

"This represents a bank deposit of an affiliated bank reflected here for your convenience and is not cash hold in your brokerage or custody account Please see the enclosed Bank Statement page(c) for specific information related to your bank deposit

72Estimated using Net Asset Value (NAV), when available, or estimated as Computed Market Value minus adjusted Cost Basis

24Dlstributions of this investment may be subject to reinvestment or recall by the partnership before or after the expiration of the commitment period

20Thls is based on Net Asset Value (NAV), when available, or estimated as total capital balance, when available, plus any contributions and minus any distributions since the last capital statement



Portfolio No- XXX-XX965-3 Page 7 of 40Page 72 of 349

Orin 1R2t-nn72M 11.0142412-•---0151.29

The Harry T. Mangurian , Jr. Foundation , Inc. - EIN: 16-1578255




ALTERNATIVE INVESTMENTS (Continued)Net Contributions/

Total Net Contributions/ Latest Cap ( Distributions)

Contributions/ Remaining (Distributions) Statement Value/ Since Last Cap Computed Economic

Commitment Distributions Commitment Since Inception Statement Date Statement Market Value 0 Gain (Loss) °

PRIVATE EQUITY

VINTAGE VII LP 2,000,000 00 590,123.21 1,441,612 18 454,322 69 190,549.00 286,838.53 477,387.53 23,064 84

Closing Date:May,20151(12' 135,800.52 Sep 30, 2017

WEST STREET CAPITAL PARTNERS VII, L P. 2,000,000 00 800,000.00 1,200,000 00 800,000.00 766,124.00 0.00 766,124.00 (33,876 00)

0.00 Sep 30, 2017

SILVER POINT DISTRESSED OPPORTUNITIES ACCESS LP1e 1,500,000.00 0.00 1,500,000.00 0.00 N/A N/A 0.00 N/A

0.00 N/A

WEST STREET ENERGY PARTNERS 1,000,000.00 829,537.00 170,463 00 609,057.00 802,254 00 (62,068 00) 740,186.00 131,129 00

Closing Date:May,20121e 220,480 00 Sep 30, 2017

BPG INVESTORS, L.P 10 275,000.00 275,000.00 0.00 275,000 00 274,783.00 0 00 274,783 00 (217.00)

0.00 Sep 30, 2017

ORT INVESTORS OFFSHORE, LP 1,000,000 00 1,040,000.00 0.00 1,040,000.00 1,069,550.00 0.00 1,069,550.00 29,550 00

Closing Oate:Dec,2014'1 0.00 Sep 30, 2017

TOTAL PRIVATE EQUITY 14,775,000.00 9200,321.87 6,598,683.87 5,112,594 .51 3,175,276.19

7,263 ,003.55

REAL ESTATE

CADRE ACCESS LP1e 1,250,000 00 0.00 1,250,000.00 0.00 N/A N/A 0.00 N/A

0.00 N/A

US REAL PROPERTY INCOME FUND 2,650,000 00 2,650,000.00 0 00 2,291,702.00 2,948,908.00 (32,153.00) 2,916,755.00 625,053.00

Closing Date:Sep,2011'° 358,298.00 Sep 30, 2017

TOTAL REAL ESTATE 3,900,000.00 2,650.000 .00 1,250,000.00 2,916,755.00 625,053.00

358,298.00

ATTACHMENT TO EXHIBIT C10Contributions may include fees. Distributions may be net of fees

Estimated using Net Asset Value INAVI, when available. or estimated as Computed Market Value minus adjusted Cost Basis Page 8 of 4021 Distributions of this investment may be subject to reinvestment or recall by the partnership before or after the expiration of the commitment period

25This is based on Net Asset Value (NAV), when available, or estimated as total capital balance, when available, plus any contributions and minus any distributions since the last capital statement

Portfolio No XXX-XX965.3 Page 73 of 349

Statement Detail

HTM, JR. FOUNDATION - SPECIAL INVESTMENTHoldings (Continued)


Schedule of Balance Sheet Assets HTM, JR. FOUNDATION - SPECIAL INVESTMENT2017 Form 990-PF - PART II, Balance Sheets Holdings (Continued)


ALTERNATIVE INVESTMENTS (Continued)Net Contributions/

Total Net Contributions/ Latest Cap (Distributions)

Contributions/ Remaining (Distributions) Statement Value/ Since Lest Cap Computed EconomicCommitment Distributions Commitment Since Inception Statement Date Statement Market Value is Gain (Loss) a

OTHER ALTERNATIVE INVESTMENTS

BROAD STREET REAL ESTATE CREDIT PARTNERS III1e 900,000.00 31,500.00 868,500.00 31,500 00 8,317.00 22,500.00 30,817.00 (683.00)0 00 Sep 30, 2017

TOTAL ALTERNATIVE INVESTMENTS 19,575,000.00 15,631,821 .87 8,717,183.87 11,902,037.04 3,891,516.72

7,621,301.55

Adjusted Cost /" Unrealized EstimatedMarket Value Original Cost Gain (Loss) Annual Income

TOTAL PORTFOLIO 12,178,501.93 8,286,985.21 3,891,516.72 3,217.7115,908,286.76

Generally, the values noted above are based on information provided by the fund administrator for purchases made on the secondary market, the information shown in Total Contribution/Distributions reflects your purchase price and your contributionsonly This information does not reflect contributions/distributions made or received by the seller from whom you purchased the position

o Original Cost is price paid by purchaser adjusted for annual ongcoal issue discount inclusions and/or return of capital adjustments , if applicable Adjusted Cost reflects adjustments to Original Cost for market discount accretion and/or premiumamortization Adjusted cost for GMS Portfolios and Alternative Investments are determined by inception to date contributions minus inception to date distributions

1tContnbauons may include fees Distributions may be net of fees

zzEstimated using Net Asset Value INAVI, when available , or estimated as Computed Market Value minus adjusted Cost Basis

ThThis is based on Net Asset Value ( NAV), when available, or estimated as total capital balance, when available, plus any contributions and minus any distributions since the last capital statement ATTAdu. MNT TO EXHIBIT C

Portfolio No XXX-XX965.3 Page 9 of 40 Page 74 of 349

nrXuI621-nn74-n1$ ()142414-----0I51-29

Irmn

The Harry T. Mangurian, Jr, Foundation, Inc. - EIN: 16-1578255



Statement Detail

HTM, JR. FOUNDATION DELAWAREHoldings

Period Ended December 31, 2017PUBLIC EQUITY

Quantity Market PriceMarket Value I





NON-US EQUITYDELAWARE: NON US EQUITY

U S DOLLAR 463.98 1 0000 463.98 463.98GOLDMAN SACHS BANK USA DEPOSIT (BDA) ("BDANOW)14 193,237.76 1 0000 193,237 76 1.0000 193,237 76 1.1595 2,240.57

Quantity Market Price

Market Value IAccrued Income Unit Cost Cost Basis

Unrealized

Gain (Loss)

Dividend

Yield

Estimated

Annual IncomeCK HUTCHI SON HLDGS LTD ADR CMN (CKHUY) 16,175.00 12.5550 203,077.13 12.8409 207,701 73 (4,624 61) 2.4258 4,926.29ABB LTD SPONSORED ADR CMN (ABB) 10,741.00 26.8200 288,073 62 229279 246,268.72 41,804.90 2.7408 7,895.49ALLIANZ SE ADR CMN (AZSEY) 11,619.00 22.9950 267,178.91 16.7768 194,929.17 72,249.74 2.6565 7,097.58BANCO SANTANDER, S.A SPON ADR (SAN) 22,812.00 6.5400 149,190 48 10.3879 236,969.20 (87,778 72) 2.9907 4,461.82BP P.L. C SPONSORED ADR CMN (BP) 7,11200 42 0300 298,917.36 43 0696 306,311 28 (7,393 92) 56626 16,926.56CANON INC ADR SPONSORED ADR CMN (CAJ) 4,583.00 37 4000 171,404.20 32 9049 150,80315 20,601 05 32644 5,595.34CHINA MOBILE LIMITED SPONSORED ADR CMN (CHL) 5,131 00 50 5400 259,320.74 51.9231- 266,417.47 (7,096.73) 3.2673 8,47280DAIMLER AG ADR CMN (DMLRY) 3,495.00 84.6350 295,799.33 79.4200 277,572 87 18,226 46 2.9884 8,83975DEUTSCHE TELEKOM AG SPONSORED ADR CMN (DTEGY) 10,129.00 17 7660 179,951 81 17.2090 174,309.96 5,641.85 3.6736 6,610.63ENEL SOCIETA PER AZIONI ADR CMN (ENLAY) 49,816.00 6.1600 306,866 56 4.5247 225,401 17 81,465.39 2.0756 6,36917ENI S.P.A SPON ADR SPONSORED ADR CMN (E) 8,47000 33.1900 281,119 30 40 5831 343,738.91 (62,619.61) 39603 11,133 27FUJIFILM HOLDINGS CORPORATION ADR CMN (FUJIY) 1,064 00 408790 43,495.26 41.2101 43,847.55 (352 29) 1.0662 463 76GLAXOSMITHKLINE PLC SPONSORED ADR CMN (GSK) 6,281.00 354700 222,787.07

3,198.20

52 5277 329,926.24 (107,139.17) 5.7985 12,918 28

HONDA MTR LTD (AMER SHS) ADR CMN (HMC) 9,620.00 34 0800 327,849 60 31.6883 304,841.13 23,008.47 2.2074 7,237.03IBERDROLA, SOCIEDAD ANONIMA SPONSORED ADA CMN(IBORY)

10,125.00 31.0290 314,168.63 29.2332 295,986.10 18,182.53 3.7566 11,802 09

ISUZU MOTORS LTD ADR ADR CMN (ISUZY) 3,35600 16 7510 56,216 36 12 9036 43,304.48 12,911.88 1.1730 659.40KINGFISHER PLC SPONSORED ADR CMN (KGFHY) 32,243 00 91370 294,604.29 8 4519 272,513 39 22,090 90 2.5999 7,659.32KONINKL IJKE AHOLD N V. SPONSORED ADR CMN (ADRNY) 13,998 00 22 0170 308,193 97 19 0887 267,204 32 40,989 65 23147 7,13374LLOYDS BANKING GROUP PLC SPONSORED ADR CMN (LYG) 88,445.00 3.7500 331,668.75 3.7387 330,673.48 995.27 3.7632 12,481.45NATIONAL GRID PLC SPONSORED ADR CMN (NGG) 2,771.00 58.8100 162,962 51

5,640 7178 0664 216,321 90 (53,359 39) 4.8959 7,97854

NOVARTIS AG-ADR SPONSORED ADR CMN (NVS) 3,219 00 83 9600 270,267.24 86 4575 278,306 62 (8,039 38) 2.7425 7,412.06

"This represents a bank deposit of an affiliated bank reflected here for your convenience and is not cash held in your brokerage or custody account Please see the enclosed Bank Statement page(s) for specific information related to your bank depositNot a Deposit Not FDIC Insured May Lose Value (Excluding Goldman Sachs Bank Deposit Account, Term Deposits and Certificates of Deposit)

Brokerage and securities services provided by Goldman, Sachs & Co Bank Deposit Account, Certificates of Deposit and Term Deposits offered by Goldman Sachs Bank USA, Member FDIC ATTACHMENT TO EXHIBIT CPortfolio No XXX•XXBDB-5

Page 10 of 40Page 151 of 349

(e$)16214I I 1141350-0142511 ----- 0I %I -2`1




Statement Detail

HTM, JR. FOUNDATION DELAWAREHoldings (Continued)


PUBLIC EQUITY ( Continued)Market Value I Unrealized Dividend Estimated

Guentity Market Price Accrued Income Unit Cost Cost Basis Gain (Loss) Yield Annual Income

NON-US EQUITY

DELAWARE: NON US EQUITY

NTT DOCOMO, INC. SPONSORED ADR CMN (DCM) 3,307.00 23.7700 78,607 39 16.8949 55,871.44 22,735 95 2 9954 2,35463

OBE INSURANCE GROUP LIMITED SPONSORED ADR CMN 19,836.00 8.3530 165,690.11 8.7687 173,935.07 (8,244 96) 47982 7,950,09

(QBIEY)ROYAL DUTCH SHELL PLC SPONSORED ADR CMN SERIES A 87.00 66 7100 5,80377 50.3926 4,384.16 1,419.61 4.7909 278.05

ROYAL DUTCH SHELL PLC SPONSORED ADR CMN SERIES B 4,409.00 68.2900 301,090.61 41.6200 183,502 76 117,587.85 5.5059 16,577 84

(RDSB)

RWE AG AKTIENGESELLSCHAFT SPON ADR (RWEOY) 1,646.00 20 4140 33,601 44 23.7213 39,045 29 (5,443.85)

SANOFI SPONSORED ADR CMN (SNY) 6,643.00 43 0000 285,649.00 49.0509 325,844.92 (40,195.92) 2.5545 7,296.79

SAP SE (SPON ADR) (SAP) 2,282.00 112 3600 256,405 52 71.7733 163,786.64 92 ,618.88 0.8724 2,236.81

SINGAPORE TELECOMMUNICATIONS L SPONSORED ADR 6,04700 26.7140 161,539 56 31. 1800 188,545.46 (27,005 90) 46915 7,57860

CMN (SGAPY) 4,200 44

TAIWAN SEMICONDUCTOR MFG ADS LTD ADS 1 ADS EQUALS

5ORDS (TSM)

6,42100 39.6500 254,592.65 17.2663 110,867.11 143,725.54 2.3228 b,91 3.b9

TAKEDA PHARMACEUTICAL COMPANY SPONSORED ADR

CMN (TKPYY)

12,304.00 28 4110 349,568.94 22.9330 282,167.32 67,401.62 2.1567 7,53912

TELEFONICA S.A. ADR SPONSORED ADR CMN (TEF) 19,800.00 96800 191,664.00 15.3512 303,952 80 (112,288 80) 3 6306 6,958.59

TELIA CO AB UNSPONSORED ADR CMN (TLSNY) 29,999.00 89280 267,831 07 10.7805 323,405.10 (55,574.03) 3 6455 9,763.65

TESCO PLC (SPONSORED) ADR SPONSORED ADR CMN

(TSCDY)

40,343.00 8.4920 342,592.76 10.3798 418,753.58 (76,160.82) 04712 1,61416

TOKIO MARINE HOLDINGS, INC ADR CMN (TKOMY) 6,77900 45.6370 309,373.22 34.1137 231,256.73 78,116.49 2.4146 7,47002

UNITED OVERSEAS BK LTD SPONSORED ADR CMN (UOVEY) 8,258.00 39 5840 326,884 67 32.9686 272,254.58 54,630.09 2.5747 8,416.25

WPP PLC ADR CMN (WPP) 1,002.00 90.5600 90,741.12 88.3084 88,485.00 2,256. 1 2 4 3 169 3,9 17.21


Portfolio No: XXX-XX8M-5 Page 11 of 40Page 152 of 349

000I 62.'i-0152-03.5 0142512---- 0151.29

The Harry T. Mangurian , Jr. Foundation , Inc. - EIN : 16-1578255



PUBLIC EQUITY (Continued)

Statement Detail

HTM, JR. FOUNDATION DELAWAREHoldings (Continued)


Market Value /Quantity Market Price Accrued Income Unit Cost Cost Basis


DividendYield


NON-US EQUITY

DELAWARE' NON US EQUITY

ZURICH INS GROUP LTD SPONSORED ADR CMN (ZURVY) 6,718.00 30.4360 204,469.05 29.0672 195,273.24 9,195.81 3.0872 6,312.27

TOTAL DELAWARE: NON US EQUITY 8,852,919.74

13,039 35

8,568,381.78 284,537 95 3 0445 268,492.73

Market ValueAdjusted Cost/

Original CostUnrealizedGain ( Loss)

Estimated

Annual Income

TOTAL PORTFOLIO 8,865 ,959.09 8,568,381.78 284,537 .95 268,492.73


Page 12 of 40

6 Original Cost is price paid by purchaser adjusted for annual original issue discount inclusions and/or return of capital adjustments, if applicable Adjusted Cost reflects adjustments to Original Cost for market discount accretion and/or premiumamortization Adjusted cost for GMS Portfolios and Alternative Investments are determined by inception to date contributions minus inception to date distributions

Portfolio No XXX-XXB00-5 Page 153 of 349

Statement DetailThe Harry T. Nangurian, Jr. Foundation, Inc. - EIN: 16-1578255

Schedule of Balance Sheet AssetsHTM, JR FOUNDATION INVESCO

2017 Form 990-PF - PART II, Balance Sheets Holdings

PUBLIC EQUITYPeriod Ended December 31, 2017




Yield to Maturity!Current Yield


US EQUITY

INVESCO. LARGE CAP VALUE

U S DOLLAR 317.55 1.0000 317.55 317.55

GOLDMAN SACHS BANK USA DEPOSIT (BDA) ('BDANOW)" 319,144.15 1.0000 319,144 15 10000 319,144.15 1.1539 3,682.49


Market Value I

Accrued Income Unit Cost Cost Basis

Unrealized

Gain (Loss)

Dividend

Yield

Estimated

Annual Income

ALTRIA GROUP, INC. CMN (MO) 702.00 71.4100 50,129 82

463.32

67 6157 47,466.22 2,663.60 36970 1,853.28

AMERICAN ELECTRIC POWER INC CMN (AEP) 924 00 73.5700 67,978.68 63.1946 58,391 81 9,586.87 3.3709 2,291.52

AMERICAN EXPRESS CO. CMN (AXP) 466.00 99.3100 46,278.46 75.3837 35,128 80 11,149 66 1 4097 652 40

AT&T INC CMN (1) 2,80800 38.8800 109,175 04 421330 118,309 58 (9,134.54) 5.1440 5,61600AUTOMATIC DATA PROCESSING INC CMN (ADP) 517 00 1171900 60,587.23

32571

103 2485 53,379.50 7,207.73 2.1504 1,30264

BAKER HUGHES,A GE CO CMN (BHGE) 1,10600 31 6400 34,993 84 321296 35,535 37 (541.53)

BRISTOL-MYERS SQUIBB COMPANY CMN (BMY) 1,373.00 612800 84,137 44 55.7310 76,518.72 7,61872 2.6110 2,196.80

CAMPBELL SOUP CO CMN (CPB) 1,56500 481100 75,29215 60 5466 94,755 43 (19,463.28) 2 9100 2,191.00

COCA-COLA COMPANY (THE) CMN (KO) 2,068.00 45.8800 94,879.84 41 6390 86,109 46 8,77038 32258 3,060.64

COLUMBIA SPORTSWEAR COMPANY COMMON STOCK(COLM)

433.00 71.8800 31,124 04 57.4508 24,876 20 6,247.84 1.0573 32906

CONOCOPHILLIPS CMN (COP) 1,366.00 54.8900 74,979 74 46.4016 63,384 57 11,595.17 1.9311 1,44796

CONSOLIDATED EDISON INC CMN (ED) 658.00 84.9500 55,89710 73 5309 48,383.33 7,513.77 3.2490 1,81608

CULLEN FROST BANKERS INC CMN ICFR) 280.00 94.6500 26,502.00 87.3400 24,455.20 2,046.80 2.4089 63840

DARDEN RESTAURANTS INC CMN (DRI) 256 00 96.0200 24,581.12 75.9277 19,437.49 5,14363 2.6245 645.12

DOMINION ENERGY INC CMN (D) 1,077.00 81.0600 87,301.62 76.9544 82,879.91 4,421.71 37997 3,31716

DUKE ENERGY CORPORATION CMN (DUK) 447 00 84.1100 37,59717 77.4411 34,61617 2,981.00 3.6381 1,36782

ELI LILLY & CO CMN (LLY) 956.00 844600 80,743 76 75 7961 72,461 07 8,28269 2.6640 2.15100

EMERSON ELECTRIC CO. CMN (EMR) 906.00 69.6900 63,13914 57.0895 51,723.08 11,416 06 27838 1,757.64

ENTERGY CORPORATION CMN (ETR) 618 00 81 3900 50,299.02 73.3489 45,329.61 4,969.41 4.3740 2,200 08

EXELON CORPORATION CMN (EXC) 2,576 00 39 4100 101,520.16 355004 91,449 03 10,071 13 3.3240 3,374.56

FEDERATED INVESTORS, INC CMN CLASS B (FII) 1,439.00 36.0800 51,91912 27.9696 40,248.25 11,670 87 2 7716 1,43900

11 This represents a bank deposit of an affiliated bank reflected here for your convenience and is not cash held in your brokerage or custody account Please see the enclosed Bank Statement page(s) for specific information related to your bank deposit

Not a Deposit Not FDIC Insured May Lose Value (Excluding Goldman Sachs Bank Deposit Account, Term Deposits and Certificates of Deposit) ATTACHMENT TO EXHIBIT CBrokerage and securities services provided by Goldman, Sachs & Co Bank Deposit Account, Certificates of Deposit and Term Deposits offered by Goldman Sachs Bank USA, Member FDIC

Portfolio No. XXX•XX050.0 Page 13 of Page 323 of 349

IM0 t623-n323-v3so.0 142u -----otci 29




Statement Detail

HTM, JR FOUNDATION INVESCOHoldings (Continued)


PUBLIC EQUITY ( Continued)MarketVelue/ Unrealized Dividend Estimated


US EQUITY

INVESCO: LARGE CAP VALUE

FIFTH THIRD BANCORP CMN (FITB) 1,793.00 30.3400 54,399.62 27 7088 49 ,681.88 4,717.74 2.1094 1,14752

286.88

FLOWSERVE CORPORATION CMN (FLS) 1,775.00 42.1300 74,780.75 47.9333 85,081.60 (10,300.85) 1.8039 1,34900

GENERAL DYNAMICS CORP CMN (GO) 288.00 2034500 58,593.60 174 7149 50,317 89 8,275.71 1.6515 967.68.

GENERAL MILLS INC CMN (GIS) 2,06800 59.2900 122,611 72 62.0986 128,419 86 (5,808.14) 3.3058 4,053.28

HARLEY-DAVIDSON INC CMN (HOG) B70 00 50.8800 44,265 60 59 5342 51,794 75 (7,52915) 2.8695 1,270.20

HARTFORD FINANCIAL SRVCS GROUP CMN (HIG) 2,268.00 56 2800 127,643 04

567.00

48.3972 109,764 85 17,87819 1.7768 2,268.00

INTERNATIONAL PAPER CO. CMN (IP) 880.00 57 9400 50,987.20 54.1232 47,628 42 3,358.78 3.2793 1,672.00

JOHNSON & JOHNSON CMN (JNJ) 460.00 139 7200 64,271 20 115 2913 53,034 00 11,237.20 2.4048 1,545 60

KEYCORP CMN (KEY) 1,93400 20.1700 39,008.78 18 3904 35,567.03 3,441.75 2.0823 812 28

KIMBERLY CLARK CORP CMN (KMB) 547.00 120.6600 66,001.02

530.59

115.9461 63,422.51 2,578.51 3.2156 2,122 36

M&T BANK CORPORATION CMN (MTB) 504 00 170 9900 86,178 96 156.2566 78,753.33 7,425.63 1.7545 1,512.00

MONDELEZ INTERNATIONAL, INC CMN (MDLZ) 1,002.00 42.8000 42,885.60

220.44

44.9300 45,019 86 (2,134.26) 1.2150 521.04

PHILIP MORRIS INTL INC CMN (PM) 369.00 105.6500 38,984 85

394.83

91 4737 33,753 80 5,231 05 4.0511 1,579 32

PPL CORPORATION CMN (PPL) 3,043 00 30 9500 94,180 85

1,20199

34.7562 105,76312 (11,582.27) 51050 4,807 94

PROCTER & GAMBLE COMPANY (THE) CMN (P6) 902.00 91,8800 82 ,875.76 84.4594 76,182.38 6,693.38 3.0022 2,488 08

RAYTHEON COMPANY CMN (RTN) 134 00 187 8500 25,171 90 143 0900 19,174 06 5,99784 16982 427.46

SEMPRA ENERGY CMN (SRE) 558 00 106 9200 59,661.36

458.96

105 3160 58,766.32 895.04 30771 1,835.82

SONOCO PRODUCTS CO CMN (SON) 980 00 53.1400 52,077 20 53 9389 52,86012 (782.92) 29356 1,52880

Portfolio No XXX-XX050-0



0001623 0324-0350.0142684 ---- 0151-29




Statement Detail

HTM, JR FOUNDATION INVESCOHoldings (Continued)


PUBLIC EQUITY ( Continued)Market Value / Unrealized Dividend Estimated


US EQUITY

INVESCO' LARGE CAP VALUE

STRYKER CORPORATION CMN (SYK) 162.00 154.8400 25,084 08 119.2500 19,318.50 5,76558 1.2142 3U4.5b

76.14

SYSCO CORPORATION CMN (SYY) 827.00 60.7300 50,223 71 56.5127 46,736 00 3,48771 2.3712 1,190.88

TAPESTRY, INC. CMN (TPR) 515 00 44.2300 22,778 45 35.7929 18,433 34 4,34511

173.81

TARGET CORPORATION CMN (TGT) 1,098.00 65.2500 71,644.50 65.9465 72,409.24 (764.74) 3.8008 2,723.04

THE KRAFT HEINZ CO CMN (KHC) 752.00 77 7600 58,475.52 866935 65,193 51 (6,717.99) 3.2150 1,88000

THE TRAVELERS COMPANIES, INC CMN (TRV) 336.00 135 6400 45,575.04 122.8700 41,284.32 4,290.72 2.1233 967.68

TIME WARNER INC. CMN (TWX) 505.00 91.4700 46,192.35 956976 • 48,327 29 (2,134 94) 17601 813.05

TJX COMPANIES INC (NEW) CMN (TJX) 693.00 76.4600 52,986 78 76.6905 53,146 52 (159 74) 1.6348 866.25

UNITED PARCEL SERVICE, INC CLASS B COMMON STOCK

(UPS)

482.00 1191500 57,430 30 111 8571 53,91511 3,515.19 2.7864 1,600.24

ZIONS BANCORP CMN (ZION) 1,471.00 508300 74,770 93 43.4637 63,93510 10,835 83 12591 941 44

WEYERHAEUSER COMPANY CMN (WY) 1,936.00 35.2600 68,263.36 32.3530 62,635.45 5,627 91 3 6302 2,478.08

ABB LTD SPONSORED ADR CMN (ABB) 1,868.00 26.8200 50,099.76 21.1263 39,463.93 10,635 83 2.7408 1,373.13

BAYER AG-SPONSORED ADR SPONSORED ADR CMN (BAYRY) 932.00 31 2210 29,097.97 33 0075 30,762.99 (1,665.02) 1 7270 502.52

BT GROUP PLC ADR CMN (BT) 3,397.00 18 2200 61,893.34

1,008.15

221997 75,412 51 (13,51917) 5.2828 3,269.70

DEUTSCHE TELEKOM AG SPONSORED ADR CMN (DTEGY) 3,338.00 17.7660 59,302 91 16.7100 55,777 98 3,524.93 3.6736 2,178.53

HEINEKEN N.V. SPONSORED ADR CMN (HEINY) 625.00 52.1930 32,620 63 37.2400 23,275 00 9,345.63 11664 380 49

L'OREAL CO (ADR) ADR CMN (LRLCY) 846.00 44.4180 37,577.63 37 2246 31,492.03 6,085.60 1.2460 468 23

PENTAIR PLC. CMN (PNR) 389.00 70.6200 27,471.18 57.4981 22,366.76 5,10442

ROYAL DUTCH SHELL PLC SPONSORED ADR CMN SERIES A

(ROSA)

465.00 66 7100 31,02015 54 2300 25,216 95 5,803 20 4.7909 1,48614

SIEMENS AKTIENGESELLSCHAFT SPONSORED ADR CMN(SIEGY)

467 00 69 7360 32,566 71 704275 32,889.64 (322.93) 23010 749.35

SSE PLC SPONSORED ADR CMN (SSEZY) 2,303.00 17.8560 41,122.37 19.7518 45,488.45 (4,366.08) 6.7090 2,75891

SUNCOR ENERGY INC. CMN (SU) 2,947.00 36 7200 108,213 84 32.9117 96,990.78 11,223.06 27389 2,963.86

ATTACUMENT TO

Page 15 of 40

EXHIBIT C

Portfolio No XXX-XX050.0Page 325 of 349


Schedule of Balance Sheet Assets HTM, JR FOUNDATION INVESCO2017 Form 990-PF - PART II, Balance Sheets Holdings (Continued)


PUBLIC EQUITY (Continued)Market Value! Unrealized Dividend Estimated

Guam Market Price Accrued Income Unit Cost Cost Basis Gain (Loss) Yield Annual Income

US EQUITY

INVESCO. LARGE CAP VALUE

TOTAL SA SPONSORED ADR CMN (TOT) 1,840.00 55.2800 101,715 20 49.6701 91,393.06 10,32214 4.2769 4,350 23

945.34

TOTAL INVESCO- LARGE CAP VALUE 3,999,223 91 3,785,150.74 214,073.17 2.7975 109,485.55

6,65316Adjusted Cost /e Unrealized Estimated

Market Value Original Cost G ai n (Lo s s) Annual Income

TOTAL PORTFOLIO 4,005,877.07 3,785,150.74 214,073.17 109,485.55

5 Original Cost gice paid by purchaser adjusted for annual original issue discount inclusions and/or return of capital adjustments, if applicable Adjusted Cost reflects adjustments to Original Cost for market discount accretion and/or premium

amortization Adjusted cost for GMS Portfolios and Alternative Investments are determined by inception to date contributions minus inception to date distributions

Portfolio No XXX-XX050-0 ATTACHMENT TO EXHIBIT C Page 326 of 349

Page 16 of 40

00(l11621.012 6-0t5a-r)l424Wi ..--rlISI.29




FIXED INCOME

Statement Detail

HTM, JR . FOUNDATION GOV/CORP I'llHoldings


Market Value/ Adjusted Cost / Unrealized Yield to Maturity / EstimatedQuantity Market Price Accrued Income Unit Cost Original Cost Gain (Loss) Current Yield Annual Income

INVESTMENT GRADE FIXED INCOME

GS- GOVERNMENT/CORPORATE FIXED INCOME

GOLDMAN SACHS BANK USA DEPOSIT (BDA)14 60,894.44 1 0000 60,894 44 1.0000 60,894 44 1.1353 691 34

Quantity / Market Value / Adjusted Cost / Unrealized Yield to Maturity EstimatedCurrent Face Market Price Accrued Income Unit Cost Original Cost Gain (loss) in Percentage Annual Income

KEYBANK NATIONAL ASSOCIATION 1.65% 02/01/2018 SER 1,400,000.00 99.9740 1,399,636.00 99.9040 1,398,656.00 980.00 1.6701 23,100.00BKNT SR LIEN S&P A- /Moody's A3 9,625.00

WAL-MART STORES, INC. 5.8% 02/15/2018 SR LIEN S&P AA 750,000 00 100.4420 753,315.00 100.1663 751,24718 2,06782 44401 43,500.00/Moody's Aa2 16,433 33 109 89 824,175,00 (70,860 00)

AUTONATION, INC. 6.75% 04/15/2018 SR LIEN S&P BBB- 500,000.00 101.2440 506,220.00 101.1490 505,744 90 47510 2.7128 33,750 00/Moody's Baa3 7,12500 108 64 543,220 00 (37,000.00)

FORD MOTOR CREDIT COMPANY LLC 5 0% 05/15/2018 SR 700,000.00 101.0180 707,126 00 100.9372 706,560 40 565 60 2 4561 35,000.00LIEN S&P BBB /Moody's Baa2 4,472.22 110.79 775,558 00 (68,432 00)

EXXON MOBIL CORPORATION 1.819% 03/15/2019 USD SR 1,500,000.00 998400 1,497,600 00 100.0755 1,501,133.02 (3,533.02) 17553 27,285 00LIEN Next Call Dt. 021519 S&P AA+ /Moody's Aaa 8,033.92 100.23 1,503,420 00 (5,820.00)

BANK OF AMERICA CORPORATION MTN 2 65% 04/01/2019 1,300,000.00 1005680 1,307,384 00 100 7229 1,309,397 71 (2,013.71) 2.0609 34,450 00

USO SER L SR LIEN S&P A- /Moody's A3 8,612.50 102.22 1,328,860 00 (21,476.00)

UNITED PARCEL SERVICE, INC. 5125% 04/01/2019 USD SR 850,000.00 103.7180 881,603.00 1001957 851,663 04 29,939.96 4.9623 43,562 50LIEN S&P A+ /Moody's Al 10,890.63 101.23 860,487.50 21,115 50

LYONOELLBASELL INDUSTRIES N.V. 5.0% 04/15/2019 USD 622,000.00 102.6730 638,626.06 103.0893 641,215.33 (2,589.27) 2.5461 31,100.00SER B SR LIEN Next Call Dt. 01 15 19 S&P BBB+ /Moody's 6,56556 113 34 704,999 68 (66,373 62)BaalCBS CORP 2 3% 08/15/2019 USD SR LIEN Next Call Dt. 07 15 1,300,000.00 99 9300 1,299,090.00 99.6960 1,296,048.00 3,042.00 2.3650 29,900.0019 S&P BBB /Moody's Baa2 11,295 56

DR PEPPER SNAPPLE GRP INC 2.0% 01/15/2020 USD SR LIEN 750,000 00 99.2180 744,135.00 99 0427 742,820.37 1,314 63 2.4840 15,000 00S&P BBB+ /Moody's Baal 6,916.67 9818 736,320 00 7,81500

"This represents a bank deposit of an affiliated bank reflected here for your convenience and is not cash held in your brokerage or custody account Please see the enclosed Bank Statement page(s) for specific information related to your bank deposit


Brokerage and securities services provided by Goldman, Sachs & Co Bank Deposit Account, Certificates of Deposit and Term Deposits offered by Goldman Sachs Bank USA, Member FDIC

Portfolio No: XXX-XX891.6 ATTACHMENT TO EXHIBIT C Page 94 of 349

Page 17 of 40

non 1623-0094-03 50-01424-4----0151-29

Statement Detail

The Harry T. Mangurian, Jr. Foundation, Inc. - EIN: 16-1578255HTM, JR. FOUNDATION GOV/CORP Fl

Schedule of Balance Sheet AssetsHoldings (Continued)



FIXED INCOME ( Continued)Quantity / Market Value / Adjusted Cost / Unrealized Yield to Maturity Estimated



GS. GOVERNMENT/CORPORATE FIXED INCOME

JPMORGAN CHASE & CO 2.25% 01/23/2020 USD SR LIEN 1,250,000 00 99.9330 1,249,162.50 99 5788 1,244,735.00 4,427.50 2.3400 28,125.00

Next Call Ot. 12 23 19 S&P A- /Moody's A3 12,343 75

ROYAL BANK OF CANADA 1.875% 02/05/2020 SER CB18 SR 650,000 00 991710 644,611 50 99.9860 649,909.00 (5,297.50) 1.8779 12,187.50

LIEN Moody's Aaa 4,942 71

AGILENT TECHNOLOGIES, INC 5.0% 07/15/2020 USD SR LIEN 1,000,000.00 1061840 1,061,840.00 103 4487 1,034,486.85 27,35315 35680 50,000.00

S&P BBB+ /Moody's Baal 23,055.56 108.31 1,083,060 00 (21,220.00)

CNA FINANCIAL CORPORATION 5 875% 08/15/2020 USD SR 1,000,000 00 108.1670 1,081,670.00 107 0206 1,070,205 95 11,464.05 3 0701 58,750 00

LIEN S&P BBB+ /Moody's Baal 22,194 44 111 84 1,118,380.00 (36,710 00)

PNC BANK, NATIONAL ASSOCIATION 2.45% 11/05/2020 USD 675,000 00 100.1500 676,012.50 99.9340 674,554 50 1,458.00 2.4641 16,537 50

SER BKNT SR LIEN Next Cal I Ot 10 06 20 S&P A /Moody's A2 2,57250

U.S. BANCORP MTN 2 35% 01/29/2021 USD SR LIEN Next 500,000.00 100 0170 500,085 00 99.9860 499,930.00 155 00 2 3530 11,750.00

Call Dt.12 29 20 S&P A+ /Moody's Al 4,961.11

WELLS FARGO & COMPANY 2 5% 03/04/2021 USD SR LIEN 1,000,000 00 99 9540 999,540 00 99 9770 999,770.00 (230 00) 2 5049 25,000 00

S&P A /Moody's A2 8,125.00

CITIGROUP INC 2.7% 03/30/2021 USD SR LIEN S&P BBB+ 750,000.00 100 3040 752,280.00 998560 748,920 00 3,36000 27310 20,250.00

/Moody's Baal 5,062 50

CAPITAL ONE, NATIONAL ASSOCIAT 2.95% 07/23/2021 USD 925,000.00 100.5960 930,513 00 99.7180 922,391 50 8,121.50 2.9950 27,287 50

SER BNKT SR LIEN Next Call Dt. 06 23 21 S&P BBB+ 11,976.18

/Moody's BaalSYNCHRONY FINANCIAL 3.75% 08/15/2021 USD SR LIEN 1,000,000.00 102 5410 1,025,410 00 100 5000 1,004,999.73 20,410.27 3.6016 37,500.00

Next Call Dt. 06 15 21 S&P BBB- 14,166.67 100 91 1,009,090.00 16,320.00HOST HOTELS & RESORTS, L.P. 6.0% 10/01/2021 USD SER Z 1,000,000 00 109.9290 1,099,290.00 108.3377 1,083,376 70 15,913.30 36025 60,000 00

SR LIEN Next Call Dt. 07 01 21 S&P BBB- /Moody's Baal 15,000 00 11514 1,151,360.00 (52,070 00)

VERIZON COMMUNICATIONS INC. 3 0% 11/01/2021 USD SR 1,000,000.00 101 1180 1,011,180 00 100 4661 1,004,661.22 6,518.78 2 8707 30,000 00

LIEN Next Call Dt. 09 01 21 S&P BBB+/Moody's Baal 5,000.00 100 77 1,007,710 00 3,470.00

AMAZON.COM INC 3.3% 12/05/2021 USD SR LIEN Next Call 675,000 00 103 2690 697,065.75 99.8760 674,163 00 22,902.75 33200 22,275 00

Dt 10 05 21 S&P AA- /Moody's Baal 1,608 75

LABORATORY CORP OF AMER 3 2% 02/01/2022 USD SR LIEN 325,000 00 101.9540 331,350.50 99 9190 324,736 75 6,61375 32130 10,400.00

S&P BBB /Moody's Baal 4,333.33

MERCK SHARP & DOHME CORP 2.35% 02/10/2022 USD SR 1,000,000 00 998660 998,660.00 98.8670 988,670.00 9,990.00 25300 23,500 00

LIEN S&P AA /Moody's Al 9,204.17

Portfolio No XXX-XX891-6Page 18 of 40

Page 95 of 349

I(N) 16214I1954)150.01424 5 IV; I - 29

The Harry T. Mangurian , Jr. Foundation, Inc. - EIN : 16-1578255Statement Detail

Schedule of Balance Sheet Assets HTM, JR . FOUNDATION GOV/CORP I'll

2017 Form 990-PF - PART II, Balance Sheets Holdings (Continued)


FIXED INCOME ( Continued)Quantity / Market Value / Adjusted Cost / Unrealized Yield to Maturity Estimated

Current Face Market Price Accrued Income Unit Cost original Cost Gain ( Loss) in Percentage Annual Income


GS. GOVERNMENT/CORPORATE FIXED INCOME

AT&T INC. 3.8% 03/15/2022 USD SER WI SR LIEN S&P BBB+ 775,000 00 103.3490 800,954.75 101.8820 789,585.50 11,369.25 29,450.00

/Moody's Baal 8,671.39

AUTOZONE, INC. 3.7% 04/15/2022 USD SR LIEN Next Call Dt. 500,000.00 103.1660 515,830.00 103.2168 516,083.92 (253.92) 2.8968 18,500 00

01 15 22 S&P BBB /Moody's Baal 3,905.56 105.19 525,960.00 (10,130 00)

ORACLE CORPORATION 2.5% 05/15/2022 USD SR LIEN Next 350,000.00 1001580 350,553 00 99.4170 347,959.50 2,593.50 2.5970 8,750.00

Call Ot. 03 15 22 S&P AA- /Moody's Al 1,118.06

KINDER MORGAN ENERGY PARTN 3.95% 09/01/2022 USD SR 200,000.00 103.2020 206,404.00 91.6700 183,339 91 23,064.09 60609 7,900.00

LIEN Next Call Dt 06 01 22 S&P BBB- /Moody's Baa3 2,633.33 88.60 177,200 00 29,204.00

CAPITAL ONE BANK (USA), NATION 3 375% 02/15/2023 USD 750,000 00 100.9870 757,402 50 99.8390 748,792 50 8,61000 3.4010 25,312 50

SUB LIEN S&P BBB /Moody's Baal 9,562.50

ING BANK N.V. HYBRID MTN 11/21/2023 USD PVT REGS SUB 325,000 00 101.1530 328,74712 101.5000 329,875.00 (1,127.88) 13,406 25

LIEN CPN 11/21/13-11/20/184125% Next Call Ot 11 21 18 1,452.34

S&P BBB+/Moody's BaalABBOTT LABORATORIES 3.4% 11/30/2023 USD SR LIEN Next 750,000.00 101 7300 762,975.00 99.6130 747,097.50 15,877.50 3.4625 25,500.00

Call Dt. 09 30 23 S&P BBB /Moody's Baa3 2,12500

UNITED TECHNOLOGIES CORPORATIO 2.8% 05/04/2024 USD 50,000.00 992620 49,631.00 100.5232 50,261.60 (630.60) 27097 1,400.00

SR LIEN Next Call Dt. 03 04 24 S&P A- /Moody's A3 221.67 100.57 50,283.50 (652 50)

XILINX INC 2.95% 06/01/2024 USD SR LIEN Next Call Dt. 04 925,000.00 993760 919,228.00 99.8870 923,954.75 (4,726 75) 29680 27,287.50

01 24 Moody's A3 2,273.96

TARGET CORPORATION 3.5% 07/01/2024 USD SR LIEN S&P A 925,000.00 104.2560 964,368.00 102.5706 948,778.09 15,589 91 3.0610 32,375.00

/Moody's A2 16,187 50 102.85 951,399 50 12,968 50

THE BOEING COMPANY 2.85% 10/30/2024 USD SR LIEN Next 1,000,000.00 100.9500 1,009,500.00 101.1693 1,011,693.35 (2,193 35) 2.6616 28,500 00

Call Dt. 07 30 24 S&P A /Moody's A2 4,750.00 101.26 1,012,610.00 (3,110.00)MANITOBA (PROVINCE OF) 1.125% 06/01/2018 SR LIEN S&P 1,000,000.00 99.7520 997,520 00 99.9000 999,000 00 (1,480.00) 1 1451 11,250 00

A+ /Moody's Aa2 937.50

ONTARIQ (PROVINCE OF) 4 0% 10/07/2019 USD SR LIEN S&P 975,000.00 103.1110 1,005,332 25 103.8072 1,012,119 80 (6,787 55) 18000 39,000 00

A+ /Moody's Aa2 9,100.00 114.80 1,119,329.25 (113,99700)

Portfolio No- XXX-XX891-6ATTACHMENT TO EXHIBIT C Page 96 of 349

Page 19 of 40

0001623-(X196-0350-0142456----n 151-29

The Harry T. Mangurian , Jr. Foundation , Inc. - EIN : 16-1578255



Statement Detail

HTM, JR. FOUNDATION GOV/CORP FIHoldings (Continued)


FIXED INCOME (Continued )Quantity / Market Value / Adjusted Cost / Unrealized Yield to Maturity Estimated



GS: GOVERNMENT/CORPORATE FIXED INCOME

U.S. TREASURY NOTE 1.375000% 05/31/2020 MN ON THE 1,050,000 00 98.7190 1,036,549.50 97.9750 1,028,737 05 7,812.45 2.2413 14,437.50

RUN Moody's An 1,226.20 94.84 995,818 36 40,731 14

FHLB 2.875% 09/11/2020 SER QL-2020 SR LIEN S&P AA+

/Moody's Aaa

U.S. TREASURY NOTE 1.875000% 08/31/2022 FA OFF THE

RUN Moody's Aaa

U.S. TREASURY NOTE 1.625000% 10/31/2023 AO ON THE

RUN Moody's Aaa

U.S. TREASURY NOTE 2.500000% 05/15/2024 MN OFF THE

RUN Moody's Aaa

FEDERAL HOME LOAN BANK SYSTEM 2 875% 06/14/2024SER RK-2024 SR LIEN S&P AA+ /Moody's Aaa

AMERICA MOVIL SAB DE CV 5 0% 10/16/2019 USD SER B SR

LIEN S&P A- /Moody's A3

TOTAL GS- GOVERNMENT/CORPORATE FIXED INCOME

550,000 00 102.1810 561,995 50 102.1241 561,682.28 313.22 2.0601 15,812.50

4,831.60 104.80 576,389.00 (14,393 50)

1,300,00000 98.5940 1,281,722.00 101.8945 1,324,627.99 (42,905.99) 14534 24,375.00

8,147.26 102.51 1,332,664.10 (50,942.10)

1,000,000.00 96.5430 965,430.00 98.6641 986,64062 (21,21062) 1.8299 16,250.00

2,715 75

950,000.00 101.1290 960,725 50 1001709 951,623.64 9,101.86 2.4708 23,750 00

2,99315 100 20 951,855 46 8,870 04

900,000 00 102.8010 925,209 00 103 4970 931,473 41 (6,264.41) 2.2890 25,875.00

1,221 87 103 71 933,399.00 (8,190 00)

1,100,000 00 104 5200 1,149,720 00 104 4997 1,149,497 05 222 95 24169 55,000 00

11,305.56 116.67 1,283,414 00 (133,694.00)

38,404,097.37 38,233,714.05 170,383 32 2.6237 1,195,032.59

sc^,ts^i.co a0,a1a,c4Dnr tZUZ1,148..791

Adjusted Cost/" Unrealized Estimated

Market Val ue _ __ _ Original Cost Gain (Loss ) Annual Incom e

TOTAL PORTFOLIO 38.733,994.63 38,233,714.05 170,383.32 1 ,195,032.59

38,913,245.91 (509,148.54)


Page 20 of 40

6 Original Cost is puce paid by purchaser adjusted for annual original issue discount inclusions and/or return of capital adjustments, if applicable Adjusted Cost reflects adjustments to Original Cost for market discount accretion and/or premiumamortization Adjusted cost for GMS Portfolios and Alternative Investments are determined by inception to date contributions minus inception to date distributions

Portfolio No- XXX-XX891.6 Page 97 of 349


Schedule of Balance Sheet Assets HTM GSAM: CORPORATE HIGH YIELD FI2017 Form 990-PF - PART II, Balance Sheets Holdings

FIXED INCOMEPeriod Ended December 31, 2017


Accrued Income Unit CostAdjusted Cost /




OTHER FIXED INCOMEGSAM. CORPORATE FIXED INCOME (HIGH YIELD)

U S DOLLAR 80.34 1 0000 80.34 80 34

GOLDMAN SACHS BANK USA DEPOSIT (BDA)14 82,619 32 1.0000 82,619.32 1.0000 82,619 32 1.1510 950.91Quantity/

Current Face Market Price

Market Value!

Accrued Income Unit Cost

Adjusted Cost/

Original Cost

Unrealized

Gain (Loss)

Yield to Maturity

in Percentage

Estimated

Annual IncomeREGENCY ENERGY PARTNERS LP 5.75% 09/01/2020 USD SRLIEN Next Call Dt. 06 01 20 S&P BBB- /Moody's Baa3

40,000.00 106.4290 42,571.60

766 6799 3968

98.50

39,758.72

39,400.002,81288

3,171606.0170 2,300.00

NV ENERGY, INC. 6.25% 11/15/2020 USD SR LIEN S&P A-/Moody's Baal

125,000 00 1098240 137,280 00

998.26

104.1247

110.75

130,155 89

138,437.50

7,12411

(1,157 50)

4.6979 7,812 50

21ST CENTURY FOX AMERICA, INC. 4.5% 02/15/2021 USDSER C SR LIEN S&P BBB+/Moody's Baal

45,000.00 105.6920 47,561.40

765.00

103.2403

108.34

46,45814

48,750.75

1,103.26

(1,18 9.3 5)3.3980 2,025.00

AT&T INC 4 6% 02/15/2021 USD SER WI SR LIEN Next CallDt. 1115 20 S&P BBB+ /Moody's Baa 1

45,000.00 105 2470 47,361.15

782.00

104.0523

106.36

46,823.53

47,860.65

537.62 2,070.00(499 50)

FRESENIUS MEDICAL CARE US FINA 5 75% 02/15/2021 USO 85,000 00 108.1920 91,963.20 100.7710 85,655.37 6,307 83 5.4781 4,887.50PVT 144A PVT SR LIEN S&P BBB- /Moody's Baa3 1 ,832.81 101.88 86,593 75 5,369.45NBCUNIVERSAL MEDIA, LLC 4.375% 04/01/2021 USD SERB 65,000.00 105.9880 68 ,892.20 103.5899 67,333.47 1,558.73 3.2028 2,843.75SR LIEN S&P A- /Moody's A3 710.94 109.05 70, 885 60 (1 ,993 40)ALTRIA GROUP, INC 4.75% 05/05/2021 USD SR LIEN S&P A- 40,000.00 107.2380 42,895.20 104.0445 41,617 79 1,27741 3.4590 1,90000/Moody's Baal 29556 109.95 43,980.80 (1,085 60)ENERGY TRANSFER PARTNERS, L.P. 4.65% 06/01/2021 USD 35,000.00 104.9660 36,738.10 101.5781 35,552.33 1,18577 4.1499 1,627.50SR LIEN Next Call Dt. 03 01 21 S&P BOB- /Moody's Baa3 135.63 103.76 36,316 00 422.10PUGET ENERGY, INC. 6.0% 09/01/2021 USD SER B SR LIEN 110,000.00 110.6340 121,697.40 103 0759 - 113,383.48 8,313 92 5.0696 6,600.00S&P BBB- /Moody's Baa3 2,200.00 106.86 117,547 25 4,150.15FRESENIUS MED CARE 5 875% 01/31/2022 PVT 144A PVT SR 20,000 00 110 0840 22,016.80 107 5304 21,506 08 510.72 38639 1,17500LIEN S&P 888- /Moody's Baa3 489.58 108 94 21,787 51 229.29

"This represents a bank deposit of an affiliated bank reflected here for your convenience and is not cash held in your brokerage or custody account Please see the enclosed Bank Statement pagels) for specific information related to your bank depositNot a Deposit. Not FDIC Insured May Lose Value (Excluding Goldman Sachs Bank Deposit Account, Term Deposits and Certificates of Deposit)



Page 114 of 349

(XM)162i11114-0t50-0142474----0151-24

Statement Detail

The Harry T. Mangurian, Jr. Foundation , Inc. - EIN: 16-1578255



HTM GSAM: CORPORATE HIGH YIELD I'llHoldings (Continued)


FIXED INCOME (Continued)Quantity / Market Value / Adjusted Cost / Unrealized Yield to Maturity Estimated


OTHER FIXED INCOME

GSAM CORPORATE FIXED INCOME (HIGH YIELD)

CONSTELLATION BRANDS, INC. 6.0% 05/01/2022 USD SR 89,000.00 112 3930 100,029.77 104.9886 93,439.87 6,589.90 4.7311 5,34000LIEN S&P BBB- /Moody's Baa3 890 00 107.80 95,942.50 4,087.27

CROWN CASTLE INTERNATIONAL COR 5.25% 01/15/2023 120,000.00 109.4950 131,394 00 101 5912 121,909.46 9,484.54 4.8900 6,300.00USD SER B SR LIEN S&P BBB- /Moody's Baa3 2,905.00 102.80 123,356.25 8,037.75

CONSTELLATION BRANDS, INC. 4.25% 05/01/2023 USD SR 5,000.00 105.7860 5,289.30 100.7004 5,03502 254 28 4.1029 212.50LIEN S&P BBB- /Moody's Baa3 35.42 101 20 5,060 00 229.30

VEREIT OPERATING PARTNER 4.875% 06/01/2026 USD SR 20,000.00 105.8290 21,165 80 100.0000 20,000.00 1,165.80 4.8750 975.00LIEN Next Ca ll Dt. 03 0 1 26 S&P BBB- /Moody's Baa3 81 25

SABINE PASS LIQUEFACTION, LLC 5.875% 06/30/2026 USD 45,000.00 112 3470 50,55615 100.0648 45,029.16 5,526.99 5.8663 2,643.75SER WI SR LIEN Next Call Dt.12 31 25 S&P BBB- /Moody's 1,321.88 100.07 45,031 25 5,524 90Baa3SUBSID OF CABLEVISION SYS CRP CVC 7.625 07/15/2018SR LIEN S&P B- /Moody's B2

45,000.00 102.2500 46,012 50

1,582.19

101.0686

110.58

45,480.88

49,762 50

531.62 5.5895 3,431 25

(3,750 00)

FRONTIER COMMUNICATIONS CORP 8 125% 10/01/2018 USD 25,000.00 99 6150 24,903 75 102 7902 25,697.55 (793 80) 4.2980 2,031 25SR LIEN S&P B /Moody's B3 507.81 113.38 28,343 75 (3,440.00)

GLP CAPITAL, L P. 4 375% 11/01/2018 USO SERB SR LIEN 15,000 00 100 7500 15,112.50 100.6506 15,097.59 14.91 3.5756 656 25Next Call Dt 08 01 18 S&P BBB- /Moody's Bat 109.37 102.00 15,300.00 (187 50)

SPRINT CAP CORP 6.9% 05/01/2019 USD SR LIEN S&P B 50,000 00 104 6250 52,312.50 88.7303 44,365.13 7,947.37 16 6991 3,450.00/Moody's Caal 575.00 7610 38,050 00 14,262 50

UNIVERSAL HEALTH SERVICES, INC 3.75% 08/01/2019 USD 55,000 00 1016250 55,893 75 100.0000 55,000.00 893.75 3.7501 2,062.50PVT 1 44A PVT SR L I EN S&P BBB- /Moody's Bat 85938

DISH DBS CORPORATION 7.875% 09/01/2019 USD SER B SR 40,000.00 107.0000 42,800.00 103 8830 41,553.19 1,246.81 5.4035 3,150.00LIEN S&P B+ /Moody's 130 1,050.00 116.35 46,539 62 (3,739 62)YUMI BRANDS, INC. 5.3% 09/15/2019 USD SR LIEN S&P B+ 15,000 00 104 0000 15,600 00 101 7418 15,261 26 338.74 42293 795.00

/Moody's 82 234.08 103.50 15,525.00 75.00

HCA INC 6.5% 02/15/2020 USD SR LIEN S&P BBB- /Moody's 125,000 00 106.0000 132,500.00 101.2421 126,552.56 5.94744 5.8696 8,12500Bat 3,069.44 103.91 129,881.25 2,618 75

SPRINT NEXTEL CORPORATION 7 0% 03/01/2020 USD PVT 85,000 00 107 0000 90,950.00 100.1687 85,143.36 5,806 64 6 9147 5,95000144A PVT SR LIEN S&P B+ /Moody's BI 1,983.33 100 50 85,425 00 5,52500

ALLY FINANCIAL INC 4 125% 03/30/2020 USD SR LIEN S&P 60,000 00 102 0000 61,200.00 98.8880 59,332 80 1,867.20 43750 2,47500BB+ 618.75

AOMAGIR NT TO EXHIBIT C


Page 115 of 349

(M101(,21fi1 11-0350-0142471 ----- 01S 1.29

The Harry T. Mangurian , Jr. Foundation , Inc. - EIN : 16-1578255 Statement Detail

Schedule of Balance Sheet Assets HTM GSAM: CORPORATE HIGH YIELD I'll2017 Form 990-PF - PART II , Balance Sheets Holdings (Continued)


FIXED INCOME ( Continued)Quantity / Market Value / Adjusted Cost/ Unrealized Yield to Maturity Estimated

Current Face Market Price Accrued Income Unit Cost Original Cost Gain ( Loss) in Percentage Annual Income

OTHER FIXED INCOME

GSAM. CORPORATE FIXED INCOME (HIGH YIELD)

SILGAN HOLDINGS INC. 5.0% 04/01/2020 USD SER B SR LIEN 61,000.00 100.5000 61,305.00 99.8750 60,923.75 381.25 5.0222 3,050.00

Next Call Ot. 04 01 18 S&P BB- /Moody's Ba3 762.50

FRONTIER COMMUNICATIONS CORPOR 8.5% 04/15/2020 2,000 00 83.0000 1,660.00 106.6756 2,133.51 (473 51) 5.3594 170 00

USD SER B SR LIEN S&P B /Moody's Ba3 3589 115.00 2,300.00 (640 00)

ALCOA INC. 6.15% 08/15/2020 USO SR LIEN S&P BBB- 55,000 00 107 5100 59,130.50 105.7447 58,159 57 970.93 3.8281 3,38250/Moody's Bat 1,277 83 108.75 59,812.50 (682 00)

CEQUEL COMMN ESCROW I, LLC 6.375% 09/15/2020 USD 44,000.00 101 5000 44,660 00 102.2286 44,980.58 (320.58) 5.5340 2,805.00

PVT BEGS SR LIEN Next Call Ot 09 15 18 S&P B /Moody's 818.13 104.25 45,870.00 (1,210.00)Caal

MGM RESORTS INTERNATIONAL 6.75% 10/01/2020 USO SER 65,000 00 108.0000 70,200.00 108.2668 70,373 40 (173.40) 3.5686 4,38750B SR LIEN S&P BB- /Moody's Ba3 1,096.88 111.69 72,600.05 (2,400 05)

NAVIENT CORPORATION 5.0% 10/26/2020 USD SR LIEN S&P 25,000.00 101.3750 25,343.75 99.3650 24,841.25 502.50 5.1251 1,250.00

B+ /Moody's Ba3 225.69

MICHAELS STORES, INC. 5.875% 12/15/2020 USD PVT 144A 70,000.00 101.3750 70,962.50 102.9904 72,093 29 (1,130.79) 4 7781 4,112.50

PVT SUB LIEN Next Call Dt 121518 S&P B /Moody's B1 182 78 105.13 73,587 50 (2,625.00)

INTELSAT JACKSON HOLDINGS S.A. 7 5% 04/01/2021 USD 30,000.00 91.0000 27,300.00 102.1615 30,648 45 (3,348.45) 6.9571 2,25000

SER B SR LIEN Next Call Dt 04 01 18 S&P CCC+ /Moody's B3 562.50 103.56 31,068.75 (3,768 75)

L BRANDS, INC. 6.625% 04/01/2021 USD SR LIEN S&P BB+ 85,000.00 109.5000 93,075.00 103.1748 87,698.60 5,376.40 5.5436 5,631.25/Moody's Bat 1,407.81 107.56 91,425.00 1,650.00

GLP CAPITAL, L P. 4.375% 04/15/2021 USD SR LIEN S&P BBB- 5,000.00 102.7500 5,137.50 100.0000 5,000.00 137.50 4.3754 218.75

/Moody's Bat 46.18GRAPHIC PACKAGING INTL INC 4 75% 04/15/2021 USD SR 85,000.00 104.5000 88,825.00 99.5588 84,625 00 4,200 00 48226 4,037 50LIEN Next Call Ot. 01 15 21 S&P BB+ /Moody's Bat 852.36

CLEAN HARBORS INC. 5.125% 06/01/2021 USD SER B SR 20,000.00 101.0000 20,200.00 102.1502 20,430.03 (230.03) 4.4398 1,025.00

LIEN Next Call Dt.12 01 18 S&P BB+ /Moody's Ba3 85.42 102.63 20,525.00 (325.00)

CENTURYLINK INC 6.45% 06/15/2021 USD SER S SR LIEN 55,000.00 101.0000 55,550.00 105.6583 58,112.08 (2,562.08) 4.6583 3,547.50

S&P B+ /Moody's B2 157.67 107 45 59,100 00 (3,550.00)

Portfolio No XXX•XX435.) ATTACHMENT TO EXHIBIT C Page 116 of 349

Page 23 of 40

0001621.0116-0350-0142476---0151-29




FIXED INCOME (Continued)

Statement Detail



Quantity / Market Value / Adjusted Cost / Unrealized Yield to Maturity EstimatedCurrent Face Market Price Accrued Income Unit Cost Original Cost Gain (Loss) in Percentage Annual Income

OTHER FIXED INCOMEGSAM: CORPORATE FIXED INCOME (HIGH YIELD)

W.R GRACE & CO-CONN 5.125% 10/01/2021 USD PVT 144A 115,000.00 105.1250 120,893 75 101.3870 116,595.00 4,298.75 4.7158 5,89375PVT SR LI EN S&P BB+/Moody's 8a3 1,473.44 102.43 117,793.75 3,100.00

1011778 BC / NEW RED FIN 4 625% 01/15/2022 USD PVT 40,000.00 102 3750 40,950.00 100.5900 40,236.01 713.99 4.5017 1,850.00144A PVT SR LIEN Next Call Dt.10 01 18 S&P B+ /Moody 's 853 06 100 62 40,246.85 703.15

CALPINE CORPORATION 6 0% 01/15/2022 USD PVT REGS SR 135,000.00 103.0000 139,050.00 103 7044 140,001 00 (951 00) 4.9765 8,100.00LIEN Next Call Dt 11 01 18 S&P BB /Moody's Bat 3,712 50 106.00 143,100.00 (4,050 00)OUTFRONT MEDIA CAPITAL LLC/ CO 5.25% 02/15/2022 USD 35,000.00 102 5000 35,875.00 101 7098 35,598 43 276.57 4.8115 1,837 50SERB SR LIEN Next Call Dt 021518 S&P BB- /Moody's 131 234.79 102.21 35,775 00 100.00

BALL CORPORATION 5.0% 03/15/2022 USD SR LIEN S&P BB+ 65,000.00 106.7500 69,387 50 99.0000 64,350 00 5,037.50 5.1291 3,25000/Moody's Bat 95694

NIELSEN FINANCE LLC 5 0% 04/15/2022 USD PVT 144A PVT 40,000.00 102 8750 41,150 00 102.7365 41,094 60 55.40 4.2943 2,00000SR LIEN Next Call Dt. 04 15 18 S&P BB+ /Moody's B1 422.22 103.50 41,400.00 (250.00)

DISH DBS CORPORATION 5.875% 07/15/2022 USD SER B SR 40,000.00 100.5000 40,200.00 100.0000 40,000 00 200.00 6.4997 2,35000LIEN S&P B+ /Moody's Ba3 1,083 61 9688 38,750 00 1,450.00NCR CORPORATION 5 0% 07/15/2022 USD SER B SR LIEN 90,000.00 101.7500 91,575 00 96 0672 86,460.44 5,114.56 6.2315 4,50000Next Call Ot. 071518 S&P 88/Moody's B1 2,075.00 93.58 84,225.00 7,350 00

VIDEOTRON LTEE 5.0% 07/15/2022 USD SERB SR LIEN S&P 90,000.00 105 2500 94,725.00 97.7500 87,975.00 6,750.00 4,50000BB /Moody's Ba2 2,075.00

CIT GROUP INC. 5.0% 08/15/2022 USD SR LIEN S&P BB+ 13,000.00 106.0000 13,780.00 106.3352 13,823.58 (43.58) 34710 650 00/Moody's Bat 245.56 107.85 14,021.11 (241.11)DAVITA HEALTHCARE PARTNERS INC 5.75% 08/15/2022 USD 40,000.00 102.8750 41,150 00 103.3759 41,350.35 (200.35) 4.9247 2,300.00SR LIEN Next Call Dt. 081518 S&P B+/Moody's 8a3 86889 106.25 42,500.00 (1,350 00)RANGE RESOURCES CORPORATION 5 0% 08/15/2022 SER WI 35,000.00 99.5000 34,825.00 97.6642 34,182.46 642 54 1,750.00SR LIEN RATE DETAILS 23914467 Next Call Dt 05 15 22 S&P 661 11 97.50 34,125 00 700.00BB+ /Moody's Ba3CONTINENTAL RESOURCES, INC. 5.0% 09/15/2022 USD SER 40,000.00 101.5000 40,600 00 104.4645 41,785 81 (1,185.81) 39505 2,00000B SR LIEN Next Call Dt. 031518 S&P BB+ /Moody's Ba3 588.89 108.38 43,350 00 (2,750 00)SPECTRUM BRANDS, INC. 6 625% 11/15/2022 USO SER B SR 75,000 00 103 5000 77,625.00 104.6925 78,519 36 (894.36) 5.5135 4,968.75LIEN Next Call Dt 11 15 18 S&P BB- /Moody's B2 634 90 106.63 79,968.75 (2,343 75)

Portfolio No )0(X-XX435-0

000162.3-01174).350-()142477 -----0 15 1.29


Page 24 of 40 Page 117 of 349

ERE= The Harry T. Mangurian, Jr. Foundation, Inc. - EIN: 16-1578255 Statement Detail

Schedule of Balance Sheet Assets HTM GSAM : CORPORATE HIGH YIELD I'll2017 Form 990-PF - PART II, Balance Sheets Holdings (Continued)


FIXED INCOME (Continued)Guantty/ Market Value / Adjusted Cost / Unrealized Yield to Maturity Estimated

Current Face Market Price Accrued Income Unit Cost Original Cost Gain (Loss) In Percentage Annual Income

OTHER FIXED INCOMEGSAM: CORPORATE FIXED INCOME (HIGH YIELD)

CINEMARK USA, INC. 5.125% 12/15/2022 USD SERB SR 45,000.00 102.2500 46,012 50 102.9617 46,332.75 (320.25) 4.4663 2,30625LIEN Next Call Dt.12 1518 S&P BB /Moody's 82 102.50 103 57 46,608.40 (595.90)

ACADIA HEALTHCARE CO INC 5.625% 02/15/2023 USD SER B 45,000.00 101.5000 45,675.00 99.0000 44,550.00 1,125.00 5.8180 2,531.25SR LIEN Next Ca ll Dt. 02 1 518 S&P B /M oody's B3 956.25

DOLLAR TREE STORES, INC 5.75% 03/01/2023 USD SER WI 50,000.00 104.7500 52,375 00 104.6566 52,328.28 46.72 2,875.00SR LIEN Next Call Dt. 03 01 18 S&P BB+ /Moody's Ba2 958.33 105.77 52,883.40 (508.40)

EQUINIX, INC. 5.375% 04/01/2023 USD SR LIEN Next Call Dt 5,000.00 103 4000 5,170.00 104.7475 5,237.38 (67.38) 4.3534 268.7504 01 18 S&P BB+/Moody's B1 6719 105.70 5,285.00 (115.00)

SEALED AIR CORPORATION 5.25% 04/01/2023 USD PVT 144A 45,000 00 106.5000 47,925.00 105.3822 47,421.98 503.02 41008 2,362.50PVT SR LIEN Next Ca ll Dt. 01 01 23 S&P BB+/Moody's Ba3 590.63 106.57 47,956.10 (31.10)

TARGA RESOURCES PARTNERS LP 5.25% 05/01/2023 USD 50,000.00 102.2500 51,125.00 101.1254 50,562.69 562.31 5.0169 2,625 00SER B SR LIEN Next Call Dt. 11 0 1 18 S&P BB- /Moody's Ba 3 437.50 101.25 50,625.00 500.00

REYNOLDS GROUP ISSUER INC. 5.125% 07/15/2023 USD PVT 40,000.00 103.5000 41,400.00 100 0000 40,000.00 1,400.00 5.1244 2,05000144A PVT SR L I EN Next Ca ll D t. 071519 S&P B+ /Moody's B1 945.28

SS&C TECHNOLOGIES HOLDINGS, IN 5.875% 07/15/2023 USD 20,000.00 105.5000 21,100.00 100.0000 20,000.00 1,100.00 1,175.00SER WI SR LIEN Next Call Dt. 071518 S&P B+/Moody's B2 541.81

WMG ACQUISITION CORP 5.0% 08/01/2023 USD PVT 144A 30,000.00 103.5000 31,050.00 100.0000 30,000.00 1,05000 4.9999 1,50000PVT SR LIEN Next Call Dt 08 01 19 S&P B+ /Moody's Ba3 625.00

L BRANDS, INC. 5.625% 10/15/2023 USD SR LIEN S&P BB+ 5,000.00 107.8750 5,393.75 105.0376 5,251.88 141.87 4.6229 281.25/Mood1/s Bat 59.38 105.75 5,287.50 106.25

MEONAX INC 5.25% 12/01/2023 USD PVT 144A PVT SR LIEN 30,000.00 101.7500 30,525.00 100.0000 30,000.00 525.00 5.2502 1,575.00Next Ca ll Dt.1 2 0 1 1 8 S&P BBB- /Moody's Bat 131.25

QORVO. INC. 6.75% 12/01/2023 USD SER WI SR LIEN Next 55,000 00 107 5000 59,125 00 101.0286 55,565 75 3,559 25 3.712.50Ca l l Dt.12 01 1 8 S&P BB+/Moody's Bat 309 38 101.14 55,625.00 3,500.00

LAMAR MEDIA CORP. 5.375% 01/15/2024 USD SERB SR LIEN 45,000.00 104 5000 47,025.00 102.7139 46,221.25 803.75 49483 2,418.75Next Ca l l Dt. 0 1 15 19 S&P BB- /Moody's Bat 1,115.31 102.75 46,237.50 787.50


Page 25 of 40

15101623-01 IX-0350-0142479----0131.29

Statement DetailThe Harry T. Mangurian, Jr. Foundation, Inc. - EIN: 16-1578255

HTM GSAM: CORPORATE HIGH YIELD F1Schedule of Balance Sheet Assets

Holdings (Continued)2017 Form 990-PF - PART II, Balance Sheets


FIXED INCOME ( Continued) -Quantity / Market Value / Adjusted Cost / Unreali zed Yield to Maturity Estimated


OTHER AXED INCOMEGSAM: CORPORATE FIXED INCOME (HIGH YIELD)

CENTENE CORPORATION 6.125% 02/15/2024 USD SER WI SR 10,000.00 105.7500 10,575 00 107.0182 10,701.82 (126 82) 4 7891 612.50LIEN Next Call Dt. 021519 S&P BB+ /Moody's Bat 231 39 108.15 10,814 50 (239 50)

MPT OPER PARTNERSP/FINL 6.375% 03/01/2024 USD SR 10,000.00 105.7500 10,575 00 106.6682 10,666 82 (91.82) 51007 637.50LI E N Next Call Dt. 03 0 1 19 S&P BBB- /Moody's Bat 212.50 108.06 10,806.20 (231.20)

HCA INC. 5.0% 03/15/2024 USO SR LIEN S&P BBB- /Moody's 5,00000 104.0000 5,200.00 101.3503 5,06751 132 49 4.7462 250.00Ball 73 61 101.75 5,087.50 112 50

HD SUPPLY INC 5.75% 04/15/2024 USD PVT 144A PVT SR 10,000 00 106 2500 10,625 00 100.0000 10,000 00 62500 5.7499 575.00LIEN Next Call Dt. 04 15 19 S&P B+ /Moody's B2 121.39

MGM GROWTH PROPERTIES OPERATIN 5.625% 05/01/2024 25,000.00 106.5000 26,625.00 100.0000 25,000 00 1,625.00 1,406.25USD SER WI SR LIEN Next Call Dt. 02 01 24 S&P BB- 234.38/Moody's 81

MPT OPERATING PARTNERSHIP 5.5% 05/01/2024 USD SR 10,000 00 103.5000 10,350 00 100.0000 10,000 00 350 00 54996 550.00LIEN Next Call Dt. 05 01 19 S&P BBB- /Moody's Bat 91.67

KFC HOLDING CO. 5.0% 06/01/2024 USD PVT 144A PVT SR 10,000.00 103.1250 10,312.50 100 0000 10,000 00 312 50 5.0004 500.00LIEN PIZZA HUT HOLDINGS LLC/TACO BE Next Call Dt. 06 01 41 6719 S&P BB /Moody's B1

PERFORMANCE FOOD GROUP 15.5% 06/01/2024 USD PVT 5,000.00 103.2500 5,162 50 100 0000 5,000.00 162.50 5.4995 275.00144A PVT SR LIEN Next Call Ot. 06 01 19 S&P BB- /Moody's 22.92B2VALVOLINE INC. 5.5% 07/15/2024 USD Next Call Dt. 071519 60,000.00 106.2500 63,750 00 105.5303 63,318.15 43185 3,300.00S&PBB+ 1,521.67 105.88 63,528.00 222.00

WMG ACQUISITION CORP 4.875% 11/01/2024 USD PVT 144A 30,000 00 103.0000 30,900.00 100.0000 30,000 00 900.00 4.8747 1,46250PVT SR LIEN Next Call Dt.111101 19 S&P B+/Moody's Ba3 243.75

CENTENE CORP 4.75% 01/15/2025 USD SR LIEN Next Call Dt. 65,000.00 101.7500 66,137 50 100 0000 65,000.00 1,13750 47480 3,087.5001 15 20 S&P BB+ /Moody's Ba2 1,42368

UNIVISION COMMUNICATIONS INC. 5.125% 02/15/2025 USD 50,000 00 97.3750 48,687.50 100 0000 50,000 00 (1,312 50) 51251 2,56250PVT 144A PVT SR LIEN Next Call Dt. 02 15 20 S&P BB- 968.06/Moody's B2

OSHKOSH CORPORATION 5 375% 03/01/2025 USO SERB SR 17,000 00 106.1250 18,041 25 104 6077 17,783 31 257.94 4 6124 913 75LIEN Next Call Dt 03 01 20 S&P BB+/Moody's Ba3 304 58 105 25 17,892 50 148.75

SYMANTEC CORPORATION 5.0% 04/15/2025 USD PVT 144A 15,000.00 104 0000 15,600 00 100.0000 15,000 00 600 00 4.9977 750.00PVT SR LIEN Next Call Dt. 04 15 20 S&P BB+ /Moody' s Baa3 158.33 TO EXHIBIT G

Portfolio No XXX-XX435-0 Page 119 of 349Page 26 of 40

0MI 1621-11119-0150-0142479-----0151-29





Statement Detail



Quantity / Market Value / Adjusted Cost / Unrealized Yield to Maturity EstimatedCurrent Face Market Price Accrued Income Unit Cost Original Cost Gain (Loss) in Percentage Annual Income

OTHER FIXED INCOME

GSAM• CORPORATE FIXED INCOME (HIGH YIELD)

DAVITA HEALTHCARE PARTNERS INC 5.0% 05/01/2025 USD 55,000.00 999700 54,983.50 102.6677 56,467 24 (1,483.74) 4.6113 2,750.00SR LIEN Next Ca ll D t. 05 0 1 20 S&P B+ /Moody's Ba3 458.33 102 75 56,512 50 (1,529 00)

AMC ENTERTAINMENT HOLDINGS INC 5.75% 06/15/2025 15,000.00 98.8750 14,831 25 101 4028 15,210.42 (37917) 5.5293 862 50USD SER B SRSUB LIEN Next Call Dt. 06 15 20 S&P B+ 38.33 101.50 15,225.00 (393.75)

SALLY HOLDINGS LLC 5.625% 12/01/2025 USD SR LIEN Next 20,000 00 99.5000 19,900.00 100.0000 20,000.00 (100 00) 56251 1,125.00Call Dt. 12 01 20 S&P BB+ /Moody's Bat 93.75

LAMAR MEDIA CORP. 5.75% 02/01/2026 USD SER WI SR LIEN 95,000.00 106.7500 101,412.50 107 5826 102,203 49 (790.99) 4.6158 5,462.50Next Call Ot. 02 0 1 21 S&P BB- /Moody's Bat 2,276.04 108.50 103,075.00 (1,662 50)

LEVEL 3 FINANCING, INC. 5.25% 03/15/2026 USD SER WI SR 85,000.00 98.1550 83,431 75 100.0000 85,000 00 (1,568 25) 5.2509 4,46250LIEN Next Call Dt. 0315 21 S&P BB /Moody's Ba3 942.08

GLP CAPITAL, L.P 5.375% 04/15/2026 USD SR LIEN S&P BBB- 15,000.00 107.2500 16,087.50 100 0000 15,000 00 1,087.50 5.3753 806.25/Moody's Bat 170.21

CCO HOLDINGS, LLC/ CAPITAL COR 5.5% 05/01/2026 USD PVT 5,000.00 102.5000 5,125.00 100 3268 5,016.34 108.66 5.4507 275.00144A PVT SR LIEN Next Call Dt 05 01 21 S&P BB /Moody's 4583 100.38 5,01875 106 25B1

GOODYEAR TIRE & RUBBER 5.0% 05/31/2026 USD SR LIEN 50,000 00 103 . 1100 51,555 00 100.0000 50 , 000.00 1 , 555.00 4.9996 2,500.00Next Call Dt . 05 31 21 S&P BB /Moody ' s Ba3 208.33

KFC HOLDING CO. 5.25% 06/01/2026 USD PVT 144A PVT SR 10,000 . 00 105 . 2500 10,525 . 00 100.0000 10,000 . 00 525 . 00 5.2503 525 00LIEN PIZZA HUT/TACO BELL Next Call Dt 06 01 21 S&P BB 43.75/Moody's Bt

POST HOLDINGS , INC. 5.0% 08/15/2026 USD PVT 144A PVT 45,000 . 00 98 . 3750 44 , 268 75 100 0000 45,000 00 (73125) 4.9997 2,250.00SR LIEN Next Call Ot 08 15 21 S&P B /Moody' s B3 850 00

MGM GROWTH PROPERTIES OPERATIN 4.5% 09/01/2026 USD 20,000 . 00 99 . 5000 19 ,900.00 100.0000 20 , 000.00 (100.00) 4.5000 900.00SER WI SR LIEN Next Call Dt. 06 0126 S&P BB- /Moody' s B1 30000

ATTACHMENT TO EXHIBIT CPortfolio No XXX•XX435-0


0001623-o 120.0350-0 142480- --0i 51-29





Statement Detail

HTM GSAM : CORPORATE HIGH YIELD I'llHoldings (Continued)


Quantity / Market Value / Adjusted Cost / Unrealized Yield to Maturity EstimatedCurrent face Market Price Accrued Income Unit Cost Original Cost Gain (Loss) in Percentage Annual Income

OTHER FIXED INCOME

GSAM: CORPORATE FIXED INCOME (HIGH YIELD)

AMC ENTERTAINMENT HOLDINGS, IN 5.875% 11/15/2026 30,000.00 98.5000 29,550.00 100.3680 30,110.41 (560.41) 1,76250

USD SRSUB LIEN Next Call Ot.11 15 21 S&P B+ /Moody's B2 225.21 100 39 30,116.25 (566.25)

TOTAL GSAM CORPORATE FIXED INCOME (HIGH YIELD) 4,360,544.98 4,246,851.31 113,693.67 51097 229,852.16

66,338.17 4,304,202 75 56,342.23

Adjusted Cost / o Unrealized EstimatedMarket Value Original Cost Gain (Loss) Annual Income

TOTAL PORTFOLIO 4,426,883.15 4,246,851.31 113,693.67 229,852.16

4,304, 202.75 56,342.23


Page 28 of 405 Original Cost is puce paid by purchaser adjusted for annual original issue discount inclusions and/or return of capital adjustments, if applicable Adjusted Cost reflects adjustments to Original Cost for market discount accretion and/or premiumamortization Adjusted cost for GMS Portfolios and Alternative Investments are determined by inception to date contributions minus inception to date dist ri butions

Portfolio No. XXX-XX435-0 Page 121 of 349

Statement DetailThe Harry T. Mangurian, Jr. Foundation , Inc. - EIN : 16-1578255

HTM, JR. FOUNDATION ENH DIV TAX EXSchedule of Balance Sheet Assets

Holdings2017 Form 990-PF - PART II, Balance Sheets


PUBLIC EQUITY -


Accrued Income Unit CostAdjusted Cost /Original Cost


Yield to Maturity /

Current Yield


US EQUITY

GSAM: ENHANCED DIVIDEND (S&P 500) TAX EXEMPT

U S DOLLAR 11,628.98 1 .0000 11,628.98 11,628 98

GOLDMAN SACHS BANK USA DEPOSIT (BDA) ('BDANOW)1t 70,349.07 1.0000 70,349.07 1.0000 70,349 07 1 1360 79914


Market Value /

Accrued Income Un it Cost Cost Basis

Unrealized

Gain (Loss)

Dividend

Yi eld

Estimated

Annual Income

3M COMPANY CMN (MMM) 1,495.00 235 3700 351,878.15 225.1204 336,554.99 15,323.16 1.9969 7,02650

ABBOTT LABORATORIES CMN (ABT) 4,698 00 57.0700 268,114.86 44 9460 211,15612 56,958.74 1 .9625 5,261.76

ABBVIE INC. CMN (ABBY) 3,75600 96.7100 363,242.76 64.9503 243,953.23 119,289.53 2.9366 10,667 04

ACTIVISION BLIZZARD INC CMN (ATVI) 1,28500 63.3200 81.366.20 49 7621 63,944 26 17,421.94 0.4738 385.50

ADOBE SYSTEMS INC CMN (ADBE) 1,065.00 175.2400 186,63060 144.7625 154,172.09 32,458 51

AETNA INC. CMN (AET) 64000 180.3900 115,449 60 130.3312 83,411.96 32,037 64 11087 1,280.00

ALIGN TECHNOLOGY, INC CMN (ALGN) 110.00 222.1900 24,440 90 235.6108 ' 25,917.19 (1,476 29)

ALPHABET INC. CMN CLASS A (GOOGL) 512 00 1,053.4000 539,340.80 735.2004 376,422.62 162,91818

ALPHABET INC CMN CLASS C (GOOG) 518.00 1,046 4000 542,035.20 751.7923 389,428 43 152,606.77

ALTRIA GROUP, INC. CMN (MO) 2,535.00 71.4100 181,024.35

1,673.10

63.8773 161,928.97 19,095.38 36970 6,692.40

AMAZON.COM INC CMN (AMZN) 743 00 1 ,169 4700 868 ,916.21 571.1217 424,343.42 444,572.79

AMERICAN EXPRESS CO. CMN (AXP) 185.00 99.3100 18,372.35 96.0373 17,766 90 605.45 1.4097 259.00

AMERICAN INTL GROUP, INC CMN (AIG) 230.00 59.5800 13,703.40 60.2281 13,852 47 (149.07) 2.1484 294.40

AMERISOURCEBERGEN CORPORATION CMN (ABC) 150.00 91.8200 13,773.00 769297 11,539.46 2,233.54 1 6554 228.00

AMGEN INC. CMN (AMGN) 2,490.00 173.9000 433,011.00 160.6782 400,088.74 32,922.26 3.0362 13,147.20

ANALOG DEVICES, INC. CMN (ADI) 1,920.00 89 .0300 170,937.60 79.5671 152,768.86 18,168.74 2.0218 3,456.00

ANDEAVOR CMN (ANGV) 570.00 114.3400 65,173.80 97.0576 55,322.86 9,850.94

ANTHEM, INC CMN (ANTM) 585 00 2250100 131 ,630.85 1771106 103,609.73 28,021 12

APPLE INC CMN (AAPL) 9,851.00 169.2300 1,667,084 73 108 9838 1 ,073,599 53 593,485 20 1.4891 24,824 52

APPLIED MATERIALS INC CMN (AMAT) 99500 51.1200 50,864.40 50.8443 50,590 07 274.33 07825 398.00

ARCHER-DANIELS-MIDLAND COMPANY CMN (ADM) 92500 40.0800 37,074.00 42.8470 39,633 49 (2,559 49) 31936 1,184.00

ARTHUR J GALLAGHER & CO CMN (AJG) 1,325.00 63 2800 83,846 .00 57.9928 76,840 47 7,005.53 2 4652 2,067.00

AT&T INC CMN (T) 17,616.00 38.8800 684,910.08 40.8829 720,193 00 (35,282 92) 51440 35,232.00

This represents a bank deposit of an affil iated bank reflected here for your convenience and is not cash held i n your brokerage or custody account Please see the enclosed Bank Statement page(sl for specific informat i on related to your bank deposit

Not a Deposit . Not FDIC Insured May Lose Value ( Excluding Goldman Sachs Bank Deposi t Account , Term Deposits and Certif i cates of Deposit) ATTACHMENT TO EXHIBIT

Brokerage and securities services provided by Goldman. Sachs & Co Bank Deposit Account, Certificates of Deposit and Term Deposits offered by Goldman Sachs Bank USA, Member FDICf 402

C

Portfolio No )XX-XX922-69 oPage Page 181 of 349

OOO 1623-0181-0351-e 14 2.541-----0131.29

Statement Detail

The Harry T. Mangurian, Jr. Foundation, Inc. - EIM: 16-1578255



HTM, JR. FOUNDATION ENH DIV TAX EXHoldings (Continued)


PUBLIC EQUITY ( Continued)Market Value/ Unrealized Dividend Estimated


US EQUITY


AUTODESK INC CMN (ADSK) 555.00 104.8300 58,180.65 109.2017 60,606.94 (2,426.29)

AUTOMATIC DATA PROCESSING INC CMN (ADP) 255.00 117.1900 29,883.45 110 6033 28,203 85 1,679.60 2.1504 642.60160.65

BAKER HUGHES,A GE CO CMN (BHGE) 195.00 31.6400 6,169.80 59 8383 11,668.47 (5,498.67)

BANK OF AMERICA CORP CMN (BAC) 18,740.00 29 5200 553,204.80 23.5399 441,137.32 112,067.48 1.6260 8,995.20

BAXTER INTERNATIONAL INC CMN (BAX) 920.00 64.6400 59,468.80

147.20

61.4994 56,579.45 2,889.35 0.9901 588.80

BB&T CORPORATION CMN (BBT) 1,815.00 49.7200 90,241.80 49 2611 89,408.96 832.84 2.6549 2,395.80

BECTON, DICKINSON AND COMPANY CMN (BDX) 270.00 214.0600 57,796.20 198.3880 53,564.75 4,231 45 14015 810.00

BERKSHIRE HATHAWAY INC. CLASS B (BRKB) 1,430.00 198.2200 283,454.60 161.7442 231,294.22 52,160.38

BEST BUY CO INC CMN (BBY) 290.00 684700 19,856 30 51.9084 15,053 45 4,802.85 1.9863 394.40

BGC PARTNERS, INC CMN CLASS A (BGCP) 8,465.00 15.1100 127,906.15 13.9594 118,166.34 9,739.81 47651 6,094.80

BLACKROCK, INC. CMN (BLK) 479.00 513 7100 246,067.09 414.6519 198,618.26 47,448.83 2.2425 5,518.08

BOEING COMPANY CMN (BA) 1,653.00 294.9100 487,486 23 191.4881 316,529 85 170,956.38 2.3194 11,306.52

BRISTOL-MYERS SQUIBB COMPANY CMN (BMY) 3,575.00 61 2800 219,076.00 58.0089 207,381 78 11,694.22 2.6110 5,720.00

CA, INC. CMN (CA) 3,835.00 33.2800 127,628.80 32.3806 124,179 70 3,44910 30649 3,911.70

CABOT OIL & GAS CORPORATION CMN (COG) 1,915.00 286000 54,769.00 24.7415 47,380.02 7,388.98 0.8392 45960

CARDINAL HEALTH, INC CMN (CAH) 2,185.00 61.2700 133,874 95

1,010.34

75.9148 165,873.79 (31,998.84) 30188 4,041.38

CARNIVAL CORPORATION CMN (CCL) 3,560.00 66.3700 236,277.20 65.7507 234,072 40 2,204.80 2.7121 6,408.00

CATERPILLAR INC (DELAWARE) CMN (CAT) 760.00 157.5800 119,760 80 106.2450 80,746.20 39,014.60 1.9799 2,371 20

CELGENE CORPORATION CMN (CELG) 930.00 104.3600 97,054.80 105.7348 98,333.33 (1,278.53)

CENTENNIAL RESOURCE DEVELOPMEN CMN (CDEV) 955.00 19.8000 18,909.00 16 9858 16,221 45 2,687.55

CF INDUSTRIES HOLDINGS, INC. CMN (CF) 1,505.00 42 5400 64, 022. 7 0 30 7 154 46,226.61 17,796 09 28209 1,80600

CHARTER COMMUNICATIONS, INC. CMN (CHTR) 40.00 335.9600 13,438.40 3251683 13,006 73 431.67

CHENIERE ENERGY INC CMN (LNG) 320.00 53 8400 17,228 80 481552 15,409.65 1,81915


Page 30 of 40

INN11623.0182-0150-01429A2----0151-29

The Harry T. Mangurian, Jr. Foundation, Inc.



- EIN : 16-1578255

Statement Detail



PUBLIC EQUITY ( Continued)


Market Value /



DividendYield

Estimated

Annual Income

US EQUITYGSAM. ENHANCED DIVIDEND (S&P 500) TAX EXEMPT

CHEVRON CORPORATION CMN (CVX) 4,45000 125.1900 557,095 50 101.2754 450,675.52 106,419.98 3.4508 19,224.00

CINEMARK HOLDINGS, INC. CMN (CNK) 545.00 34.8200 18,976 90 34.3540 18,722 91 253.99 3.3314 632 20

CINTAS CORPORATION CMN (CTAS) 140.00 155.8300 21,816.20 148.1723 20,744.12 1,072 08 1.0396 226.80

CISCO SYSTEMS, INC. CMN (CSCO) 17,274.00 38.3000 661,594.20 31 2058 539,049.06 122,545.14 30287 20,037.84

CITIGROUP INC. CMN (C) 520.00 74 4100 38,693 20 73.7985 38,375 22 317.98

CME GROUP INC. CMN CLASS A (CME) 470.00 146.0500 68,643.50

1,645 00

124 0523 58,304.56 10,338 94 1 8076 1,240.80

COCA-COLA COMPANY (THE) CMN (KU) 15,285.00 45.8800 701,275.80 44 9270 686,708.62 14,56718 3.2258 22,621.80

COGNIZANT TECHNOLOGY SOLUTIONS CORP CLASS A (CTSH) 39500 71.0200 28,052 90 74 7257 29,516.67 (1,463 77) 0.8448 237.00

COMCAST CORPORATION CMN CLASS A VOTING (CMCSA) 8,270.00 40 0500 331,213 50 34.8193 287,955.50 43,258 00 1.5730 5,210.10

CONCHO RESOURCES INC. CMN (CXO) 395.00 150.2200 59,336 90 123.3638• 48,728 71 10,608.19

CONOCOPHILLIPS CMN (COP) 1.932 00 54 8900 106,047 48 51 5100 99,517 27 6,530 21 1.9311 2,047.92

CORNING INCORPORATED CMN (GLW) 235 00 31.9900 7,517 65 31.2792 7,35061 167.04 1.9381 145.70

COTY, INC. CMN CLASS A (COTY) 1,810.00 19.8900 36,000.90 17.9119 32,420.62 3,580.28 2.5138 905.00

CSX CORPORATION CMN (CSX) 1,76500 55.0100 97,092.65 52 3170 92,339.54 4,75311 1.4543 1,412.00

CUMMINS INC COMMON STOCK (CMI) 60500 176 6400 106,867 20 1801542 108,993 30 (2,126.10) 24457 2,613.60

CVS HEALTH CORP CMN (CVS) 210.00 72 5000 15,225 00 76.0365 15,967.67 (742.67) 2.7586 420.00

CYPRESS SEMICONDUCTOR CORPORAT CMN (CY) 5,075.00 15 2400 77,343.00

55825

13.3893 67,950 75 9,39225 28871 2,23300

DEERE & COMPANY CMN (DE) 170 00 156.5100 26,606 70

102.00

121 0306 20,575.21 6,031 49 1 5334 408 00

DELTA AIR LINES, INC. CMN (DAL) 1,810.00 56.0000 104,720.00 46.3105 86,712.78 18,007.22 2.1786 2,281.40

DIAMONDBACK ENERGY INC CMN (FANG) 410.00 126 2500 51,762 50 826346 33,880.18 17,882.32

DOMINION ENERGY INC CMN (D) 3,60000 81.0600 291,816.00 80.4108 289,478 89 2,33711 3.7997 11,088 00

DOMTAR CORPORATION CMN CLASS (UFS) 665.00 49 5200 32,930.80

275.98

36.7559 24,442.68 8,488.12 3.3522 1,103.90

DOWOUPONT INC. CMN (DWDP) 3,935.00 71 2200 280,250.70 63 5772 250,176 39 30,074 31 21342 5,981 20

DUKE ENERGY CORPORATION CMN (DUK) 4,88500 84.1100 410,877.35 881198 430,465.22 (19,587.87) 3.6381 14,94B 10

EASTMAN CHEMICAL COMPANY CMN (EMN) 44500 92 6400 41,224 80

249.20

86.4548 38,472 40 2,75240 24180 996.80


Portfolio No XXX-XX922-6

INII11623-Ill ni-111 511-1 1-02 W 1-----111 S I -29


The Harry T. Mangurian , Jr. Foundation, Inc. - EIN : 16-1578255




Holdings (Continued)


Market Value / Unrealized Dividend EstimatedQuantity Market Price Accrued Income Unit Cost Cost Basis Gain (Loss) Yield Annual Income

US EQUITYGSAM: ENHANCED DIVIDEND (S&P 500) TAX EXEMPT

ELECTRONIC ARTS CMN (EA) 210.00 105.0600 22,062.60 115.3520 24,223.92 (2,161.32)

ELI LILLY & CO CMN (LLY) 2,575.00 84.4600 217,484.50 82.6008 212,696.97 4,787.53 2.6640 5,793.75

EMERSON ELECTRIC CO. CMN (EMR) 2,960.00 69.6900 206,282.40 67 3365 199,316.06 6,966.34 2.7838 5,742.40

ENERGEN CORP CMN (EGN) 5.00 57 5700 287.85 51.1220 255 61 32.24

ENTERGY CORPORATION CMN (ETR) 200.00 81 3900 16,278.00 86.4803 17,296.06 (1,018.06) 4.3740 712.00

EOG RESOURCES INC CMN (EOG) 1,960.00 107 9100 211,503 60 8B 3007 173,069 32 38,434.28 0.6209 1,313.20

EQT CORPORATION CMN (EQT) 308.00 56.9200 17,531.36 49.5886 15,273.29 2,258.07 0.2108 36.96

ERIE INDEMNITY COMPANY CL-A CMN CLASS A (ERIE) 595.00 121.8400 72,494.80 115.8908 68,955 00 3,539.80 2.7577 1,99920

EXPEDIA, INC CMN (EXPE) 130 00 119.7700 15,57010 120 3425 15,644.52 (74.42)

EXTENDED STAY AMERICA, INC. CMN (STAY) 1,665.00 19.0000 31,635 00 16.2629 27,077 73 4,557.27 4 4211 1,398.60

EXXON MOBIL CORPORATION CMN (XOM) 6,760.00 83.6400 565,406 40 86.2417 582,993.95 (17,587.55) 3.6824 20,820 80

FACEBOOK, INC. CMN CLASS A (FB) 4,675.00 176.4600 824,950.50 95.6040 446,948 49 378,002.01 -

FEDERATED INVESTORS, INC. CMN CLASS B (FII) 20.00 36.0800 721.60 30.2325 60465 116.95 2.7716 2000

FIDELITY NATIONAL FINANCIAL, I CMN (FNF) 2,120.00 39.2400 83,188 80 37.3408 79,162.57 4,02623 2.7523 2,289.60

FIDELITY NAIL INFO SVCS INC CMN (FIS) 390.00 94.0900 36,695.10 93 2382 36,362 90 332.20 12329 452.40

FIRST AMERICAN FIN CORP CMN (FAF) 1,335.00 56.0400 74,813 40 48.5564 64,822.81 9,990.59 2.7123 2,029.20

FIRSTENERGY CORP. CMN (FE) 2,230.00 30.6200 68,282.60 32.6792 72,874.51 (4,591.91) 4.7028 3,21120

FLOWERS FOODS INC CMN (FLO) 3,100.00 19 3100 59,861.00 17.6552 54,731 16 5,129 84 35215 2,108.00

FNB CORPORATION (VA) CMN (FNB) 13,605 00 13 8200 188,021.10 12.7860 173,953.54 14,067.56 34732 6,530.40

FORD MOTOR COMPANY CMN (F) 7,740.00 12.4900 96,672.60 11.3119 87,554.13 9,118.47 48038 4,644.00

GAMESTOP CORP CMN CLASS A (GME) 5,750.00 17 9500 103,212.50 18.9004 108,677.39 (5,464 89) 8.4680 8,740.00

GAP INC CMN (0) 565.00 34.0600 19,243.90 22.5225 12,725.22 6,518.68 2.7011 519.80

GENERAL ELECTRIC CO CMN (GE) 34,349.00 17.4500 599,390 05

4,121 88

25.8261 887,102.05 (287,712.00) 2 7507 16,487.52

GENERAL MOTORS COMPANY CMN (GM) 5,593.00 40.9900 229,257.07 34 6574 193,838 95 35,418.12 3.7082 8,501.36

Portfolio No . )=-XX922.6 ATTACHMENT TO EXHIBIT C Page 184 of 349

Page 32 of 40

Statement Detail

HTM, JR. FOUNDATION ENH DIV TAX EX

000 1623-0184.0350 - n 142544---dn 51-29

Statement Detail






PUBLIC EQUITY (Continued)Market Value / Unrealized Dividend Estimated

Ouanfi Market Price Accrued Income Unit Cost Cost Basis Gain (Loss) Yield Annual Income

US EQUITY


GENUINE PARTS CO CMN (GPC) 5.00 95.0100 475.05 82.0800 410.40 6465 2 8416 I J.5u

3 38

GILEAD SCIENCES CMN (GILD) 3,587.00 71 6400 256,972 68 70.2267 251,903.19 5,06949 2.9034 7,460.96

H & R BLOCK INC. CMN (HRB) 2,405.00 26.2200 63,05910 26.3216 63,303 45 (244.35) 3.6613 2,308.80

577.20

HALLIBURTON COMPANY CMN (HAL) 1,635.00 488700 79,902 45 42 7885 69,959.13 9,943.32 1.4733 1,177.20

HARRIS CORP CMN (HRS) 195 00 141 6500 27,621.75 121.2041 23,634.80 3,98695 1.6096 444.60

HEWLETT PACKARD ENTERPRISE CO CMN (HPE) 1,125.00 14.3600 16,155.00 13.6496 15,355.75 799.25 2.0891 337.50

84.38

HONEYWELL INTL INC CMN (HON) 2,305.00 153 3600 353,494.80 144.7525 333,654.42 19,840 38 1.9431 6,868.90

HP INC. CMN (HPQ) 5,130.00 21.0100 107,781.30 17.9680 92,175 68 15,605.62

714.61

HUNTINGTON BANCSHARES INCORPOR CMN (HBAN) 19,905 00 14.5600 289 ,816.80 13.7245 273,185 46 16 , 631 34 30220 8,75820

2,189.55

ILLINOIS TOOL WORKS CMN (ITW) 20.00 166.8500 3,337.0015.60

136.8870 2,737.74 59926 1.8699 62 40

ILLUMINA, INC. CMN (ILMN) 93.00 218.4900 20,319.57 186.3389 17,329.52 2,990.05

INCYTE CORPORATION CMN (INCY) 90.00 94.7100 8,523.90 130.3127 11,728.14 (3,204 24)

INTEL CORPORATION CMN (INTC) 8,550.00 461600 394,668.00 39.4259 337,091.22 57,576.78 23614 9,319.50

INTERNATIONAL PAPER CO. CMN (IP) 3,780.00 57 9400 219,013.20 57.2430 216,378.63 2,634.57 3.2793 7,182.00

INTERPUBLIC GROUP COS CMN IIPG) 6,495.00 20.1600 130,939 20 21.3722 138,812.28 (7,873.08) 35714 4,676.40

INTL BUSINESS MACHINES CORP CMN (IBM) 3,650.00 153.4200 559,983.00 156.3740 570,764.92 (10,781.92) 39108 21,900.00

INTUITIVE SURGICAL, INC. CMN (ISRG) 55.00 364.9400 20,071.70 378.2122 20,801.67 (729,97)

INVESCO LTD. CMN (IVZ) 7,700.00 365400 281,358 00 354530 272,988.15 8,369.85 3.1746 8,932.00

JANUS HENDERSON GROUP PLC CMN (JHG) 3,705.00 38.2600 141,753.30 34.5700 128,081.85 13,671.45 3.3455 4,742.40

JOHNSON & JOHNSON CMN (JNJ) 5,88500 139.7200 822,252.20 129.8273 764,033.40 58,218.80 2.4048 19,773.60

JPMORGAN CHASE & CO CMN (JPM) 6,971 00 106.9400 745,478.74 95.6152 666,533 74 78,94b.UU z.u94b I5 ,b It) U4

KAR AUCTION SERVICES, INC. CMN (KAR) 89000 50 5100 44,953.90 44.5216 39,624.23 5,329.67 2 7717 1,246 00

311.50

KELLOGG COMPANY CMN (K) 850.00 67 9800 57,783.00 70.8635 60,233 96 (2,450.96) 31774 1,836.00

RTTRXA CTATTACERM TO

Portfolio No- XXX-XX922-6Page 33 of 40

Page 185 of 349

0001623-0185 -0350-0 142545--0151-29


Schedule of Balance Sheet Assets HTM, JR. FOUNDATION ENH DIV TAX EX2017 Form 990-PF - PART II, Balance Sheets Holdings (Continued)

PUBLIC EQUITY ( Continued)Period Ended December 31, 2017



DividendYield


US EQUITY


KIMBERLY CLARK CORP CMN (KMBI 3,335.00 120.6600 402,401.10

3,234.95117.2858 391,148 04 11,253.06 3.2156 12,939 80

KINDER MORGAN INC CMN CLASS P (KMI) 390.00 18.0700 7,047.30 19.6720 7,67208 (624.78) 27670 195 00

KLA-TENCOR CORPORATION CMN (KLAC) 635.00 105.0700 66,719 45 95.7977 60,831.51 5,867.94 2 2461 1,498.60

KOHL'S CORP (WISCONSIN) CMN (KSS) 1,325.00 54.2300 71,854.75 38.9529 51,612 59 20,24216 4 0568 2,915.00

L BRANDS, INC. CMN (LB) 4,196 00 60.2200 252,68312 44.0249 184,728.61 67,954.51 3.9854 10,070 40

LAM RESEARCH CORPORATION CMN (LRCX) 275.00 184.0700 50,619 25137 50

162.2316 44,613.69 6,005.56 1.0865 550 00

LAS VEGAS SANDS CORP. CMN (LVS) 3,180.00 69.4900 220,978.20 60.3742 191,989.99 28,988.21 4.2020 9,285.60

LEGG MASON INC CMN (LM) 1,060.00 41 9800 44,498.80296.80

36.8561 39,067 46 5,431.34 2.6679 1,18720

LEGGETT & PLATT, INCORPORATED CMN (LEG) 780.00 47.7300 37,229 40

28080

451558 35,221.53 2,007 87 3 0170 1,123.20

LOCKHEED MARTIN CORPORATION CMN (LMT) 1,45000 321.0500 465,522.50 308.1677 446,843.15 18,679 35 2.4918 11,600.00

LOGMEIN INC CMN (LOGM) 60.00 114.5000 6,870.00 112.8367 6,77020 99 80 0.8734 60.00

MACY'S INC. CMN (M) 6,980.00 25.1900 175,826.202,634. 95

20.8072 145,234.27 30,591.93 5.9944 10,539.80

MARATHON PETROLEUM CORPORATION CMN (MPC) 1,110.00 65.9800 73,237.80 49.5375 54,986.59 18,251.21 2.4250 1,776.00MASTERCARD INCORPORATED CMN CLASS A (MA) 390.00 151.3600 59,030.40 118 5017 46,215.65 12,814 75 0.6607 390.00

MAXIM INTEGRATED PRODUCTS INC CMN (MXIM) 2,435.00 52.2800 127,301.80 49.2686 119,968.92 7,332.88 2.7544 3,506.40

MC DONALDS CORP CMN (MCD) 3,15000 172.1200 542,178.00 153 6927 484,131.92 58,046.08 2.3472 12,726.00

MERCK & CO. INC CMN (MRK) 7,400.00 56.2700 416,398.00 63.8112 472,202 75 (55,804 75) 3.4121 14,208.003,552.00

MERCURY GENERAL CORPORATION CMN (MCY) 2,350.00 534400 125,584.00 556616 130.804 87 (5,220 87) 4.6781 5,87500

MICROCHIP TECHNOLOGY INCORPORA CMN (MCHP) 9000 87.8800 7,909.20 938653 8,447.88 (538.68) 1 6500 130 50

MICRON TECHNOLOGY, INC. CMN (MU) 1,060.00 41.1200 43,587.20 38.6272 40,944.83 2,642.37

Portfolio No XXX-XX922.6 NXTAL;EMNT TU EXHIBIT t; Page 186 of 349

Page 34 of 40

Ot K) 1621-0186-0150-0 1 42W-----0151.29




- EIN: 16-1578255

Statement Detail




Duentity Market Price

Market ValueAccrued Income Un it Cost Cost Basis


DividendYield


US EQUITY


MICROSOFT CORPORATION CMN (MSFT) 15.958.00 85.5400 1,365,047 32 49 7191 793,417.47 571,629.85 1.9640 26,809.44

MONDELEZ INTERNATIONAL, INC. CMN (MDLZ) 1,875.00 42 8000 80,250 00412.50

41.6392 78,073.42 2,176.58 1.2150 975 00

NATIONAL OILWELL VARCO INC COMMON STOCK CMN (NOV) 150.00 36.0200 5,403.00 31 5937 4,739.05 663.95 0.5552 30.00

NAVIENT CORPORATION CMN (NAVI) 9,685.00 13.3200 129,004 20 13 7144 132,824.01 (3,819.81) 4.8048 6,198 40

NETFLIX COM INC CMN (NFLX) 840 00 191.9600 161,246 40 100 0379 84,031.83 77,214 57

NEW YORK COMMUNITY BANCORP, IN CMN (NYCB) 28,130 00 13 0200 366,252 60 12.6242 355,118.86 11,133 74 5.2227 19,128.40

NEWMONT MINING CORPORATION CMN (NEM) 1,01500 37.5200 38,082 80 19 0207 19,306.05 18,776.75 07996 304 50

NIKE CLASS-B CMN CLASS B (NKE) 580.00 62.5500 36,279 00116 00

54 8199 31,795 57 4,483.43 1.2790 464.00

NUCOR CORPORATION CMN (NUE) 605.00 63.5800 38,465 90229.90

63 7032 38,540 43 (74 53) 2.3907 919 60

NVIDIA CORP CMN (NVDA) 1,220.00 193.5000 236,070 00 129 7601 158,307 32 77,762.68 0.3101 732.00

OCCIDENTAL PETROLEUM CORP CMN (OXY) 2,227.00 73.6600 164,040 82

1,714 79

71.7928 159,882 63 4,15819 41814 6,85916

OLD REPUBLIC INTL CORP CMN (ORI) 8,88500 21 3800 189,961.30 191256 169,930.99 20,030 31 3.5547 6,75260

OLIN CORPORATION CMN (OLN) 880.00 35 5800 31,310.40 34 4384 30,305.78 1,004.62 22485 704.00

OMNICOM GROUP CMN (OMC) 1,455.00 72 8300 105,967 65

873.00

701029 101,999 74 3,967.91 3.2953 3,492.00

ONEOK INC CMN (OKE) 710.00 53 4500 37,949.50 53.5336 38,008.83 (59.33) 5.5753 2,11580

ORACLE CORPORATION CMN (ORCL) 5,29700 47 2800 250,442.16 43.1306 228,462 87 21,979.29 1.6074 4,02572

P G & E CORPORATION CMN (PCG) 1,195.00 44 8300 53,571 85 70 2472 83,945 40 (30,373 55)

PACWEST BANCORP CMN (PACW) 8,45500 50.4000 426,132 00 47.5225 401,802 82 24,329.18 3.9683 16,910 00

PARSLEY ENERGY, INC. CMN (PE) 1,240.00 294400 36,505 60 27 0720 33,569.23 2,936.37

PAYCHEX, INC. CMN (PAYX) 56000 68 0800 38,124.80 56 3821 31,573 98 6,550.82 2.9377 1,120 00

PAYPAL HOLDINGS INC CMN (PYPL) 905 00 73 6200 66,626.10 61.6388 55,78313 10,842.97

PEPSICO, INC. CMN (PEP) 4,437.00 119 9200 532,085 04

3,571 79

115.1337 510,84819 21,236 85 26851 14,28714

PFIZER INC CMN (PFE) 23,234 00 36.2200 841,535 48 33 3921 775,832 98 65,702.50 3.7548 31,598.24


Portfolio No: XXX-XX922-6

(M411621-0187-035()-0142i47-----11151-29


The Harry T. Mangurian. Jr. Foundation, Inc. - EIN: 16-1578255



Statement Detail

HTM, JR . FOUNDATION ENH DIV TAX EXHoldings (Continued)



Uuami Market PriceMarket Value /



DividendYield



PHILIP MORRIS INTL INC CMN (PM) 4,053.00 105.6500 428,199 45

4,336.71

99.0058 401,270.32 26,929.13 4.0511 17,346.84

PHILLIPS 66 CMN (PSX) 570.00 101.1500 57,655.50 83.5226 47,607.88 10,047.62 2.7682 1,596.00

PINNACLE FOODS INC. CMN (PF) 470.00 59.4700 27,950.90

152.75

53.6904 25,234.49 2,716.41 21860 611.00

PIONEER NATURAL RESOURCES CO CMN (PXD) 295.00 172.8500 50,990.75 165 8311 48,92017 2,070.58 0.0463 23.60

PITNEY-BOWES INC CMN (P81) 12,095.00 11 1800 135,222.10 130504 157,845.16 (22,623.06) 6.7084 9,071 25

PPL CORPORATION CMN (PPL) 11,505.00 30.9500 356,079 75

4,544.48

394234 453,566.22 (97,486.47) 51050 18,177.90

PRAXAIR, INC. CMN (PX) 455.00 154.6800 70,379 40 133.3083 60,655 26 9,724.14 2.0365 1,433 25

PRICELINE GROUP INC/THE CMN (PCLN) 44.00 1,737.7400 76,460.56 1,629 7893 71,710 73 4,749.83

PRINCIPAL FINANCIAL GROUP, INC CMN (PFG) 3,645.00 70.5600 257,191 20 62.7180 228,607.11 28,584 09 2.7778 7,144.20

PROASSURANCE CORP CMN (PRA) 1,545.00 57.1500 88,296 75

7,72500

63.1583 97,579.59 (9,282 84) 2.1697 1,915.80

PROCTER & GAMBLE COMPANY (THE) CMN (PG) 3,614.00 91.8800 332,054 32 90.6183 327,494 63 4,559.69 30022 9,968.86

PRUDENTIAL FINANCIAL INC CMN (PRU) 1,579.00 114.9800 181,553.42 111.0640 175,370 05 6,183 37 2.6091 4,737 00

QUALCOMM INC CMN (QCOM) 4,775.00 64.0200 305,695 50 588693 281,100 76 24,594.74 3.5614 10,887.00

QUEST DIAGNOSTICS INCORPORATED CMN (DGX) 210.00 98.4900 20,682 90 994267 20,879.61 (196.71) 1.8276 378.00

REGAL ENTERTAINMENT GROUP CMN CLASS A (RGCI 13,885.00 23.0100 319,493.85 16 7850 233,059.66 86,434.19 3.8244 12,218.80

REGIONS FINANCIAL CORPORATION CMN (RF) 3,655.00 17.2800 63,158.40

328.95

14.1651 51,773.46 11,384.94 2.0833 1,315.80

REPUBLIC SERVICES INC CMN (RSG) 165.00 67.6100 11,155.65

56 93

63.9825 10,557.11 598.54 2.0411 227.70

RESMED INC. CMN (HMO) 435.00 84.6900 36,840.15 82 9993 36,104.71 73544 1.6531 609.00

ROCKWELL AUTOMATION INC CMN (ROK) 195.00 196 3500 38,288 25 198 9502 38,795 29 (507 04) 1.7010 651.30

RSP PERMIAN INC CMN (RSPPI 65500 40 6800 26,645 40 32.7444 21,447.58 5,197.82

Portfolio No XXX-XX922-6 ATTACHMENT

Page 36 of

TO EXHIBIT

40

C Page 188 of 349

ODO 1623-0188-0350-0142548--015 1 -29

The Harry T. Mangurian, Jr. Foundation, Inc. - EIN :



Statement Detail16-1578255




Guantity Market PriceMarket Value /


DividendYield


US EQUITYGSAM: ENHANCED DIVIDEND (S&P 500) TAX EXEMPT

SABRE CORPORATION CMN (SABR) 215.00 20.5000 4,407.50 18 3951 3,954.95 452.55 2.7317 120.40SALESFORCE.COM, INC CMN (CRM) 930.00 102.2300 95,073.90 887088 82,499.15 12,574.75

SCANA CORP CMN (SCG) 1,93000 39 7800 76,775.40

1,182.13

491094 94,781 22 (18,005.82) 6.1589 4,728.50

SCHLUMBERGER LTD CMN (SLB) 2,969.00 67.3900 200,080.91

1,484.50

72.2911 214,632.42 (14,551.51) 29678 5,93800

SIX FLAGS ENTERTAINMENT CORPOR CMN (SIX) 2,18500 66.5700 145,455.45 61.4031 134,165.76 11,289.69 4 2061 6,118 00STARBUCKS CORP. CMN (SBUX) 955.00 57 4300 54,845.65 552333 52,747.76 2,09789 2.0895 1,146.00

STRYKER CORPORATION CMN (SYK) 510.00 154.8400 78,968.40

239.70

139.3399 71,063.37 7,905.03 1.2142 95880

SUNTRUST BANKS INC CMN (STI) 4,500.00 64 5900 290,655 00 60.2641 271,188.44 19,466 56 2.4772 7,200.00

SYSCO CORPORATION CMN (SYY) 1,165.00 60.7300 70,750.45 563522 65,650.31 5,10014 23712 1,677 60

T. ROWE PRICE GROUP, INC CMN (TROW) 1,595 00 104 9300 167,363 35 84 0610 134,077.31 33,286 04 2.1729 3,63660TAPESTRY, INC. CMN (TPR) 3,685.00 44.2300 162,987.55

1,243.6940.7301 150,090.24 12,897.31

TARGET CORPORATION CMN (TGT) 1,130.00 652500 73,732 50 597004 67,461.40 6,271 10 3.8008 2,80240

TEXAS INSTRUMENTS INC. CMN (TXN) 2,575.00 104.4400 268,933.00 78.7112 202,681.25 66,251 75 2.3746 6,38600

TFS FINANCIAL CORPORATION CMN (TFSL) 8,505.00 14.9400 127,064 70 15.3979 130,959.25 (3,894.55) 4.5515 5,783.40

THE HERSHEY COMPANY CMN (HSY) 480.00 113.5100 54,484.80 104.7391 50,274.77 4,210.03 2.3117 1,259.52THE KRAFT HEINZ CO CMN (KHC) 3,740.00 77.7600 290,822.40 76.3465 285,536.01 5,286.39 3.2150 9,350.00

THE SOUTHERN CO. CMN (SO) 6,755.00 48.0900 324,847.95 51.6523 348,911.52 (24,063.57) 48243 15,671.60

THE WILLIAMS COMPANIES, INC CMN (WMB) 1,625.00 30.4900 49,546.25 34 6649 56,330 50 (6,784.25) 3.9357 1,950.00

THERMO FISHER SCIENTIFIC INC CMN (TMO) 70.00 189.8800 13,291.60

10.50

191.9974 13,439,82 (148.22) 0.3160 42.00

TIFFANY & CO CMN (TIF( 260 00 103 9500 27,027.00130.00

87 9819 22,875 29 4,151 71 19240 520 00

TUPPERWARE BRANDS CORPORATION CMN (TUP) 2,460.00 62.7000 154,242.00

1,672.80

581188 142,972 37 11,269.63 4.3381 6,69120

U.S. BANCORP CMN (USB) 1,67500 53.5800 89,746.50

502.50

54.3756 91,079.05 (1,332 55) 2.2396 2,01000

Portfolio No. XXX-XX922-6

0001623-0189.0350-0142549--0131-29



Schedule of Balance Sheet Assets HTM, JR. FOUNDATION ENH DIV TAX EX2017 Form 990-PF - PART II, Balance Sheets Holdings (Continued)



Quantity Market PriceMarkel Value /

Accrued Income Unit Cost Cost BasisUnrealizedGain ( Loss)

DividendYield



UNION PACIFIC CORP. CMN (UNP) 1,580.00 134.1000 211,878.00 109.6185 173,197.18 38,680.82 1.9836 4,202.80UNITED PARCEL SERVICE, INC. CLASS B COMMON STOCK(UPS)

3,968.00 119.1500 472,787.20 113 9248 452,053 66 20,733.54 27864 13,173.76

UNITED TECHNOLOGIES CORPORATIO CMN (UTX) 1,61500 127.5700 206,025.55 1201269 194,004.91 12,020.64 2.1949 4,52200UNITEDHEALTH GROUP INCORPORATE CMN (UNH) 2,352.00 220.4600 518,521 92 141.0932 331,851.21 186,670.71 1.3608 7,056.00VALERO ENERGY CORPORATION CMN (VLO) 790.00 91.9100 72,608 90 66.7630 52,742 79 19,866.11 3.0465 2,21200VERIZON COMMUNICATIONS INC. CMN (VZ) 6,714.00 52.9300 355,372.02 508703 341,543 27 13,828.75 4.4587 15,845 04VERTEX PHARMACEUTICALS INCORPO CMN (VRTX) 310.00 149 8600 46,456.60 126.5077 39,217.38 7,239.22VF CORP CMN (VFC) 1,025.00 74.0000 75,850.00 68.2429 69,948.96 5,901 04 2.4865 1,886.00VIACOM INC CMN CLASS 8 (VIAB) 20.00 30.8100 616.20

4.00

30.5710 611 42 4.78 2.5966 16 00

VISA INC. CMN CLASS A (V) 2,008.00 114.0200 228,952.16 93.2452 187,236.38 41,715.78 0.6841 1,566.24WAL MART STORES INC CMN (WMT) 4,364.00 98.7500 430,945.00

2,225.64

77.4370 337,935.21 93,009.79 2.0658 8,902.56

WALGREENS BOOTS ALLIANCE, INC. CMN (WBA) 1,540.00 72.6200 111,834.80 67.9661 104,667.72 7,167.08WALT DISNEY COMPANY (THE) CMN (DIS) 1,880.00 107 5100 202,118.80

1,579.20

98.3749 184,944 82 17,173.98 1.5626 3,158 40

WASTE MANAGEMENT INC CMN (WM) 55000 863000 47,465.00 76.7461 42,210.36 5,254.64 1.9699 935.00WELLS FARGO & CO (NEW) CMN (WFC) 3,275.00 60.6700 198,694 25 55.7589 182,610.46 16,083 79 2.5713 5,109.00WESTERN DIGITAL CORPORATION CMN (WDC) 790 00 79.5300 62,828.70

395.00

591347 46,716 40 16,112.30 2.5148 1,580.00

WESTERN UNION COMPANY (THE) CMN (WU) 4,795 00 19.0100 91,152 95 19.2890 92,490 99 (1,338.04) 3.6823 3,356.50WESTROCK COMPANY CMN (WRK) 1,24000 63.2100 78,380 40 60.0306 74,437.96 3,942.44 2.7211 2,132.80WPX ENERGY, INC CMN (WPX) 445.00 14 0700 6,261.15 121610 5,411.64 849.51WYNDHAM WORLDWIDE CORP. CMN (W(N) 40 00 115.8700 4,634.80 105.7418 4,22967 405.13 2.0022 92 80XEROX CORPORATION CMN (XRX) 3,010.00 29.1500 87,741.50

752 5028.7336 86,48810 1,253.40

Portfolio No X (X-XX921-6 ATTACHMENT TO EXHIBIT

Page 38 of 40

C Page 190 of 349

(Xk) I6214I M-0350-0142550 --•--011; 1-29

The Harry T. Mangurian, Jr. Foundation, Inc. - EIN:



Statement Detail

16-1578255 HTM, JR . FOUNDATION ENH DIV TAX EXHoldings (Continued)





Dividend

YieldEstimated

Annual Income

US EQUITYGSAM ENHANCED DIVIDEND (S&P 500) TAX EXEMPT

XILINX INCORPORATED CMN (XLNX) 275.00 67.4200 18,540 50 72.5811 19,959.79 (1,419 29) 2.0765 385.00

THE HOME DEPOT, INC CMN (HD) 2,532 00 189 5300 479,889 96 151 8124 384,388.99 95,500 97 1.8783 9,013.92

AMERICAN TOWER CORPORATION CMN (AMT) 1,58500 142.6700 226,131 95

1,10950

104 3684 165,423.97 60,707 98 0 9532 2,155.60

CORESITE REALTY CORP CMN (COR) 225 00 113.9000 25,627.50

220.50

118.2262 26,600 90 (973 40) 3.4416 882.00

CROWN CASTLE INTL CORP CMN (CCI) 1,590.00 111.0100 176,505 90 94.6379 150,47419 26,031 71 29547 5,21520CYRUSONE INC CMN (CONE) 570.00 59.5300 33,932.10

239.40

48.8038 27,81818 6,113.92 2.8221 957.60

EQUINIX, INC. REIT (EQIX) 408.00 453.2200 184,913.76 357 4477 145,838.66 39,075.10 1 5445 2,856.00

EQUITY RESIDENTIAL CMN (EQA) 300.00 63.7700 19,131 00

151 13

67.2326• 20,169.78 (1,038 78) 3.1598 604.50

ESSEX PROPERTY TRUST INC CMN (ESS) 335.00 241.3700 80,858.95

586.25

237 6783 79,622.24 1,23671 2.9001 2,345.00

MID-AMERICA APT CMNTYS INC CMN (MAA) 400 00 100 5600 40,224.00 106.1681 42,467 24 (2,243.24) 36695 1,47600

PROLOGIS INC CMN (PLD) 2,14000 64.5100 138,051 40 601026 128,619 49 9,431.91 2.0462 2,82480

SBA COMMUNICATIONS CORPORATION CMN (SBAC) 69500 163.3600 113,535 20 146.0884 101,531.42 12,003 78

SUN COMMUNITIES INC CMN (SUI) 310 00 92.7800 28,761.80

207.70

85.0219 26,356.79 2,405.01 2.8886 830.80

ALEXANDRIA REAL ESTATE EQUITIES, INC (ARE) 105 00 130.5900 13,711.95

94.50

118.0511 12,395.37 1,316.58 2.7567 378.00

DIGITAL REALTY TRUST, INC. CMN (DLR) 73500 113 9000 83,716.50683.55

109 3536 80,374.86 3,341.64 3.2660 2,734.20

ACCENTURE PLC CMN (ACN) 290.00 153 0900 44,396.10 131.1474 38,032.74 6,363.36 17375 771.40

ALLERGAN PLC CMN (AGN) 201 00 163 5800 32,879 58 218 4040 43,899 20 (11,019 62) 17117 562 80

BROADCOM LIMITED CMN (AVGO) 1,207.00 256.9000 310,078.30 233 4530 281,777.82 28,300.48

CHUBB LTD CMN (CB) 160 00 146.1300 23,380.80

113 60

141 9371 22,709 93 670.87

COPA HOLDINGS, S.A. CMN CLASS A (CPA) 195.00 134.0600 26,141.70 123 5170 24,085.81 2,05589 22378 585 00

EATON CORP PLC CMN (ETN) 24000 79.0100 18,962.40 79 2791 19,026 99 (64.59) 30376 57600

ATTACHMENT TO EXHIBIT CPortfolio No XXX-XX922-6

W)162 t -11191-IIi50.0142551----0151-24


The Harry T. Mangurian, Jr. Foundation , Inc. - EIN : 16-1578255




Statement Detail





DividendYield


US EQUITY


GARMIN LTD CMN (GRMN) 1,260.00 59 5700 75,058.20 51.5598 64,965 38 10,092.82 3.4245 2,57040INTERNATIONAL GAME TECHNOLOGY PLC CMN (IGT) 70.00 26.5100 1,855.70 23 5426 1,647.98 207.72 3 0177 56.00JOHNSON CONTROLS INTERNATIONAL CMN (JCI) 2,553.00 381100 97,294.83

531 02

38.8105 99,083.23 (1,788.40) 2.7289 2,655.12

LYONDELLBASELL INDUSTRIES N.V. CMN CLASS A (LYB) 1,540.00 110 3200 169,892 80 87.4882 134,731.83 35,160 97 3.2632 5,544.00MEDTRONIC PUBLIC LIMITED COMPA CMN (MDT) 6,100.00 80.7500 492,575 00 80 7818 492,769.01 (194.01)

MERCADOLIBRE INC. CMN (MELT) 115.00 314.6600 36,185.90

17 25

264 5794 30,426.63 5,75927 0.1907 69.00

NIELSEN HLDGS PLC CMN (NLSN) 2,020.00 36.4000 73,528.00 37.3620 75,471 26 (1,943.26) 3.7363 2,747.20ROYAL CARIBBEAN CRUISES LTD ISIN- LR0008862868 (RCL) 550.00 119 2800 65,604.00

330 00

113.7903 62,584 68 3,019.32 2.0121 1,320.00

SEAGATE TECHNOLOGY PLC CMN (STX) 3,895.00 41 8400 162,966 80

1,9630833.0475 128,720.04 34,246 76

TE CONNECTIVITY LTD CMN (TEL) 400 00 95 0400 38,016.00 89.5157 35,806 28 2,209.72TOTAL GSAM: ENHANCED DIVIDEND (S&P 500) TAX EXEMPT 43,652,498.34

67,954 06

38,373,907 59 5,278,590.75 2.8234 1,058,855 34

Market ValueAdjusted Cost /e

Ori ginal CostUnrealized

Gain (Loss)Estimated

Annual IncomeTOTAL PORTFOLIO 43,720,452.40 38 ,373,907.59 5,278,590.75 1,058,855.34

Original Cost is price paid by purchaser adjusted for annual original issue discount inclusions and/or return of capital adjustments, if applicable Adjusted Cost reflects adjustments to Original Cost for market discount accretion and/or premiumamortization Adjusted cost for GMS Portfolios and Alternative Investments are determined by inception to date contributions minus inception to date distributions ATTACHMENT TO EXHIBIT CPortfolio No. XXX-XX922-6


0001623.0192.0350-0142552----- OI51.29

THE HARRY T. MANGURIAN . JR. FOUNDATION, INC.FEDERAL TAX I.D. # 16-1578255FORM 990-PF - PART IVSCHEDULE OF CAPITAL GAINS AND LOSSESFOR THE YEAR ENDED DECEMBER 31, 2017

SUMMARY OF CAPITAL GAINS I (LOSSES):

Financial Institution

Publicly Traded Securities:Goldman Sachs & Co. - ADV. ALLAccount # 020 - 46700 -7

Goldman Sachs & Co. - LAZARDDisallowed LossesAccount # 051 - 60049 - 2

Goldman Sachs & Co. - H.Y. CORP. F.I.Ordinary Gain / (Loss)Account # 021 - 94435 - 0

Goldman Sachs & Co. - INVESCOAccount # 051 - 60050 - 0

Goldman Sachs & Co. - GOVT / CORP. F I.Account # 020 - 51891 - 6

Goldman Sachs & Co. - DELAWAREDisallowed Losses

Account # 046 - 53800 - 5

Goldman Sachs & Co. - ENH. DIV. TAX EX.Disallowed LossesAccount # 046 - 62922 - 6

EXHIBIT D(Page 1 of 2)

Cost Basis/ Net Short-Term Net Long-Term Total NetGross Disallowed Capital Capital Capital

Proceeds Losses Gain / (Loss) Gain / (Loss) Gain / (Loss)

$4,428,487 $4,607,373 $5 ($178,891) ($178,886)

2,888,022 2,677,607 63,639 165,877 229,516(19,101)

1,117,627 1,096,842 77 18,331 20,78550 2,327

561,137 575,415 (3,495) (10,783) (14,278)

3,373,852 3,357,983 0 15,869 15,869

1,532,371 1,467, 746 (215) 67,566 67,351(2,726)

60,080,308 56,999,849 2,039,634 1,087,134 3,126,768(46,309)

SubTotal - Publicly Traded Securities 73,981,804 70,714,679 2,099,695 1,167,430 3,267,125***PER FORMS 1099***

THE HARRY T. MANGURIAN , JR. FOUNDATION, INC.FEDERAL TAX I.D . # 16-1578255 EXHIBIT DFORM 990-PF - PART IV (Page 2 of 2)SCHEDULE OF CAPITAL GAINS AND LOSSESFOR THE YEAR ENDED DECEMBER 31, 2017

SUMMARY OF CAPITAL GAINS / (LOSSES): Cost Basis/ Net Short-Term Net Long-Term Total NetGross Disallowed Capital Capital Capital

Financial Institution Proceeds Losses Gain / (Loss) Gain / (Loss) Gain / (Loss)

Other L. P. Gains I (Losses):West Street Energy Partners, L.P. N/A N/A (14,147) (12,358) (26,505)(Schedule K-1 - FEI # 45-5302489)

West Street Energy Partners AIV-1, L. P. N/A N/A 0 4,101 4,101(Schedule K-1 - FEI # 45-5499354)

West Street Capital Partners VII Parallel, L. P. N/A N/A 180 0 180(Schedule K-1 - FEI # 81-4370542)

Goldman Sachs Vintage Fund V Offshore, L. P. N/A N/A 17,949 459,109 477,058

Goldman Sachs Vintage Fund VI Offshore, L.P. N/A N/A 3,635 241,884 245,519

Goldman Sachs Vintage Fund VII Offshore, L P. N/A N / A 0 47,560 47,560

SubTotal - Other L . P. Gains/(Losses) 0 0 7,617 740,296 747,913

TOTAL - CAPITAL GAINS I (LOSSES) $73,981,804 $70 ,714,679 $2 , 107,312 $1,907,726 $4,015,038

***PER FORM 990-PF***

THE HARRY T. MANGURIAN, JR. FOUNDATION. INC.FEDERAL TAX I.D. # 16-1578255FORM 990-PF - PART VIII. LINE IFOUNDATION OFFICERS & DIRECTORSFOR THE YEAR ENDED DECEMBER 31, 2017

EXHIBIT E

Contrib. to Emp. Expense A/CNames, addresses and titles of Hours / Week Ben. Plans & Def. and Otherofficers, directors, trustees, etc. Devoted Compensation Compensation Allowances

Stephen G. Mehallis 40 Hours $145,000 $0 $04221 N.E. 25th AvenueFort Lauderdale, Florida 33308President / Director

Gordon W Latz 40 Hours $145,000 $0 $02811 N.E. 40th StreetFort Lauderdale, Florida 33308Vice President-Grants / Secretary / Director

Beth P. Piana 40 Hours $127,038 $0 $08423 N.W. 80th CourtTamarac, Florida 33321Vice President-Finance / Treasurer

Charles Glenn Leonard, Esq. 1 Hour $5,000 $0 $01523 Middle River DriveFort Lauderdale, Florida 33306Chairman / Director

Nora Gillary 1 Hour $5,000 $0 $0512 Waterford Lake DriveCary, North Carolina 27519Director

Paul C. Jameson, Jr. 1 Hour $5,000 $0 $02756 N.E. 35th DriveFort Lauderdale, Florida 33308Director

TOTAL COMPENSATION $432,038

EXHIBIT E

THE HARRY T. MANGURIAN , JR. FOUNDATION, INC.FEDERAL TAX I.D . # 16-1578255FORM 990-PF - PART X. LINE 1aAVERAGE MONTHLY FAIR MARKET VALUES - SECURITIESFOR THE YEAR ENDING DECEMBER 31, 2017

Average Monthly AnnualAmount of Monthly

Month Securities Held Average

JANUARY $140,536,759

FEBRUARY 142,084,560

MARCH 143,340,328

APRIL 144,441,243

MAY 145,621,951

JUNE 144, 975,890

JULY 145,094,189

AUGUST 146,581,317

SEPTEMBER 145,831,499

OCTOBER 145,169,571

NOVEMBER 145,851,907

DECEMBER 146,852,069

TOTAL - SECURITIES $1,736, 381,283 / 12 = $144,698,440

EXHIBIT F

EXHIBIT F

THE HARRY T. MANGURIAN, JR. FOUNDATION, INC.FEDERAL TAX I.D. # 16-1578255FORM 990-PF - PART X. LINE lbAVERAGE MONTHLY FAIR MARKET VALUES - CASHFOR THE YEAR ENDED DECEMBER 31, 2017

Average Monthly AnnualAmount of Monthly

Month Cash Held Average

JANUARY $1,967,533

FEBRUARY 2,227,125

MARCH 2,383,794

APRIL 2,173,544

MAY 2,233,853

JUNE 2, 851,560

JULY 2, 921,059

AUGUST 2,151,711

SEPTEMBER 1,744,213

OCTOBER 1,952,947

NOVEMBER 1,815,778

DECEMBER 1,300,101

TOTAL-CASH $25,723,218 / 12 = $2,143,602

EXHIBIT G

EXHIBIT G

THE HARRY T. MANGURIAN, JR. FOUNDATION, INC.FEDERAL TAX I. D. # 16-1578255FORM 990-PF - PART XV, LINE 3a EXHIBIT HGRANTS AND CONTIBUTIONS PAID DURING THE YEAR (Page 1 of 11)FOR THE YEAR ENDED DECEMBER 31, 2017

Relationship to Status of Purpose of

Recipien t Foundation Manager Recipient Contribution Amoun

American Cancer Society N/A PC To support cancer research & education, and raise awareness to $5,0003363 West Commerical Boulevard save lives from cancer.Fort Lauderdale, Florida 33309

Mayo Clinic - Florida N/A PC Continued support for Lewy Body Dementia research via the Mayo Clinic 1,150,0004500 San Pablo Road Dorothy & Harry T Mangunan, Jr Lewy Body Dementia ProgramJacksonville, Florida 32224

Holy Cross Hospital N/A PC Support for the Dorothy J Mangurian Women's Center at HCH HealthPlex, 505,110

4725 North Federal Highway support for research at the Phil Smith Neurosicence Institute at HCH, andFort Lauderdale, Florida 33308 support for the Jim Moran Heart & Vascular Center at HCH

American Diabetes Association N/A PC To support Camp Gene, ADA's Florida Summer Camp for children with 20,0006400 North Andrews Ave, Suite 480 diabetesFort Lauderdale, Florida 33309

The Ohio State University Foundation N/A PC Continued support for Lewy Body Dementia research, establishment of 1,385,000Office of University Development The Harry T Mangunan, Jr Foundation Cancer Drug Discoveries Fund,Post Office Box 710811 establishment of the Harry T Mangurian, Jr Fund for Faculty ExcellenceColumbus, Ohio 43271-0811 at OSU's Fisher College of Business.

Les Turner ALS Foundation WA PC Support for the ALS Walk4Life which helps fund patient care and education 5,000

5550 W. Touhy Ave., Suite 202 for Amyotrophlc Lateral Sclerosis (ALS) and other motor neuron diseases.Skokie, Illinois 60077

University of Texas Foundation N/A PC Continued support for the Harry T Mangunan, Jr Fund for Leukemia 250,000MD Anderson Cancer Center Immunotherapy to ensure the highest quality research for the treatment1515 Holcombe Road of leukemiaHouston , Texas 77030

THE HARRY T. MANGURIAN, JR. FOUNDATION, INC.FEDERAL TAX 1. D. # 16-1578255FORM 990-PF - PART XV, LINE 3aGRANTS AND CONTIBUTIONS PAID DURING THE YEARFOR THE YEAR ENDED DECEMBER 31, 2017

Relationship toRecipient Foundation Manager

Leukemia and Lymphoma Society N/A3 International Drive, Suite 200Rye Brook, New York 10573

EXHIBIT H(Page 2 of 11)

Status of Purpose ofRecipient Contribution Amount

PC Continued support for "A New Design to Beat AML", a clinical tnal protocol, $1,010,000the purpose of which is to make early treatment decisions and offer precisiontherapies to newly diagnosed AML patients, and support for the LLS Light theNight Walk in Broward County, Florida

Healthy Mothers, Healthy Babies-Broward N/A PC To support the organization's mission to reduce infant deaths by strengthen- 1,0005546 W Oakland Park Blvd, Suite 201 ing families through a comprehensive approach to prenatal care, parenting,Lauderhill, Florida 33313 education and support services

The Women's Breast & Heart Initiative NIA PC To support the expansion of the "One in Three/One in Eight" Program so 10,00014125 N W 80th Avenue that more medically underserved, low income women can be reached andMiami Lakes, Florida 33016 educated on how to detect and fight breast cancer and heart disease

Children's Diagnostic & Treatment Center N/A PC To support the organization's mission to provide comprehensive medical 1,0001401 South Federal Highway care for children in the South Florida community with chronic illnessesFort Lauderdale, Florida 33316 and disabilities

Friends of Birch State Park N/A PC Support to help preserve, conserve, enhance and promote Hugh Taylor Birch 2,0003109 East Sunrise Boulevard State Park through educational activities, community outreach, guidedFort Lauderdale, Florida 33304 tours, events and programs

PACE Center for Girls Broward NIA PC To support PACE's delinquency prevention/intervention program for young and 6,200

2225 North Andrews Avenue adolescent girls in Broward County, FL which provides them the opportunity

Wilton Manors , Florida 33311 for a better future through education , counseling , training and advocacy

Lollypop Farm N/A PC To support Lollypop Farm's Equine Rehabilitation and Adoption Program which 10,000

Humane Society of Greater Rochester allows intervention via a comprehensive assessment, individualized training and99 Victor Road focus on matching a horse 's history and personality with a complementaryC--,4 M , Vnr4 laAFn arlnntnn hnmP

THE HARRY T. MANGURIAN , JR. FOUNDATION, INC.FEDERAL TAX I. D. # 16-1578255FORM 990-PF - PART XV, LINE 3a EXHIBIT HGRANTS AND CONTIBUTIONS PAID DURING THE YEAR (Page 3 of 11)FOR THE YEAR ENDED DECEMBER 31, 2017

Relationship to Status of Purpose ofRecipient Foundation Manager Recipient Contribution

Scholarship Opportunities for Success N/A PC To support their scholarship program that assists women of low income withPost Office Box 340622 financial aid for education so that they may improve their futures and theColumbus, Ohio 43234 lives of their families.

Sawgrass Nature Ctr & Wildlife Hospital N/A PC Support for the Nature Center where people can come to observe birds,3000 Sportsplex Drive mammals, reptiles and plants native to So Fla, and for the Wildlife HospitalCoral Springs, Florida 33065 which cares for injured, sick and orphaned wild birds, mammals and reptiles

Chromosome Disorder Outreach, IncPost Office Box 724Boca Raton. Florida 33429-0724

Oceanside Emmaus, Inc8650 West Sample RoadCoral Springs, Florida 33065

The Friendly Home3156 East AvenueRochester, New York 14618

Wheelchair Foundation3820 Blackhawk RoadDanville, California 94506

Symphony of the Americas

2425 E Commercial Blvd, Suite 405Fort Lauderdale, Florida 33308

N/A PC Support to help CDO fund family programs , increase awareness and communityunderstanding of all chromosome disorders, and promote research and develop-ment of effective treatments for these rare disorders

N/A PC Support for the second Walk to Emmaus in Nigeria, a spiritual renewalprogram intended to strengthen the local churches and their congregationsthrough the development of Christian disciples and leaders

N/A PC Support to enable Memory Care capital and programming enhancementswhich will impact all of The Friendly Home's Memory Care patients andprovide them with the best possible care and services

N/A PC Support to enable delivery of 20 wheelchairs to Cleveland Clinic, 20 wheel-chairs to the disabled in Broward County, and one container of 100 wheel-chairs for the United States Navy's "Continuing Promise" program

N/A PC Support to promote world class music in South Florida, to enrich the lives ofpeople in the the South Florida community through the power of music, and toencourage the growth of cultural interests & educational activities in the fine arts

Amount

$5,000

3,500

25,000

5,000

50,000

28,000

1,000


FEDERAL TAX I. D. # 16-1578255

FORM 990-PF - PART XV, LINE 3a EXHIBIT H

GRANTS AND CONTIBUTIONS PAID DURING THE YEAR (Page 4 of 11)


Relationship to Status of Purpose of

Recipient Foundation Manager Recipient Contribution Amount

Exponent Philanthropy N/A PC Support to further Exponent Philanthropy's mission to enhance the power $1,000

1720 "N" Street Nothwest of philanthropy by providing donors with peer learning opportunities, resources

Washington, DC 20036 and a collective voice in and beyond the philanthropic community

Children's Aid Club N/A PC Support to further the club's mission to provide assistance to families with 10,000

Post Office Box 11503 children in the home who find themselves in crisis situations and follow up

Fort Lauderdale, Florida 33339 with additional assistance as needed to help families get back on track and

become self-sufficient

The Billy Thompson Foundation N/A PC To support their 5-Star Gifts Boot Camp which provides a focus-driven and 25,000

1839 West Hillsboro Boulevard wholesome learning environment that fosters spintual growth, responsibility,

Deerfield Beach, Flonda 33442 character and maturity

Pelotonia N/A PC Support for innovative and life saving cancer research at The Ohio State 1,000

L-3454 University Comprehensive Cancer Center Pelotonia is a grass roots bike

Columbus, Ohio 43260-3454 tour with one goal to end cancer

Community Foundation of Braward N/A PC Support to further their mission of providing leadership on community solu- 10,000

910 East Las Olas Blvd, Suite 200 tions and fostering philanthropy that connects people who care with causes

Fort Lauderdale, Florida 33301 that matter

Cardinal Gibbons High School N/A PC To support the school and its dedication to preparing students to meet the 1,000

2900 N E 47th Street challenges of this world through academic, moral, social, athletic, artistic

Fort Lauderdale, Florida 33308 and spiritual development.

I Care I Cure Childhood Cancer Fdtn N/A PC Support to help I Care I Cure raise awareness and funds for cutting edge 1,250

P 0 Box 291386 research for targeted and less toxic cures and treatments for childhood

Davie, Florida 33329 cancer so that more children survive, with healthier outcomes

THE HARRY T. MANGURIAN , JR. FOUNDATION, INC.FEDERAL TAX I. D . # 16-1578255FORM 990-PF - PART XV, LINE 3a EXHIBIT HGRANTS AND CONTIBUTIONS PAID DURING THE YEAR (Page 5 of 11)FOR THE YEAR ENDED DECEMBER 31, 2017

Relationship to Status of Purpose ofRecipient Foundation Manager Recipient Contribution Amount

Lighthouse of Broward N/A PC To support their mission to provide specialized rehabilitation and collaborative $2,500

650 North Andrews Avenue health care solutions that enhance the independence, productivity and dignity

Fort Lauderdale, Florida 33311 of children and adults who are blind or visually impaired.

Boys & Girls Clubs of Broward County N/A PC To support the clubs in assisting youth, especially those who need it most, to 1,000

877 N W 61st Street reach their full potential as productive, caring and responsible citizens, by pro-Fort Lauderdale, Florida 33309 viding them with a safe place to learn and grow

The Pink Ribbon Foundation N/A PC Support for obtaining speakers for the Breast Cancer Support Group meetings 5,0003900 Galt Ocean Drive, #1401 and for covering the administrative costs of conducting those meetings whichFort Lauderdale, Florida 33308 offer patient and family support

Museum of Discovery and Science N/A PC To support the Museum's mission to provide experiential pathways to lifelong 5,000401 Southwest 2nd Street learning in science for children and adults through exhibits, classes, programs,Fort Lauderdale, Florida 33312 camps and films

Deliver the Dream N/A PC To support their "Beyond the Cancer" program which helps cancer patients 5,000

3223 N W 10th Terrace, Ste 602 and their families obtain appropriate psychological and emotional support

Fort Lauderdale, Florida 33309 services to cope with their diagnosis of a child with cancer

Broward Partnership for the Homeless N/A PC To support the Partnership's mission to reduce homelessness in the South 2,700

920 Northwest 7th Avenue Florida community by promoting independence and self worth through advocacy,

Fort Lauderdale, Florida 33311-7229 short-term housing, and comprehensive services

Covenant House - Florida N/A PC To support Covenant House's "Executive Sleep Out" which unites people in 500

733 Breakers Avenue compassion, solidarity and action to make an immediate and lasting impactFort Lauderdale, Florida 33304 on the homeless young people of South Florida who live at Covenant House

THE HARRY T. MANGURIAN, JR. FOUNDATION, INC.FEDERAL TAX I. D. # 16-1578255FORM 990-PF - PART XV, LINE 3aGRANTS AND CONTIBUTIONS PAID DURING THE YEARFOR THE YEAR ENDED DECEMBER 31, 2017



Cystic Fibrosis Foundation- S Florida N/A PC To support research and drug development leading to individualized treatments $5,0003443 N W 55th Street, Bldg 1 (and eventually a cure) and high quality, specialized care so that all people withFort Lauderdale, Florida 33309 CF can have the opportunity to lead full and productive lives

St Mark's Episcopal School N/A PC To support St Mark's commitment to providing an education of academic excel- 1,0001750 East Oakland Park Boulevard lence with includes spiritual development, ethnic and cultural diversity, serviceFort Lauderdale, Florida 33334 to community and respect for self and others.

KidSafe Foundation20283 State Road 7, Suite 106Boca Raton, Florida 33498

Gift of Life Marrow Registry800 Yamato Road , Suite 101Boca Raton , Florida 33431

Cleveland Clinic - Florida

2950 Cleveland Clinic BoulevardWeston, Florida 33331

Archbishop E A McCarthy High School5451 South Flamingo RoadSouthwest Ranches, Florida 33330

A Prom to Remember

Unforgettable Prom Foundation

1007 North Federal Highwaycurt i n-i.m.io Fi..n.i. zzinA

N/A PC To support the implementation and expansion of KidSafe's three-part education 10,000program ("KidSafe for Kids", KidSafe Parent Seminars, and KidSafe TeacherWorkshops) into Broward County, Florida

N/A PC Continued support for the Campus Ambassador Program, which will expand its 25,000outreach into the Hispanic/Latino college community in order to help even morechildren and adults find matching donors for blood and marrow transplants

N/A PC Continued support for the Mangurian Neurology Fellowship Program , support to 1,085,000

establish the Harry T. Mangurlan , Jr. Simulation Lab, a multi-dlsclplnary stateof the art simulation suite that would be used for medical education of students,residents , fellows, physicians/surgeons , nurses , techs , firefighters and EMT's

N/A PC To support the high school's dedication to the formation of tomorrows leaders 1,000through a Roman Catholic experience that provides excellence in Atmosphere,Academics , the Arts, and Athletics

N/A PC To support their annual event that gives teens ages 12 - 19 who have been 1,600affected by cancer the ultimate prom experience at no cost to them or theirfamilies


Relationship to Status of Purpose ofReci pien t Foundation Manager Recipient Contribution Amount

Bethesda Foundation, Inc N/A PC To support the Mary Jo Cropper Family Center for Breast Care which provides $10,000

10500 Montgomery Road services for early detection, rapid diagnosis and treatment and improves survival

Cincinnati, Ohio 45242 rates for those with breast cancer

Leadership Broward Foundation, Inc1421 S.E 4th Avenue, Suite DFort Lauderdale, Florida 33316

The Salvation Army - Broward County1445 West Broward BoulevardFort Lauderdale, Florida 33312

Baptist Health S Florida Foundation1575 San Ignacio Avenue, Suite 406Coral Gables, Florida 33146

The FLITE Center1100 West McNab RoadFort Lauderdale , Florida 33309

N/A PC To support their mission to develop and inspire individuals to serve our com-munity and be a catapult for positive change and leadership developmentthrough awareness, engagement and transformation

N/A PC To support the "Red Shield ReDesign Bash," where creative, inspired and imagi-native individuals take old pieces of furniture and transform them into art, withsaid art being auctioned off to fund the Army's many shelter/feeding programs

N/A PC To establish The Harry T. Mangunan, Jr Foundation Telemediciner Fund at Bap-tist Health South Florida to extend care to the community's underserved andto the areas of critical need

N/A PC To support the young people in Broward County's dependency system by offering

a single, convenient point of access to the broad range of services and support

they need to become successful adults

1,000

3,000

1,000,000

1.000

St Jude Childrens Research Hospital262 Danny Thomas PlaceMemphis, Tennessee 38105

Special Olympics-Florida (Broward Cnty )Nova Southeastern University3301 College AvenueFort Lauderdale, Florida 33314

N/A PC To support the hospital's mission of advancing cures, and means of prevention,for pediatric catastrophic diseases through research and treatment, with no childbeing denied treatment based on race, religion or a family's ability to pay

N/A PC To support Sallarulo's Race for Champions, which not only raises funds for Spe-

cial Olympics but also raises awareness of the free programs provided by S 0that enrich the lives of children and adults with intellectual and developmentaldisabilities by providing the invaluable gifts of self confidence and self-imagewhich carry over into all aspects of their lives

6,000

10,000


Relationship to Status of Purpose ofReci pien t Foundation Manager Reci ien Contribution

Women in Distress of Broward County N/A PC To support WID's mission of serving all living in unsafe situations because of

Post Office Box 50187 domestic violence, including those with special needs, and providing victims ofLighthouse Point, Florida 33074 domestic abuse a stabilized, safe environment

Junior League of Greater Ft. Lauderdale N/A PC To support the JL women and their commitment to promoting voluntarism, de-

704 Southeast First Street veloping the potential of women, and improving their communities through the

Fort Lauderdale, Florida 33301 effective action and leadership of trained volunteers

Henderson Behavioral Health N/A PC To support HBH's mission to provide accessible, cost effective and quality be-4740 North State Road 7, Bldg C havioral healthcare services, as well as advocacy, supported employment andLauderdale Lakes, Florida 33319 housing to people in South Florida with mental illnesses and substance abuse

disorders so that they may reclaim their lives

Humane Society of Brow Cnty (PAWS) N/A PC To support HSBC's mission to provide shelter, aid and responsible adoptions

2070 Griffin Road to the animals entrusted to their care, and to expand community awarenessFort Lauderdale, Florida 33312 through education regarding respect and kindness to all animals

Jack & Jill Children's Center N/A PC To support J&J's Early Childhood Program which serves disadvantaged children

1315 West Broward Boulevard and families in Broward County by building strong educational foundations for

Fort Lauderdale, Florida 33312 their children's future and strengthening families to break the cycle of poverty

Boy Scouts of America N/A PC To support their 2017 Camping Program which provides youth one of the finest

South Florida Council opportunities to grow and mature in their relations with others, to develop con-

15255 N.W. 82nd Avenue fidence and self-respect, to share and cooperate with others as part of a team,

Miami Lakes, Florida 33016 and to build their communities by serving others.

Sheridan House Family Ministries N/A PC To support the ministry's mission to honor Christ by serving the needs of children

1700 South Flamingo Road and families, and by teaching the basics necessary to grow a healthy family in

Davie, Florida 33325 today's society

Amount

$2,500

2,000

1,000

2,000

10,000

5,000

1,000


Relationship to Status of Purpose ofReci pient Foundation Manager Recipient Contribution

Broward Public Library Foundation N/A PC To support the Library's 2017/2018 SAT/ACT Workshops for College-Bound100 South Andrews Avenue Students, a program of SAT and ACT prep classes for low-income studentsFort Lauderdale, Florida 33301 who have a desire to go to college and move themselves out of poverty

Broward Performing Arts Foundation N/A PC To support BPAF's mission to sustain, develop and secure the future for the201 S W 5th Avenue performing arts by providing the local population access to the arts and artsFort Lauderdale, Florida 33312 education programs at the Broward Center for the Performing Arts

The First Tee of Broward N/A PC To support their 2017 Veterans Program where PGA professionals and coaches1111 Eagle Trace Boulevard of The First Tee provide expert instruction on the game of golf and adaptiveCoral Springs, Florida 33071 equipment (when necessary) to military veterans completely free of charge

University of Florida Foundation N/A PC To establish The Harry T Mangunan, Jr Foundation Support Fund for the StudyP O. Box 14425 of Therapy Resistant Leukemia, continued support for the Dorothy MangunanGainesville, Florida 32604-9949 Headquarters for Lewy Body Dementia, the Dorothy Mangunan Fund for Lewy

Body Dementia Fellows, and the Mangunan Think Tank for Lewy Body Dementia

4Kids of South Florida, Inc. NIA PC To support the mission of 4Kids of providing hope for at-nsk children and families

2717 West Cypress Creek Road by mobilizing and equipping the faith community and offering homes, families,Fort Lauderdale, Florida 33309 therapy and resources to rescue, protect and nurture those that need it most

Juvenile Diabetes Research Foundation N/A PC To support JDRF's mission to accelerate life changing breakthroughs to cure,3411 N W 9th Avenue, Suite 701 prevent and treat Typel Diabetes and its complications, and promote advocacyFort Lauderdale, Florida 33309 and awareness of this disease that strikes both children and adults

Nova Southeastern University N/A PC A grant In Memonum to support The Terry Stiles School of Real Estate Develop-H W Huizenga College of Business ment at the H Wayne Huizenga School of Business and Entrepreneurship at3301 College Avenue NSU, which will award a Masters Degree and also allow worthy students to com-Fort Lauderdale, Florida 33314 plete their studies by providing scholarships in Terry Stiles' name

Amount

$5,000

10,000

20,000

700,000

4,000

1,000

25,000

THE HARRY T. MANGURIAN, JR. FOUNDATION, INC.FEDERAL TAX I. D. # 16-1578255FORM 990-PF - PART XV, LINE 3aGRANTS AND CONTIBUTIONS PAID DURING THE YEARFOR THE YEAR ENDED DECEMBER 31, 2017


Relationship to Status of Purpose ofRecipient Foundation Manager Reci pient Contribution Amount

Florida Atlantic University Foundation N/A PC Support for establishment of The Harry T Mangunan, Jr Foundation ADRD $575,500777 Glades Road, ADM 295 Medical Research Fund at the Charles E Schmidt College of Medicine, contin-Boca Raton, Florida 33431 ued support for FAU's Athletic Programs, continued support for Pine Jog Environ-

mental Education Center programs; and continued support for The Harry T Man-gunan, Jr Foundation Support Fund for Autism and Related Disabilities

The Philanthropy Roundtable N/A PC To support their mission to foster excellence in philanthropy, to protect philan- 1,0001120 20th Street N W , Suite 550 South thropic freedom, to assist donors in achieving their philanthropic intent, and toWashington, D C 20036 help donors advance liberty, opportunity, and personal responsibility in America

and abroad

Fellowship of Christian Athletes N/A PC To support FCA Broward's Summer Trench Warrior / Leadership Camps which 22,000Post Office Box 845 offer comprehensive athletic, spiritual and leadership training for both athletesDania Beach, Florida 33304 and coaches in a camp environment.

Grandma's Place, Inc N/A PC To support emergency foster care for children (ages birth to 12 years) who have 5,000184 Sparrow Drive suffered abuse, neglect or abandonment and have been removed from theirRoyal Palm Beach, Florida 33411 homes by the Florida Department of Children and Families

Art & Culture Center / Hollywood N/A PC To support ACCH's mission to cultivate creativity and the support of the arts in 1,000

1650 Harrison Street the South Florida community through educational programs, innovation, and

Hollywood, Florida 33020 collaboration

Cameras for Kids Foundation N/A PC To support their "Point and Shoot" therapeutic intervention program for disadvan- 2,500

368 South Military Trail taged teens living in foster care (ages 11-18), which mentors and educates themDeerfield Beach, Florida 33442 on the basic concepts of art and photography



HOPE South Florida N/A PC To support HOPE's mission to provide meals, crisis and rapid re-housing assist- $1,0001100 North Andrews Avenue ance, and support services for single mothers, families, veterans and individualsFort Lauderdale, Florida 33311 experiencing homelessness

Velosano (Cleveland Clinic) N/A PC To support (1) rider in the 2017 Velosano Bike Ride, which supports innovative 5009500 Euclid Avenue, DVB-103 cancer research conducted in Clinical Trials at Cleveland Clinic and ClevelandCleveland, Ohio 44195 Clinic Florida that help to improve cancer patients' treatments and outcomes.

Palm Beach Cnty Youth Football League N/A PC To support PBCYFL's mission to provide a wholesome and quality youth sports 1,0003645 Gun Club Road program for inner city boys and girls ages 6-15 where they can learn sportsman-West Palm Beach, Florida 33416 ship, responsibility, fair play and the skills of football and cheerleading

Central Florida Functional Medicine N/A NC / I Support for crisis alternative medical treatments for Delaney A (a minor, last 23,9001395 N Courteney Parkway, Suite 208 name withheld for privacy), a 10-year old female diagnosed with PANDAS

Merritt Island, Florida 32953 (Pediatric Acute Onset Neuropsychiatric Syndrome), for whom all other tradi-tional medical treatments had failed [ Expenditure Responsibility Grant -PANDAS Alternative Medical Treatment for Delaney A - See Exhibit K )

TOTAL $8,130,260

The Harry T . Mangurian Jr. Foundation , Inc. - Tax ID # 16-15782552017 Form 990-PF - Part XV, Line 3b

Grants and Contributions Approved for Future PaymentFor the Year Ended December 31, 2017

Distribution Year

Name of 501(c)(3) Organization 2018 2019 2020 2021

Holy Cross Hospital (Moran HeartNasc Institute) $200,000 Aug4725 North Federal HighwayFort Lauderdale, Florida 33308

Holy Cross Hospital (Phil Smith Neurological Institute) 250,000 Jun4725 North Federal HighwayFort Lauderdale, Florida 33308

The Ohio State University Fdtn (Lewy Body Dementia) 100,000 OctOffice of DevelopmentPost Office Box 710811Columbus, Ohio 43271-0811

The Ohio State University Fdtn (Memory Disorders) 200,000 OctOffice of DevelopmentPost Office Box 710811Columbus, Ohio 43271-0811

The Ohio State University Fdtn (Cancer Drug Discovery) 500,000 Sep $500,000 Sep $500,000 SepOffice of DevelopmentPost Office Box 710811Columbus, Ohio 43271-0811

The Ohio State University Fdtn (Brain/Human Performance) 500,000 Sep 500,000 Sep 500,000 SepOffice of DevelopmentPost Office Box 710811Columbus, Ohio 43271-0811

Florida Atlantic University Fdtn (ADRD Medical Research) 500,000 Sep

777 Glades Road, ADM 295Boca Raton ,Flonda 33431

EXHIBIT J

(Page 1 of 3)

2022 2023 TOTAL

$200,000

250,000

100,000

200,000

1,500,000

1,500,000

500,000

The Harry T. Mangurian Jr. Foundation, Inc. - Tax ID # 16-15782552017 Form 990-PF - Part XV, Line 3b

Grants and Contributions Approved for Future PaymentFor the Year Ended December 31, 2017

Distribution Year

EXHIBIT J

(Page 2 of 3)

Name of 501 (c)(3) Organization 2018 2019 2020 2021 2022 2023 TOTAL

Leukemia and Lymphoma Society ( Beat AML) $ 1,000,000 Sep $1,000 , 000 Sep $1,000,000 Sep $3,000,0003 International Drive, Suite 200Rye Brook , New York 10573

Baptist Health South Florida Foundation (Telemedicine ) 1,000, 000 Nov 1,000,0001575 San Ignacio Avenue , Suite 406Coral Gables , Florida 33146

The Women's Breast & Heart Initiative 10,000 Mar 10 , 000 Mar 20,000(Breast Cancer & Heart Health Outreach Program)14125 N W 80th AvenueMiami Lakes, Flonda 33016

Cleveland Clinic Florida (Neurology Research Fellow) 85,000 Mar 85,0002950 Cleveland Clinic BoulevardWeston , Florida 33331

Cleveland Clinic Florida ( Simulation Center ) 1,000, 000 Jul 1 , 000,0002950 Cleveland Clinic BoulevardWeston , Florida 33331

University of Florida Foundation (Lewy Body Research ) 200,000 Mar 200,000 Mar 400,000P. 0 Box 14425Gainesville , Florida 32604-9949

University of Florida Foundation ( Drug Resistant Leukemia ) 500,000 Sep 500,000

P 0 Box 14425Gainesville, Florida 32604-9949

The Harry T. Mangurian Jr. Foundation , Inc. - Tax ID # 16-15782552017 Form 990-PF - Part XV, Line 3b EXHIBIT J

Grants and Contributions Approved for Future Payment (Page 3 of 3)For the Year Ended December 31, 2017

Distribution Year

Name of 501(c)(3) Organization 2018 2019 2020 2021 2022 2023 TOTAL

Mayo Clinic - Florida (Lewy Body Research) $1,100,000 Sep $1,050,000 Sep $2,150,0004500 San Pablo RoadJacksonville, Florida 32224

Total Future Chartable Distributions $7,145,000 $3,260,000 $2,000,000 $0 $0 $0 $12,405,000

NOTE : The above-listed future year charitable commitments are all authorized by separate written agreements.


FEDERAL TAX I.D. # 16-1578255

FORM 990-PF - PART VII-B, LINE 5c

EXPENDITURE RESPONSIBILITY STATEMENT


Recioient's Name and Address Grant Amount Date of Grant

Central Florida Functional Medicine $10,520 3/21/2017

1395 N. Courtney Pkwy., Suite 208

Merritt Island , Florida 32953

(TREATMENT #1)

Central Florida Functional Medicine $13,380 7/5/2017

1395 N . Courtney Pkwy., Suite 208

Merritt Island , Florida 32953

(TREATMENT #2)TOTAL

Puroose of Grant

EXHIBIT K

(Page 1 of 40)

Amount

Expended

As of 12/31117

$10,520

$13,380

$23,900

To provide crisis financial support for alternative medicine treatments for Delaney A. (a minor, last name

withheld for privacy purposes), a 10-year old female diagnosed with PANDAS (Pediatric Autoimmune

Neuropsychiatric Disorders Associated with Streptococcal Infections) in October 2013, for whom all

other traditional medical treatments had failed.

Diversions

Dates of Reports by Grantee by Grantee

4/6/2017 None

6/20/2017 None

8/20/2018 None

EXHIBIT K

(Page 1 of 40)


2017 FORM 990-PF - PART VII-B, LINE 5c


Memorandum

To: Steve Mehallis, PresidentHarry T. Mangurian , Jr. Foundation, Inc.

From : Louis C. Anderson , Esq.Date : 7/12/2011Subject : Guidelines for Making Foundation Grants to Individuals

Although personal gifts made by an individual to individuals do not qualify for taxdeductions, private foundations may make much needed cash grants to individualsand families in times of need, and for charitable purposes, although thesedistributions require extensive record-keeping, and reporting requirements.Distributions to individuals fall into 3 broad categories: gifts made to individuals inneed due to poverty or temporary distress; gifts made to individuals to conductcharitable activities; and gifts made to individuals for study, travel, or similarpurposes.

(A) Gifts to Individuals in Need Due to Poverty or Temporary Distress. Aprivate foundation may distribute monies directly to an indigent to take careof basic living needs or may distribute funds to people who are in crisis.

For example , if a private foundation makes grants to indigent individuals toenable them to purchase furniture ; provide emergency relief after ahurricane ; provide emergency funds in the instance of a job loss; avoidhomelessness , or help a family during a medical emergency; such grants arenot taxable expenditures within the meaning of IRC 4945(d)(3) even if therequirements of IRC 4945(g) are not met.

However, such grants must still meet the requirements of IRC 4945(d)(5) and170(c)(2)(B) which makes the grant a "taxable expenditure" if the grant is notused for:

(i) religious, charitable, scientific, literary, or educationalpurposes, or

(ii) to foster national or international amateur sportscompetition (but only if no part of its activities involvethe provision of athletic facilities or equipment), or

(iii) for the prevention of cruelty to children or animals.

EXHIBIT K

Page 2 of 40


2017 FORK 990-PF - PART VII-B, LINE 5c


The IRS does not require prior approval for hardship or emergency grants toindividuals in dire need, but documentation and good record keeping are highlyrecommended. For example, the Foundation should document who the needyindividuals are (including name, address); the circumstances regarding their need;how and why they were selected; the objective criteria used in assessing their needs;and the amount the recipient received. Grants to individuals as outlined above wouldbe included on the IRS Form 990.

In fact, the Foundation might even establish specific guidelines and criteria for grantsto individuals based on need. In this way, you would have criteria to show the IRSas to how the grants were objectively awarded so that they would not be "taxableexpenditures."

(B) Gifts to Individuals to Conduct Activities in Furtherance of CharitablePurposes . Gifts to individuals to conduct activities in furtherance ofcharitable purposes may cover salary or operating costs for charitableprojects, such as research for a charitable purpose. Grants to individuals alsorequire good record keeping and documentation as mentioned above, but donot require prior approval from the IRS. These gifts would be reported on theIRS form 990.

(C) Gifts to Individuals for Travel, Study, or Similar Purposes(Scholarships). Foundations that plan to make grants for scholarships mustget approval for the program from the IRS prior to making scholarshipawards. If the Foundation decides to create and award scholarships after ithas received tax-exempt status, it must seek approval through a private letterruling.

However, in certain circumstances , prior IRS approval is not necessary. Forexample , in Rev. Rul. 75-393, 1975-2 C.B. 251, a private foundation madegrants to individuals in recognition of past literary works . They were not madeto finance any activities and no conditions were imposed on the manner inwhich it could be expended by the grantee . The Service concluded the grantswere made not for study, travel or similar purpose, and, thus, do not fall withinIRC 4945(d)(3).

If the Harry T. Mangurian Foundation, Jr., Inc. plans on awarding a grant orscholarship to an individual, please let me know, and I will provide you with moreinformation on this section.

Please let me know if this addresses your questions regarding guidelines for giftingto individuals, or if you have any additional questions. Thank you.

EXHIBIT K

Page 3 of 40

THE HARRY T. MANGUBIAN , JR. FOUNDATION, INC. - EIN : 16-1578255

Tr9UNIATECN (r)uci,

2017 FORM 990-PP - PART VII-B, LINE 5c


(GRANTS TO HITHMIDUAIS'AmOT IEI WAY TO MAKE A ThIFIFIEIIENCIE

by Sharon Schneider In our everyday lives, we sometimes come across people in our community facingPhilanthropicDireetor tough times and we want to reach out: we take our family to a neighborhood

harbcyue to raise money for a child's kidney transplant: we drop spare change in thecoffer can next to the cash register to support the family of a fallen firefighter, ourcongregation provides hoe-cooked meals, child care, and other forms of supportto families in the midst of crisis

But although 'tic can and do hair an impart as individuals, many philanthropically-inclined people don'r reali,e that a private foundation can provide anorher forma ofcritical support: it can provide much-needed cash grants directly to individuals andfamilies in times of need. Foundations are often in an excellent position to respondquickly, Araibly and with good stewardship Awing a time of crisis-when quickaction is most needed. Rather than making ad-hoc gifts, you can make tax-exemptgrants, secruu- aside a specific amount each veal as part of a Inng-term strategy tosupport individuals in need

Mail)' peopi ,rent a\' arc that the IRS hermits private foundations to make hardshipand emergency `rants to individuals 'aithout ad,ancc approval as long as the founda-non documents, among other rhinos, the recipients acid for assisrance. the objectivecriteria applied to assess need: the process by which recipients were selected; and thenanme, address and amount distributed to each recipient. Grants can be avNarded forLmci`uicv ielicf (such as Folloxving HurricanL Katrina) and hardship assistance

ti ,such as job loss or when a family inemher is faced Nvirh a life-rhreatenin illness).

The four stories that follow provide some examples of how Foundation Source clientshave used grants to individuals to provide much-needed support at critical moments.Even a small amount of money can make a big difference in someone's life

Helppug families avoid homelessness

Shortly after their family foundation wascreated, Barb and Stephen Miller met ayoung woman at a community event whoworked for Prairie State Legal, an Illinoisnonprofit which provides legal assistance

to low-income families who are facing

credit problems, eviction notices, utilityshut-offs and other legal action. PrairieState Legal helps their clients navigatethe often unfriendly and unforgivinglabyrinth of bureaucracy. Without theirassistance, many of these families wouldend up slipping into homelessnessbecause of something as simple as an

E MBIT K

Page 4 of 40 ^LDnhnue O

GRANTS TO INDIVIDUALS : A NEw WAY TO MASK A DIFFEEZNCB

THE HARRY T. MANGOBIAN , JR. FOUNDATION , INC. - EIN : 16-1578255

2017 FORK 990-PF - PART VII-B, Line 5c - EXPENDITURE RESPONSIBILITY STATEMENT

unpaid utility bill, which could cause themto lose their public benefits.

After hearing about the work of PrairieState Legal, Barb and Stephen asked thewoman "how can we help? If you couldhave anything to make your job easier,what would it be?"

After thinking it over, the woman said

what they could really use is a small reserveof flexible funds for difficult situations

that came across their desk. As an example,

suppose a grandmother owed $1,200 in

electric bills because her grandson stole her

social security number to set up, run upand then run out on an account. If shecouldn't pay the bill in 30 days, the electric

company would file a complaint which

would wipe out her eligibility for all public

benefits, including her Section 8 voucher.

In such a scenario, Prairie State could

negotiate with the electric company to get

them to forgive her late fees and financecharges of $500, bringing the balance to

$700. They even might be able to get$200 from the utilities assistance fund

toward the bill, bringing the balance to

$500. If they could get the payments

down to $300, the grandmother could

realistically make payments of $25/month.

But where could they get the $200 to

bridge the gap?

Barb and Stephen knew they wanted toprovide bridge funding for such one-timeneeds, support that could really make adifference in keeping families in theirhomes. We happily told them aboutFoundation Source's process for makinghardship grants to individuals and howit worked. Next, they would provide anapplication form to Prairie State, whowould find eligible families and fill outthe simple form. Then Prairie State wouldforward them to Barb and Stephen forapproval and on to Foundation Source forprocessing. The whole thing would becompleted in just a few days.

Today, after 13 grants to individuals oflimited means, the Millers report they feelenergized and gratified by their involve-ment with these families and the differencetheir gifts are making in enabling them tostay in their homes.

Medical distress grants provide lightduring a family's darkest hours

The father of a family with three teenagersreached out to Foundation Source aftergiving them each $5,000 to grant as theywished. The father was hoping for some.help to get his offspring inspired andheaded in the right direction.

In speaking with his oldest daughter Mimi,

Foundation Source learned that she had

been diagnosed with brain cancer when

she was just 13 years old. At that time, she

was told by the doctors that she would

likely either die or slip into a persistent

vegetative state, but fortunately, neither of

those things happened. Mimi was now ahealthy and happy 17-year old, although

she had unhappy memories of her

experience with the doctors and hospital

who predicted her demise.

Mimi's recollection of the trauma causedby their prognosis led her to want to protectother young people from such negativeexperiences. She wanted to do somethingto help them with the psychological battlesthat accompany serious illness.

Knowing that simply writing a check to achildren's health organization would neverbe satisfying to Mimi, we introduced theidea of "medical distress" grants. Throughthis innovative new program, familiesfacing a life-threatening diagnosis areeligible to receive grants from a privatefoundation. And the funds can be usedfor many purposes, not just medical bills.In this case, Mimi began to imagine thefamilies and their teenage patients usingthe grant money to pay critical expenses

EXHIBIT K

Page 5 of 40 (continual)

Ganrirs ro INDmDuA s: A Nsv WAX to M.ucs A Dirrrswcs

THE HARRY T. MANGURIAN, JR. FOUNDATION , INC. - EIN : 16-1578255

2017 FORK 990-PF

ci

- PART VII-B, Line 5c . - EXPENDITURE RESPONSIBILITY STATEMENT-

and thereby free up funds for airfare for aspecial someone to come visit, or maybeprovide a theme-park adventure to offerrespite to the whole family, or maybebuying a laptop to keep up with school-work and friends while in the hospital forextended periods.

After initial research uncovered a special-ized pediatric palliative care team at one ofthe local hospitals, we reached out to thehead of the team to tell her about Mimi

and her desire to help others facing a life-threatening diagnosis. The team leader wastouched by the young cancer survivor'sstory and was willing to work throughsome process and patient privacy issues tofunction as Mimi's eyes and ears in nomi-nating families who needed some comfortduring their darkest hours. The programlaunched immediately.

Mimi's dad recently described one exampleof her work with adolescent patients:

"There !vas It 9_yeal-o/i/g •l tc'itl, (jc;ticEib o5;s au'aili ; ii /niic Jui ei )'. A'(r11r of

her fiends iolru had this singe; ' sin vived.vet Aflint hell iva;ttcrl to ti)' it to ic'lirz;e/,,'r .ufi•ri ii . 77'c,gl, l bad lireu zwallinW0111b c ,n the rl,elehrns hospital l,.tt'uig toinke over 20 pills per da p anti cnu/til;lrteipl;', to, )y neatlnenl,. He, rlrrrl leers gunea;111 lice Sr:1K/c inoll'cr had 1'ee;till)' lostho job. The gu 1 askedfir a laptopco1)lplltt', llitir Qrlillc to help i't't Pits, the,

tutlt' I'!. nit pero,ia//y delivered lie best

tt'is/'ec 7;td gale he, ivorc/c of'ei i ourage-i/lent and it big hugdill[ told her that she

ttlso had been gii cu it bleak diagnosis at

the septic /rofulal rand that soin(tilnr's

tl,c,;• is a pall; to firll lecut'ri-)t "

In addition to providing Medical DistressGrants, Mimi has become a member ofthe hospital's teen advisory board so thatshe can continue to be an advocate foryoung patients much like herself She's notonly helping others, but in the processMimi gained confidence in her own ability

to make a difference. In fact, Mimi wroteabout her philanthropic work in her collegeentrance essays and was accepted into herfirst-choice university.

Not just for teenagers

Over a thousand miles away, anotherfamily used our medical distress grantsto individuals process to help the familiesof cancer patients in whatever way theyneeded: assistance with utilities during thewinter; cab fare to visit the hospital; newschool clothes for kids whose parents spendevery dime on medical bills. The oncologystaff at the hospital identifies families inneed, our client approves the request andFoundation Source executes the grant.

The hospital staff reached out to our clientto tell him about the difficult circumstancesof the family of Mr. Johnson, a man diag-nosed with terminal cancer. The Johnson'sfurnace had broken and they were told itwould cost $2,500 to fix it - money thatthe Family did not have. It was the thick ofa frigid New England winter and the family

wanted to focus their energy on their ailingfather but their home was unlivable with-out a working furnace. Our client made amedical distress grant so the family could

fix their furnace. A few days later,

Foundation Source received this email:

'M; /olinson died yesterday, just three

days after I,rile his li"fe the hardship

rant r/,et k. He pas.,ed away knowing hisfint/r htvl been helped, his zvilr could

focus on carlnzfat bi;u in his final days,u,id t1'c fririnly call better- cope ivit/, their

loss. Thanks again. "

Direct disaster relief

In fall 2007, a series of wildfires destroyedhundreds of homes in the San Diego area.Many families barely escaped with theirlives, and didn't have time to pack upclothes, toiletries and household necessities.Like many disaster victims, they were

EXHIBIT K

Page 6 of 40(continued)

Gar rris ro INDrvmuAis: A New WAY ro MA= A Divyecuwce

THE HARRY T . MANGURIAN , JR. FOUNDATION , INC. - EIN : 16-1578255

2017 FORM 990-PF - PART VII-B, Line 5c - EXPENDITURE RESPONSIBILITY STATEMENT

without immediate access to critical cash

to start rebuilding their lives until theinsuran ce company was able to review

their claim and issue a check - a processwhich can take weeks or months.

After several clients contacted us askinghow their private foundation could helpfamilies displaced by the wildfires,Foundation Source located organizationsin the San Diego area that could serve asreliable partners, including several church-es in the Episcopal diocese of San Diegoand a government relief services office inRancho Bernardo, as well as a Vice Mayorfor one of the surrounding towns.

After establishing contact with reliefworkers on the ground we explained theemergency assistance grants process andtrained the workers how to identify anddocument families in need. The workerswere sent simple forms via email and theybegan submitting vetted applicationsright away.

Ten Foundation Source clients asked toreview the applications forwarded by the

partner charities. Within a week of thefires, fifteen families received emergencyassistance grants ranging from $1,000

to $5,000.

Following up on an emergency assistancegrant a month later, one foundation washappy to find the family had used themoney to rent an apartment and buy basichousehold and school supplies to helptheir children maintain a sense of normalcy.Although the recipient family now hadsome breathing room in their finances,our client told them, 'We don't expectyou to pay us back. But we hope you'llpay it forward, and help another familyin need someday.'

FOUNDATION SOURCE PHILANTHROPIC SERVICES

55 Walls Drive, Fairfield, CT 06824

800-839-0054 Phone800-839-1764 Fait

Please visit us at www.foundationsource.com

An individual answer forindividual needs

Grants to individuals provide a uniqueopportunity for fenders to "pay it forward,"and help those who have fallen on hardtimes to avoid the downward spiral thatcan accompany serious illness or a missedpayday. In the past, foundations would shyaway from providing funds directly toaffected individuals because of confusionabout how a foundation can provide suchsupport under IRS regulations.

To dear the way for our clients to makethese direct, high-impact grants withoutthe worry of administrative burden orcompliance concerns, Foundation Sourceworked out a streamlined process designedto meet all IRS requirements in order tofacilitate grants to individuals.

Ifthese ideas get you inspired please don'thesitate to contact Foundation Source.

EXHIBIT K

Page 7 of 40

FOUNDATIONource-

Making More Foundations Great Foundations"

GRANis TO INDIVIDUALS : A New WAY To MAKE A DIFFERENCE 4

Long Term Prognosis I PANDAS Network Page 1 of 4


2017 FORK 990-PF - PART VII-B, Line 5c - EXPENDITURE RESPONSIBILITY STATEMENT

Select Page

PANDAS NETWORKPediatric Autoimmune Neuropsychiatric Disorders

National Institute of Mental HealthEck 'Outreach Partnership Program

National Partner

f V o

LONG TERM PROGNOSIS.

` PANDAS/PANS POST-PUBERTYParents'often ask if-their child will "outgrow" PANDAS and PANS. One has to look at that

question from two points of view.

1. Does a child "outgrow" getting strep infections (the trigger for PANDAS) as they hit

adulthood?

2. Does the child "outgrow" the actual autoimmune disorder?

There is currently no long-term prospective study on the outcome of this newly identified

(1998) illness. According to Swedo in her landmark paper,'The age of the host also may

determine susceptibility (to PANDAS); it is known that rheumatic fever is quite rare after

puberty. It appears that the developmental changes of adolescence may decrease the

vulnerability to the cross-reactive autoimmunity. It is also possible that the postpubertal

decrease in incidence (44) is related to the fact that the rate of GABHS infections falls

EMT IT K

httn•/hw.w nnndn nP.twnr1c nrvhtnclerstandina-nandacnans/lona-term-nroffnosis/ 2/2/2017

Long Term Prognosis I PANDAS Network THE HAggy T. HAtGuIAw, JR. FOUNDATION , INC. Page 2 of 42017 FORK 990-PF - PART VII-B, Line 5c - EXPENDITURE

dramatically around the age of 12 presumably because the child has develo ed antibodies RESPONSIBILITYp

against the conserved portion of the M-protein (i.e., the child is able to make antibodies thatSTATEMENT

recognize all strains of GABHS) (V. Fischetti, personal communication, 1994)."

As for the autoimmune aspect of PANDAS, theories are that:

1. Overtime the body develops a natural immunity through a natural immunological maturing

process.

2. The thymus (producer of antibodies in children) largely shuts down at adulthood.

The hope is that the child's immune system will eventually learn to develop the correct

antibody response to strep as they get older.

When discussing PANDAS, one has to remember that strep is the trigger. With PANDAS, it is

important to keep strep at bay and not to incite the autoimmune response over and over.

Hence, why many children stay on a prophylactic dose of antibiotics well Into adulthood

to try to prevent strep infections.

Even if a subsequent exacerbation is caught quickly, it does not mean it will be an easier

recovery or any less severe. We are hearing from anecdotal reports that often exacerbations

worsen each time they occur. There is no way in knowing how a child will react. The immune

system is on high alert. No matter what your choice of treatment, protecting the child from

more strep infections or proximity to ANYONE sick with strep in the First Year of Healing needs

to remain high priority. We, as parents and doctors, owe it to these children to give them the

best chance of recovery and no future suffering.

PANDAS may stop for some girls at onset of menses. It is currently believed through follow up

conversations with parents that only 2-3% of all pediatric cases have recurring issues into

young adulthood. It is not clear yet if that 2-3% did not get adequate preventative care in the

earlier years. Doctors will try to clarify that issue in the near future. The NIM H is completing a

prospective 8-year study of PANDAS children in 2010 following children with PANDAS-onset

OCD and Non-PANDAS OCD. According to Swedo in a February 2011 interview, she stated that

half of the children in that 8 year study, no longer had symptoms. Some still had some type of

symptoms present but they were able to be managed through medications or they were so

minute, they did not impede the person's life and no medication was even needed. It is not

clear what type if any treatment these children have received.

Whether PANDAS can eventually become a chronic condition that will continue into adulthood,

no one really has an answer for that. Even practicing doctor and researcher, Dr. Tanya Murphy

states inClinical Factors Associated with PANDAS (pdf provided by the NIH). "Whether children

with a PANDAS subtype typically will go on to remission or progress to a more chronic course

of illness is not known." For this reason , parents MUST remain vigilant in protecting theirEXHIBIT K

Page 9 of 40

http://www.pandasnetwork .org/understanding -pandaspans/long-term-prognosis/ 2/2/2017

Long Term Prognosis I PANDAS Network Page 3 of 4THE HARRY T. MANGURIAN, JR. FOUNDATION, INC.

children from contracting strep. Also. do not assume one can forgo treatment as a child

in hopes that puberty holds the key.EIN:, 16-1578255 - 2017 FORM 990-PF - PART. VII-B,

Line 5c_- EXPENDITURE RESPONSIBILITY STATEMENT

WHAT IS THE LONG-TERM OUTCOME OF THIS SYNDROME?It is still not entirely known.

Doctors watching PANDAS patients over the last decade feel that if the child continues to suffer

from some dysfunction (mood lability or anxiety or mild tics) the long-term outcome seems to

depend on: severity of initial episode, number of recurrences, family history and many other

factors.

In severe cases, it takes time to heal and outcomes of each child are uncertain. But most

parents agree, that by puberty, if children have been treated by one of the PANDAS treatments

(antibiotics at each exacerbation or IVIG or PEX if the child does not improve on antibiotics)

-they have a healthy outcome and function without problems. The proper function of the

basal ganglia is difficult to monitor. So doctors aren't able yet to determine if any persistent

symptoms are related to dysfunction (temporary) or damage (longer term).

Therefore, in acute PANDAS cases, where cessation of acute symptoms just does not occur,

parents opt for IVIG or Plasma exchange in order to hopes of preventing permanent damage.

Search

..

EXHIBIT K

Page 10 of 40

http://www:pandasnetwor-kor-glunderstanding-pandaspansQong-ternLprognosis 2/2/2Q17

Long Term Prognosis I PANDAS Network Page 4 of 4

THE HARRY T. MANGURIAN , JR. FOUNDATION , INC. - EIN - 16-1578255

2017 FORK 990-PF - PART VII-B , Line 5c - EXPENDITURE RESPONSIBILITY STATEMENT

SI9(UR

Email Address Submit

Copyright © 2016 PANDAS Network - All Rights Reserved I PANDAS Network.org 655 Oak Grove Avenue #1373, Menlo

Park, CA 94026 1 FEIN #37-1666562 1 Disclaimer

4{ ,

EXHIBIT K

Page 11 of 40

httn_//www.nandasnetwork.or¢/understanding-nandasvans/1ong-term-prognosis/ 2/2/2017

Thank you/ link for you


From : Barbara A [email protected]> EIN: 16-1578255To: drexelinv <[email protected]>

2017 FORM 990-PF - PART VII-B, Line 5cSubject Thank you/ link for you

Date: Thu, Feb 16, 2017 11:12 am EXPENDITURE RESPONSIBILITY STATEMENT

Dear Mr. Mehallis,

Page 1 of 1

It was a privilege to speak with you today. Thank you for taking time out of your busy schedule to make it happen!

I am sending you a link concerning a documentary about PANDAS. My husband and I have seen it at a privateviewing at UF. It is due to be released to the public in May.I contacted the producer, Tim Sorel, and asked him if he would be able to have you and other people from yourfoundation see the film before Its release. He said he would do whatever he needs to do to get it to you before itsrelease if you would like to see it. It will reveal to you a lot of information about PANDAS. Please let me know if youwould like to see it.

http://www.mvkidisnotcrazy.com/

Home , My Kid Is Not Crazywww.mykidisnotcrazy.com

My Kid Is Not Crazy is the Cinematic, pediatric equivalent of BRAIN ON FIRE-MEETS-Infectious Madness. A

film that will change the way we look at mental illness forever.

Once again, thank you. May God bless you.

Barbara A40M

EXHIBIT K

Page 12 of 40

https://mail.aol:com/webmail=std/en=us/PrintMessage -2/-1-6/201?-

THE HARRY T. MANCURIAN, JR. FOUNDATION , INC. - EIN : 16-1578255

PRESS INMR;MATiOWMedia access tdthe produdionteam:-Markowitz :Comniunicotions.4.12-577-5140=Saul@Mat^kowitzCommun!cntions:com8 [email protected]

About the Film Releus 2017 - Rs 85 mitre s - not rmedMore than 30 years ago, Susan Swedola doctor with the National Institutes of Health 0discovered that an undiagnosed strep infection was thecause of one child's disabling illness. The more Swedo dug, the more evidence she found: Strep was linked to symptoms normally chalked upto psychiatric illness. She also discovered how non-accepting modern medicine can be of new ideas.

Swedo has put her reputation and career in jeopardy as she fights to cure the condition she named: Pediatric Autoimmune NeuropsychiatricDisorder Associated with Streptococcal Infections (PANDAS). Neurologists Jonathan Mink, Roger Kurlan, Harvey Singer and others publiclyridicule Swedo and her PANDAS theory, creating controversy over diagnoses and treatment. This group has become known on social media asthe "non-believers." The result: the entire pediatric-care industry is confused and doesn't know what to do...and it's the children who suffer.

"My Kid is Not Crazy," a film by Tim Sorel, trucks the journeyof six children and their families as they become tangled in thenightmare of a medical system heavily influenced by the phar-maceutical industry. Here it's common for a caregiver to prescribea young child with a Selective Serotonin Uptake Inhibitor (SSRI)but hesitate to prescribe an antibiotic to counteract a potentialinfectious-based trigger. For some of these kids, what happensafter several years is shocking and sad.

Key Themes

R-^

N7

Susan Swedo, MD, Senior Investigator, Neuroscience Branch, NIMH

I1. Children presenting with severe rapid-onset OCD will often be referred to psychiatry. A medicalissue like infection is seldom considered.

The brain is biologic. Could in fact all mental illness as we know it be caused by a medical issue?

It is estimated that 1 -in-250 children may have PANDAS and most will be improperly diagnosed.The potential for these children needing full-time care for the rest of their lives is very real.

EXHIBIT K

Page 13 of 40

2017 FORM 990-PF - PART VII-B, LINE 5c - EXPENDITURE RESPONSIBILITY STATEMENT

THE HARRY T. MANGU IAN, JR. FOUNDATION , INC. - EIN : 16-1578255

'2017 FOAM 990-PF - PART VII-B, LINE 5c - EXPENDITURE RESPONSIBILITY STATEMENT

Nine-year-old Kathryn Ulicki was a normal, healthy child. Shewas a star student, athlete and dancer. In a matter of days,she would become totally dysfunctional . Kathryn had alarmingrapid-onset OCD refusing to eat or drink. She had tremendousseparation anxiety and would become panicked if her parentswere not in sight. She had trouble sleeping and showed signs of

:v. age regression in vocabulary and handwriting.

How did this happen?The Ulickis and many families like IhemG fumed to a fractured medical system,where there is fierce disagreement about how to help their daughter. More often ~1.. rthan not, a child with these symptoms would be diagnosed as having menial illness.They'd be treated with antFpsychotic medication, behavior therapy, and even has-pitalizotion. The film follows the Ulickis and reveals how a parent needs to quicklybecome a medical expert and take control of their child's healthcare decisions.

Drew Maxwell, now 18, went through more than 11 years of misdiagnoses. From the age of6, Drew was given more than a dozen psychiatric, anti-anxiety and antidepressants. She washospitalized for seven weeks in a psychiatric hospital. The teen become despondent and suicidal.Her tenacious mather111lani stuck by her ailing daughter when the rest of Drew's familyabandoned her...writing her off as a psychiatric case.

The film recounts Drew's unbelievable childhood as no one in the medical community could fig-ure out what was wrong. Fed-up with the lack of response from the medical community, parentslike Tiffani use social media to bond by the hundreds of thousands of parents

Wk,o,D 'is PANDAS?

1NDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Strepto-ccal Infections) occurs when strep triggers a misdirected immune response resultsinflammation on a child's brain. In turn, the child quickly begins to exhibit life chang-3 symptoms such as OCD, anxiety, tics, personality changes, decline in math andLndwriting abilities, sensory sensitivities, restrictive eating, and more.

EXHIBIT K

Page 14 of 40

A PANDAS Family

The Kid who was missed


PIroducer/Me day

2

37 states during fllmina

Director Tim Sorel (Women, Children and AIDS, The Trap Of Saving Cambodia , Lifecasters) isa University of Florida Professor and documentary filmmaker. Inspired by chance meetings withparents who had children with PANDAS symptoms, Sorel set out on a two-and-a-half-year journeyembedding with several families as they navigate a nearly impossible medical system, insurancedenials and general non-acceptance of these children . Sorel also interviews the nation ' s top ex-perts in science , medicine and treatment to separate fact from fiction.

Big + e, 4's Statement

Interacting, with, PANDAS families^in:ctiiis. is indeed, its'.own uniquebrand: ft.'s a hotbed-ofzover oyersfirnufoted,freakedout.parents.(trying to pretend they,are_°norwal'peop)e:

,

It•s_not just-the'holes,intheir_child's medicaIIcare. Parrent^ ore'blbmedd^by, doctorrand+im-mediate family that they cre,respoitsible fof their'child's condition-#e=to bad parenting,

One mom, stated that'-she wished-her clild'hdd' Leukemias at.least ithere would be sympathy, insurance, and Ronald McDonaldhouse.

' It is my hope someone influential m overnment will see t*shim and make funding available for research. There is a reason

J;why these children are suddenly struck by PANDAS and reasonswhy some respond to treatment and others do not.

!k1[esue^Qiliog-these_chiLdcso _Sbaatec^us^.__. _

Tim Sorel

EXHIBIT K

Page 15 of 40

L017 FORM 990-PF - PART VII-B, LINE Sc - EXPENDITURE RESPONSIBILITY STATEMENT


2017 FORM 990-PP - PATY VII-B, LINE 5c - EXPENDITURE RESPONSIBILITY STATEMENT

Welcome

The Children' s Postinfectous Autoimmune Encephalopathy (CPAE) Center of Excellence at the

UA Steele Center, developed in cooperation with the NIH/NIMH is the first in the U.S. to implement an

integrated model of basic science and clinical research, clinical care and teaching to address a spectrum

of neuropsychiatric disorders that are often misdiagnosed, underdiagnosed or undiagnosed in children.

Postinfectious Autoimmune Encephalopathy(PAE)is a condition where an infection triggers an

autoimmune reaction that targets the brain, leading to changes in neurologic function, mood and

behavior. PAE includes disorders such as PANS (Pediatric Acute-onset Neuropsychiatric Syndrome),

PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infection) and

Sydenham chorea.

`The CPAE Center of Excellence has three goals:

1. To deliver multidisciplinary, state-of-the-art care to children who experience behavioral and

neurological changes after an infection.

2. To investigate the causes of Postinfectious Autoimmune Encephalopathy (PAE).

3. To find new treatments to Improve outcomes and eventually cure children with Postinfectious

Autoimmune Encephalopathy (PAE).

Basic science and translational research of PAE is conducted at the UA Steele Center , a world-renowned

research center with cutting-edge researchers studying inflammation, microbiome, and the genetics of

complex diseases.

EXHIBIT K

Page 16 of 40

Children's Postinfectious AutoimmuneEncephalopathy (CPAE) Center of Excellence

THE HARRY T . MANGURIAN , JR. FOUNDATION , INC. - EIN : 16-1578255

2017 FORK 990-PF - PART VII-B , LINE 5c - EXPENDITURE RESPONSIBILITY STATEMENT

Clinical services are provided at Banner - Diamond Children's Multispecialty Clinic, and children treatedat the center will be offered enrollment in clinical research trials led by UA Steele Center physician-researchers.

Symptoms:

• OCD (obsessive/compulsive disorder)>• Tics• Restrictive eating• Anxiety>• Depression• Irritability and aggression• Difficulty with schoolwork• Behavioral regression• Changes in handwriting• Severe separation anxiety• Sensory sensitivities• Hallucinations

• Frequent urination

• Severe sleep disturbance

Steele Children's Research CenterArizona Health Sciences Center

1501 N Campbell Avenue, Room 3301PO Box 245073

Tucson, Arizona 85724-5073

000All content p 2017 Arizona Board of Regents . All rights reserved.The University of Arizona is an EEO/AA - P9/W/DN Employer.

login

4

Connect with us

EMBIT K

Page 17 of 40



Dept of Pediatrics Find a Clinical Trial o Patient Careo Research & Education

DONATE NOW

WelcomeResearch AreasEventsOur SupportersGiving OptionsCPAENewsSteele - PhoenixContact UsFor PhysiciansEducationDivisionsFacultySteele Children's Research CenterNews

• Administration

Contact Us

Home

CPAE

Clinical Services

Research

Clinic Address:

Banner ,r Diamond Children 's Multispecialty Clinic

535 N. Wilmot Rd. Ste 101

Tucson, AZ 85711

Make an appointment:

520-694-KIDS (5437)

Other info:

520-626-6301

EXHIBIT K

Page 18 of 40

The National Institute of Mental Health: www.nimh.nih.govTHE

CRYT. MANGURIAN, JR. FOUNDATION, INC.

EIN: 16-1578255

2017 FORM 990-PF - PART VII-B, LINE 5cENDITUREXP RESPONSIBILITYPrincipal Investigator: Susan Swedo E

Susan Swedo

Pediatrics and Developmental Neuroscience Branch (PDNB) (wwwv ntmli nih eov/nabs-nt- nimlh/rese8rclh -areas/clinics-nnd-labs /pdnb/indcx . shtml)

Biography

Dr. Swedo is currently Chief Pediatrics & Developmental Neuroscience Branch at the NIMH. Dr. Swedo receivedher M.D. from Southern Illinois University School of Medicine and completed her pediatrics residency at Children'sMemorial Hospital (Northwestern University) in Chicago. Dr. Swedo began her career as a hospital-basedpediatrician in Evanston, IL and was later named Chief of Adolescent Medicine at the McGaw Medical Center ofNorthwestern University. She moved to the Washington area in 1986 and joined the staff of the Child PsychiatryBranch at the National Institute of Mental Health, where she conducted research on childhood obsessive-compulsivedisorder (OCD). Dr. Swedo and her NIMH team were the first to identify a new subtype of pediatric OCD, in whichsymptoms are triggered by cross-reactive antibodies produced in response to infections with Group A beta-hemolytic streptococci. The subgroup is known by the acronym, PANDAS, which stands for: Pediatric AutoimmuneNeuropsychiatric Disorders Associated with Streptococcal infections. This work led to the development of severalnovel therapies, including use of intravenous immunoglobulin (IVIG) and plasmapheresis to treat acutely illchildren, and antibiotics prophylaxis to prevent strep-triggered neuropsychiatric exacerbations. Subsequent work hasrevealed that the cross-reactive antibodies are unique to the PANDAS subgroup and have biologic activity in theCNS.

In 2002, Dr., Swedo moved to the extramural side ofNIMH to serve as Associate Director for Pediatric Researchand Director of the Division of Pediatric Translational Research. She returned to the Pediatrics & DevelopmentalNeuroscience Branch in May 2006 to establish a multi-disciplinary, clinical research team dedicated to studies ofautism spectrum disorders and related neurodevelopmental disorders. Studies of childhood-onset OCD are alsounderway in the Branch.

Research Interests

The Pediatrics and Developmental Neuroscience Branch is comprised of a clinical research team investigating theetiology , phenomenology, pathophysiology and treatment of developmental disorders and childhood psychiatricdisorders . Autism spectrum disorders and childhood-onset obsessive compulsive disorder (and particularly thePANDAS subtype) are of particular research interest.

EXHIBIT K

Page 19 of 40


S-clected Publications 2017 FORM 990-PF - PART VII-B, LINE 5c - EXPENDITURERESPONSIBILITY STMT.

A magnetization transfer imaging study of corpus callosum myelination in young children with autism . Gozzi M,Nielson DM, Lenroot RK, Ostuni JL, Luckenbaugh DA, Thurm AE, Giedd JN, Swedo SE. Biol Psychiatry. 2012Aug 1;72(3):215-20. doi: 10. 10 16/j.biopsych.2012.01.026. Epub 2012 Mar 2. PMID: 22386453.

An open label trial of donepezil for enhancement of rapid eye movement sleep in young children with autismspectrum disorders . Buckley AW, Sassower K, Rodriguez AJ, Jennison K, Wingert K, Buckley J, Thurm A, Sato S,Swedo S . JChild Adolesc Psychopharmacol . 2011 Aug;2I(4):353-7 . doi: 10 . 1089/cap.2010.0121. PMID:21851192.

Rapid eye movement sleep percentage in children with autism compared with children with developmental delayand typical development . Buckley AW, Rodriguez AJ, Jennison K, Buckley J, Thurm A, Sato S, Swedo S. ArchPediatr Adolesc Med. 2010 Nov; 164(11):1032-7. doi: 10. 1 001/archpediatrics.2010.202. PMID: 21041596.

Children with obsessive-compulsive disorder : are they just little adults . Kalra SK, Swedo SE. JClin Invest. 2009Apr; 119(4):737-46. doi: 10.1172/JC137563. Epub 2009 Apr 1. PMID: 19339765.

Magnuson Clinical Center, Room 1C250, MSC 1255BETFIESDA, MD 20814

Phone : +1 301 496 5323

swedos(@,mail.nih.gov

IRP News and Multimedia

•PMDD Tied to Sex I-loimone-Reactive Genes (www.nimh.nih . gov//ncws/science -news/2017/sex -horrnone-

sensitivc-gcne-complex- linked-to-premenstrual -snood -disordcr.shtm 11

NIMH's Francis McMahon, M.D.. Awarded Colvin Prize (www.nimh .nih.gov//ne%vs/scicncc-

news/2016/nimhs- frencis -mcmahon-md-awarded-IzrestiFsous-coly in-prizc.shtml

0

Fearful Feelings. Behaviors Untangled (www.nimh. nih.eov//news/science-news/2016/circuitry-for-fearful - fcelincs-

bchavior-untangled - in-anxiety-disorders . shtml)

More (www.nimh.nih . eov//labs-at - nimh/irp-pews-and-multimcdia .shtmI)

TOP

EXHIBIT K

Page 20 of 40

Re: Thank you/ link for you

THE HARRY T. MANGQRIAN , JR. FOUNDATION, INC.From: [email protected]> EIN: 16-1578255

To: drexelinv <drexelinv@aol .com> 2017 FORM 990-PF - PART VII-B, LINE 5c

Subject Re: Thank you/ link for you EXPENDITURE RESPONSIBILITY STATEMENT

Date: Thu, Feb 16,2017 12:26 pm

Dear Beth,

Page 1 of 2

Thank you for your quick reply. I am now sending you the links to the Drs. Delaney has seen who have confirmedher diagnosis of PANDAS. If the foundation needs any medical records for any of these drs. I will sign a release ofinfomation. Each had their own role in helping in Delaney's recovery so far. We are grateful for their expertise.None of them are a clear path to IVIG, which is the only option we haven't done yet.

Thanks for passing along this info. God bless,Barb

Delaney was seen by Dr. Puskur, a pediatric psychiatrist from October 2013 to May 2016.http://www.sushilpuskurmd.com/

Dr. Sushil Puskur Ocala, Floridawww.sushilpuskurmd.com

Dr. Sushil Puskur Transcranial Magnetic Stimulation (TMS)

Specialist About TMS : Transcranial magnetic stimulation is a

procedure that uses magnetic fields to ...

Delaney visited the-Rothman Center a few times while being treated by Dr. Puskur. They confirmed the PANDASdiagnosi$and also gave, recommendations to Dr. Puskur during hertreatment. httr)://heaIth.usf.edu/medicine/pediatrics/rothman/index.htm

Rothman Center Home - Rothman - USFHealth - Tampa, Floridahealth.usf.edu

The Rothman Center for Pediatric Neuropsychiatry. The Rothman

Center offers an integrated practice of clinical care for individuals

with obsessive-compulsive disorder ...

Delaney had OCD treatment at UF for over a year when she was 7 to 8 years old. I can get exact dates if you need

them.https://ufhealth.org/uf-health-child-psychiatry-springhill-health-center EXHIBIT K

Page 21 of 40

https://mail.aol.com/webmail-std/en-us/PrintMessage 2/16/2017

Re: Thank you/ link for youTHE HARRY T. MANGURIAN , JR. FOUNDATION INC. - EIN: 16-1578255

Page 2 of 2

2017 FORM 990-PF - PART VII-B , LINE 5c - EXPENDITURE RESPONSIBILITY

UF Health Child Psychiatry - Springhill HealthSTATE>E'TCenter I UF ...ufhealth.org

Medical Records. To obtain a copy of your medical records from

UF Health Child Psychiatry - Springhill Health Center, please

contact 352-265-HELP (4357).

From : Barbara AvowSent : Thursday, February 16, 2017 11:12:25 AMTo: [email protected]: Thank you/ link for you

Dear Mr. Mehallis,

It was a privilege to speak with you today. Thank you for taking time out of your busy schedule to make it happen!

I am sending you a link concerning a documentary about PANDAS. My husband and I have seen it at a privateviewing at UF. It is due to be released to the public in May.

I contacted the producer, Tim Sorel, and asked him if he would be able to have you and other people from yourfoundation see the film before its release. He said he would do whatever he needs to do to get it to you before itsrelease if you would like to see it. It will reveal to you a lot of information about PANDAS. Please let me know if youwould like to see it.

http://www.mvkidisnotcrazy.com/

Home I My Kid Is Not Crazywww.mykid isnotcrazy.cam

My Kid Is Not Crazy is the Cinematic, pediatric equivalent of BRAIN ON FIRE-MEETS-Infectious Madness. A

film that will change the way we look at mental illness forever.

Once again, thank you. May God bless you.

Barbara A11111111111=^

EXHIBIT K

Page 22 of 40

https://mail.aol .com/webmail -std/en-us/PrintMessage 2/16/2017

Last email today I promise. Page 1 of 1

THE HARRY T. MANGIIBIAN,JR. FOUNDATION, INC.From: BarbaraAr<[email protected]> EIN: 16-1578255

To: drexelinv <[email protected]> 2017 FORK 990-PF - PART VII-B, LINE 5c

Subject: Last email today I promise. EXPENDITURE RESPONSIBILITY STATEMENT

Date: Thu, Feb 16, 2017 2:08 pm

Dear Beth,

I just wanted to pass along this thought that came to my mind. After looking at the Drs. links I sent in the previousemail, you will see that those doctors have better credentials than Scott Smith , PA. The question is : Why did yougo from drs . with all these credentials to a PA? I was thinking about that as I was washing dishes (its when I get a lotof my thinking done) CQ*

At first we sought him out because he had a child with PANDAS, and I knew he would understand the condition. Butthe real answer is this: Scott Smith, PA, did not recommend that we change any of the treatments that Delaney wason. He did not ask me to leave any of the other Drs. He kept all of her treatment from the Pediatric Psychiatrist andadded the element of helping to heal her digestion and adrenal issues. She had an undiagnosed bowel infectionwhen we saw him in the Spring. It was adding to her overall symptoms. Over the summer, Delaney had a goodstretch of time where she improved due to that infection being resolved.

It made sense to me to stay with someone who would continue Delaney on her medications while doing furthertesting of her other issues and addressing those. I trust Scott Smith because he took into consideration all theexpertise of the doctors we had and didn't seek to change what had worked. He only added to her treatment. If hehad not followed the protocol of medications that Dr. Puskur, the psychiatrist, had given, I would not have feltcomfortable with him.

I just wanted to share what I was finally able to put into words. I am grateful to all the medical professionals whohave helped Delaney. I feel they have done all they can to help her. I am also open to and hopeful that there aremore professionals out there that can continue to help her. Unfortunately, there are so few people who know howto diagnose and treat PANDAS. I am grateful that the Foundation may be able to open doors to even better

treatment.

Thanks for listening to the answer that I was finally able to articulate. Have a great day!

God bless,Barb

EXHIBIT K

Page 23 of 40

https://mail.aol .com/webmail -std/en-us/PrintMessage 2/16/2017

THE HARRY T. MANGURIAN, JR. FOUNDATION, INC. - EIN: 16-15782552017 FORM 990-PF - PART VII-B, LINE 5c - EXPENDITURE RESPONSIBILITY STATEMENT

HE.CHALLENGES

OF EVALUATINGANDTREATING PANDAS

IN CHILDRENWITH AUTISM

BY SCOTT M. SMITH, PA

INTRODUCTION

Pediatric autoimmune neuropsychiatric disorders associated with

streptococcal infection (PANDAS) is a relatively new diagnostic term

used to describe an acute change in neuropsychiatnc symptoms

occurring in relationship to a group A beta-hemolytic Streptococcus

infection (GABHS) or exposure' The hallmark of PANDAS is an

acute onset or exacerbation of obsessive-compulsive disorder (OCD)

and/or tics These core symptoms are accompanied by additional

neurologic symptoms, of which several are possible Because of the

acute nature of symptom onset and severity, the striking change from

baseline seen in PANDAS is easily identifiable in children without

preexisting and often conflicting medical conditions such as autism.

In previously healthy children, the change is so acute that parents

can often tell you the exact day the exacerbation began, even

after months have passed. The identification of PANDAS in children

with preexisting autism can prove much more difficult, however The

symptoms of PANDAS often overlap with the symptoms commonly

seen in autism and can mimic other common causes of behavioral

changes. Parents sometimes describe the acute changes of PANDAS

as a second regression in their child's autism symptoms.

Earlier identification of PANDAS in patients with autism can

lead to improved outcomes and allow for easier control of acuteexacerbations. Not understanding or recognizing that the observedchanges may be related to PANDAS delays the diagnosis Whenthe diagnosis is delayed, the ability to gain control over the acutesymptoms of PANDAS becomes more challenging because thedisorder can become refractory to first-line treatments For thisreason, a better understanding of the acute changes associated withPANDAS as seen within the autism subpopulation may lead to earlieridentification and improved treatment outcomes. PANDAS should,

therefore, be considered in children with autism when there is anacute change in behaviors.

Recently, a broader diagnostic term has been developed in

response to identification of other non-streptococcal infectious agentsas causes of similar acute symptom changes. The new syndrome,

called pediatric acute-onset neuropsychiotric syndrome (PANS), may

be triggered by such infectious agents as Mycopfasma pneumoniae,which causes a form of pneumonia, Epstein-Barr virus, which

causes mononucleosis; influenza virus types A and B, and Borreho

burgdorfen (the bacteria that cause Lyme disease) For the purposes

of this article, only PAN DAS exacerbations related to GABHS will be

discussedEXHIBIT K

Page 24 of 40

Earlier identification ofPANDAS in patients with autism can lead to improved outcomes

and allow for easier control of acute exacerbations . Not understanding or recognizing that

the observed changes may be related to PANDAS delays the diagnosis . When the diagnosis

is delayed, the ability to gain control over the acute symptoms ofPANDAS becomes more

challenging because the disorder can become refractory to firstline treatments.

W-VA=v mq PZft UEDwrm P6a69p+ • MftrW SaD CE 014ESr ThO1piN & orNnrsi'ql4 • oe r O4 119

- THE HARRY 71MIANGURIAN. JR_ FOUNDATION . INC_ EIW: 16-1578255

2017 FORM - PART VII-B. LINE 5cEXPENDITURE RESPONSIBILITY STATEMENT -'"

I

j =r

Am

may;

O ^coutt G ad °' '+^B w., Ul n ^l a°r6•-n yê • " "^f.

:9^

tl îr ^` (^1^SS'î.9"44^YI '^Qr`^ÎBSI'4i rSti ^°^^•'^ Q ô rr^^

,1fG^`_^'rc^b^ .^ ^^sDS^' OJF.Yf"'tF.MI'u^^^ /°y »? o°eiP sr} u\

\ 'î"" 3aRl;f^M^4 d1B^dE' uctDS $^C0^5 "" N1 wrm ,^ , , a „ o .

o ^dl^ SL ^,^îYRPFp r6^ìladFF Cc^C^`Yc'b5^+c S, PrcCc a"^¢ rS

V_ orall, Is_- fir,

v+p "o

/^_^:no o ^R^Yr^R,dr^rrn•,' Fa Jr - a., B,-ti• <c^,a .r

-i7 p o <SP" o ;8 A,A B., rw'irv U".

ru+anL .r "cvc^Qld'C9 .saw

EXHIBIT K. PAGE 25 OF 40

o o4jo



STREPTOCOCCUS INFECTION AND SYDENHAM CHOREA

GABHS infection has long been linked to neurologic symptoms in a

condihon called Sydenham chorea (SC). In this condition, an acute

onset of neurologic symptoms can manifest over o few hours. SC is

associated with post-streptococcal rheumatic fever, and symptoms

can include a movement disorder called chorea. Chorea is a type

of dyskinesia that primarily affects the limbs, causing involuntarymovements that are often described as dance-like. In addition tochorea, cognition can be slowed, gross and fine motor skills mayregress, and facial tics can occur. Frequently encountered in SC is a'milkmaid's grip; in which there is a repetitive relaxing and tensing ofthe hands similar to the mohon used to milk a cowWhile an obvious link to post-streptococcal rheumatic fever

was observed long ago, it wasn't until 1993 that antibodies to

streptococcal proteins were found to cross-react with human brain

tissue,2 creating the potential for autoimmunity through a process

called molecular mimicry. In 1997, a subgroup of children with acute

onset of OCD or Tourette syndrome was found to have elevated

levels of the rheumatic fever biomarker lymphocyte D8/17.3 In

this study, healthy control children were compared with children

with a diagnosis of PANDAS and children with SC. The PANDAS

and SC groups both demonstrated significantly elevated D8/17

markers when compared with controls. This supported the notion

that PANDAS may represent a new form of post-streptococcal

outoimmunity other than SC. Many of the symptoms seen within SC

can be seen in individuals with PANDAS.

SIGNS AND SYMPTOMS OF PANDASWhile a GABHS infection can present as pharyngitis , it is important to

remember that this infection also can occur in many other areas of the

body For example, GABHS can be the cause of sinusitis, otitis media,

and impetigo . Because of this, a sore throat may not be mentioned in

the medical history, and a normal throat culture may not be sufficient

in a PANDAS workup ( see Clinical evaluation). Other signs and

symptoms of GABHS infection frequently encountered in the pediatric

population include abdominal pain, vomiting, and vaginal or perionalredness.There are multiple symptoms frequently encountered in acute

cases of PANDAS. A solid understanding of primary and secondary

symptoms associated with PANDAS can help determine in which

patients with autism a secondary diagnosis of PANDAS should be

suspected or considered. The current diagnostic criteria for PANDAS

include the following primary symptoms:'

n Presence of OCD and/or a tic disordern Pre-puberty pediatric onset of symptoms (age 3 years

to puberty)

• Episodic course of symptom severityn Association with a GABHS infectionn Association with neurologic abnormalities (motor

hyperactivity, adventitious movements)

Whereas the changes brought on by PANDAS are quite abrupt

and distinct in a child without a prior diagnosis of autism ( allowing

medical intervention and treatment to be sought 2arly in the course

of the illness), the lines are not as clear in a child with diagnosed

autism . It can be difficult to know which symptoms are attributable to

autism and which may be caused by PANDAS. Consequently, the

secondary symptoms that can be seen with PANDAS are useful for

building a case for PANDAS when'a diagnosis of autism is already

established . The secondary symptoms ( described in greater detail

below) may include the following symptoms:

• Movement disordersn Fine and gross motor skill changesn Attention-deficit/hyperactivity disorder (ADHD)

n Separation anxiety

n Changes in moodn Urinary frequency and/or enuresis (bedwetting)n Sleep abnormalities

Movement disorders While new onset or worsening of tics is very

common in PANDAS, other movement disorders also may be seen

Similar to the above-mentioned SC, chorea-like movement disorders

can be observed. Chorea symptoms can vary greatly from mild

movements to violent thrashing. A milkmaid's grip may be witnessed

during the initial consultation or described by parents and teachers.

Fine and gross motor skill changes : As seen in SC, there may be

a regression in fine or gross motor skills This may be identified in

handwriting or coloring samples, which con be useful tools when

building a case for PANDAS. Teachers may notify parents that the

child's handwriting has regressed or that their work has become

sloppy. Handwriting and coloring should be discussed during the

initial PANDAS interview. Parents may also observe a new onset or

worsening of sensory defensiveness.

EXh IBIT K

Page 26 of 40While a GABHS infection can present as pharyngitis, it is important to remember thatthis infection also can occur in many other areas ofthe body. For example, GABHS can

be the cause ofsinusitis, otitis media, and impetigo.

R '411 WITH FeOISSIp'1 -AUTISM SarfXE DIGFSP 71= IOVINAL OrAUrb90rE • ISSUE 04 121

THE HARRY T. 1 2GUR7 f, JR. P0U1D®TI0L INC. - EIZ: 16-1578255

2017 FOR 990-PP - PART VII-E, LINE 5c - EXPENDITURE RESPONSIBILITY START

Individuals with autism and PANDAS have both been shown to haveabnormal autoantibodies to the basal ganglia.

ADHD • Attention and focus tend to worsen, with children becoming

easily distractible and fidgety. Because these are also symptoms

seen in children with autism, changes from the child's prior baseline

must be identified. Unlike traditional ADHD, in which the brain locks

appropriate stimulation, these some symptoms seen in PANDAS may

actually represent overstimulation of the brain. Stimulant medications

commonly used to treat ADHD may exacerbate PANDAS symptoms-

Separation anxiety and mood . Separation anxiety and phobias

can manifest in children with no prior history of these behaviors.

These debilitating symptoms can begin quite suddenly. Parents may

describe a personality change, emotional lability, oppositional

defiance, and rage-like behaviors. Parents also may report a

regression in age-appropriate activities and play skills, including

choice of toys or television shows and videos

Urinary frequency and enuresis A common symptom encountered

in PANDAS is an increase in urinary frequency and/or a return ofnighttime bedwetting. In the process of ruling out other potential

causes of urinary frequency, a review of all other PANDAS symptoms

should take place to uncover other subtle changes that otherwise

may have been missed.

Sleep abnormalities : The symptoms of PANDAS can occur throughout

the day but frequently worsen at night. Repetitive behaviors and

racing thoughts often inhibit the initiation of sleep

AUTISM AND PANDAS

Successfully identifying PANDAS when a diagnosis of autism is

already established is challenging for many reasons As already

mentioned, there is a significant amount of symptom overlap between

the two conditions..The•pnmory manifestation of PANDAS (an acute

onset of OCD and/or tics with secondary neurologic abnormalities)

is similar tb symptoms commonly observed in autism In fact, restricted,

repetitive, and stereotyped patterns of behavior ore part of the

Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-

TR) diagnostic criteria for autism Other symptoms consistent with

PANDAS are challenges that families of children with autism face on

a regular basis Moreover, the semi-acute PANDAS-related changes

observed in children with autism are often more subtle than the acute

symptom changes seen in an otherwise neurotypical child with

PANDAS, these changes may go unnoticed in children with autism in

whom there is already a certain amount of behavioral variability on a

day-to-day or week-to-week basis.

In addition to the symptom overlap, there is also overlap inunderlying pathology. Individuals with autism and PANDAS haveboth been shown to have abnormal autoantibodies to the basalganglia. The basal ganglia play an important role in controllingmovement and behavior and may also play a role in motivation.Dysfunction of the basal ganglia has been linked with neurologicconditions including Tourette syndrome," Parkinson's disease,'Huntington's diseose,° and OCD.7 In 2007, a study demonstratedthat b-tubulin located within the basal ganglia in the caudate nucleus

(a key part of the brain's learning and memory system) was the target

122 AUnSM saBUCE OY'.6r 1 E plpwe OFNJ1@MaG • __ a • PBrrlur®vwnH PAN

for autoimmunity in SC.B Both autism and PANDAS also target the

caudate nucleus. A 2003 study showed that children with autism

had several autoimmune reactions to brain tissue when compared

with age-matched controls,9 including outoantibodies to the caudote

nucleus. Another study from 2006 showed increased ontibrain

antibodies in patients with autism (including the caudate nucleus)

when compared with normal controls.1°

In healthy populations, the development of autoantibodies to braintissue is inhibited by the blood-brain barrier (BBB). The BBB restrictsthe access of circulating antibodies to brain tissue, decreasing thepotential for immunologic cross-reaction and autoimmunity In 2010,a study in mice that reproduced the symptoms of PANDAS stated,The mode of disrupting blood-brash barrier integrity, differentiallyaffects the ultimate CNS [central nervous system] distributionof these antibodies and is shown to be an additional important

determinant of neuropsychiatric outcomes."" Blood-brain barrier

dysfunction appears to be a particularly strong indicator of PANDAS

vulnerability. Autism, with its correlation with brain autoantibodies, isthought to have similar BBB dysfunction A new concept described byDr. Theoharis Theoharides of Tufts University discusses how histamine

at; ^ •-

w

release from mast cells may be a possible contributor to blood-brain

barrier disruption and dysfunction .12.13

Overactivation of calcium-colmodulm dependent protein kmase II

(CoM kmase II) has been identified in both SC and PANDAS.'"'

CoM kinase II is a brain enzyme involved in calcium homeostasis

and in many signaling cascades. CaM kinase II also may ploy a

role in learning and memory An increase in CoM kinose II activity

leads to elevated production of the enzyme tyrosine hydroxylase, an

important enzyme that regulates dopamine production. Increased

levels of tyrosine hydroxylose in turn lead to overproduction of the

neurotransmitter dopamine, which is highly involved in basal ganglia

activity Dopamine dysfunction, therefore, provides a proposed

mechanism for the symptoms observed in SC and PANDAS.

Dopamine dysfunction and/or dysregulation have also been

identified in studies of autism.16•"

The atypical antipsychotic medication Risperdal0, commonlyused in autism and currently the only FDA-approved treatment for

Page 27 of 40

TIE HARRY T . MANGURIAN , JR. FOUNDATION , INC. - EIN : 16-1578255

2017 FORN 990-PF - PART VII-B LINE 5c - EXPENDITURE RESPONSIBILITY STATEMENTand anh-DNase B are unnecessary in securing athis condition, is thought to work by antagonizing

dopamine type II receptors (D2),'B effectively PANDAS diagnosis if streptococcal infection has

blocking dopamine from its receptor site. already been proven by culture However, the

11Medications that increase dopamine levels, such " - ' .- - antibody titers can be useful in culture-negative

-as the common ADHD stimulant medications cases because they remain elevated for severall fConcerta©and Adderall©, may exacerbate weeks beyond streptococca ection. Titers canin

PANDAS symptoms and often are not tolerated be completed at the initial visit and repeated afterin children with autism Concerto, as per the six weeks. It is important to recognize that whilepackage insert, is contraindicated in patients with positive antibody titers can help support a clinical

tics, a current diagnosis of Tourette syndrome, diagnosis of PANDAS, normal antibody titers door a family history of Tourette syndrome The not rule out PANDAS as a possible cause of acuteAdderoll® package insert identifies exacerbation r - ; - symptom changes. In 1974, a study that measuredof motor or phonic tics as a potential side effect streptococcal antibody titers in children who hadand movement disorders as a possible side effect. - already tested positive for streptococcal infectionThese medications, therefore, should be monitored W ;r .. by throat culture showed that these antibodies doclosely in children with autism and used cautiously not rise in every streptococcal infection 19 ASOor avoided altogether in patients with PANDAS. titers were elevated in lust 52% of the culture-

' positive cases in this study, and anti-DNose B titersCLINICAL EVALUATION were elevated in only 35% of the culture-positiveA diagnosis of PANDAS requires specific acute cases. Unfortunately, there have been instancessymptomatic changes occurring in association with a GABHS where parents have reported acute symptom changes after binfection or exposure. While other infectious agents may create documented streptococcal infection, and the pediatrician, althoughsimilar symptoms, PANDAS, by definition, must be related to a suspecting PANDAS, has ruled it out after the ASO and anti-DNaseGABHS infection. As already mentioned, experts recently hove B titers returned as normalcreated the broader term PANS to acknowledge the potential Additional tests have been used to help determine whichinvolvement of other infectious agents. cases may be consistent with PANDAS. While these tests are notOnce a correlation with streptococcal infection has been diagnostic, they have aided in the decision making process in

established by medical history, physical exam, or abnormal difficult-to-identify cases of PANDAS. For example, testing completedstreptococcal test results (cultures or titers), it is important to initiate at the University of Oklahoma that examined cell signaling showedtreatment (see Treatment of PANDAS). To date, there are no abnormal CoM kmase II activity. As already mentioned, elevated

diagnostic tests for PANDAS itself. The diagnosis is, therefore, clinical CaM kinase II activity has been found in patients with SC'3,20 andand is made by assessing appearance (signs and symptoms) and PANDAS14 The SC biomorker, lymphocyte D8/17, has also been areviewing pertinent history (streptococcal infection or exposure). valuable tool in identifying patients with PANDAS in cases where theConducting a physical exam and obtaining a detailed history are acute symptom exacerbation may have been missed. Unfortunately,paramount A thorough physical exam may include examining the neither the CaM kinase II nor the lymphocyte D8/17 tests aretonsils for erythema and exudates and examining the patient for commercially available at this timesigns of impetigo, vaginal redness, a red perional ring, and cervical Upon initial presentation, if a relationship with GABHS infectionlymphadenopathy As part of the detailed medical history, providers has not been established, providers should obtain the followingshould look for a history of recent acute illness in relationship laboratory tests:with PANDAS symptom Onset. Signs and symptoms related to the

illness (such as sore throat, tender lymph nodes, abdominal pain,

vomiting , and skm' rashes ) are of particular interest . I also recommend

obtaining a history of any illnesses of family members living in

the home in relationship to the patient's acute symptom change.

Because Lyme disease con be an additional potential trigger for

acute symptom exacerbation , obtaining a history of tick bites also is

recommended.

Streptococcol antibody titers such as antistreptolysin 0 (ASO)

n Rapid throat culture

• 72-hour throat culture• ASO titern Anti-DNose B titer

n Comprehensive metabolic profile (CMP)• Complete blood count (CBC)n Testing for Mycoplasma pneumoniae and/or Lyme disease

(if suggested by history)

EXHIBIT K

Page 28 of 40

It is important to recognize that while positive antibody titers can help support a clinicaldiagnosis ofPANDAS, normal antibody titers do not rule out PANDAS as a possiblecause ofacute symptom changes. In 1974, a study that measured streptococcal antibodytiters in children who had already tested positive for streptococcal infection by throat

culture showed that these antibodies do not rise in every streptococcal infection.

THE HARRY T. MANGURIAN , JR. FOUNDATION,2017 FORM 990-PF - PART VII-B, LINE 5c

A Yole-Brown Obsessive-Compulsive Scale score and tic scoresare also helpful tools in evaluating PAN DAS2 These tests, oftenperformed by neurologists, psychiatrists, and psychologists canquantify changes in OCD or tic behaviors, help identify repeatexacerbations, and help evaluate treatment success.

If no temporal relationship with streptococcal infection is elicited byhistory, exam, or laboratory testing, or if the patient is not respondingto the initial treatment plan, then the following tests are indicated:

n Mycoplasma pneumonioe

n Lyme disease screening (ELISA and Western blot(n Repeat ASO titern Repeat anti -DNase B titer

n Immunoglobulin studies (IgG, IgM, IgA, IgE)

• Urine organic acid testing ( looking for clostridia markers)

It is important to again emphasize that PANDAS is a clinical

diagnosis. Most of our current testing is targeted at identifying

a potential triggering agent. However, when the initial acuteexacerbation is missed , many of the strep markers may have already

normalized . Providers must, therefore,rely on current symptoms and post

history and use good clinical judgment

to make o PANDAS diagnosis.

TREATMENT OF PANDAS

Treatment of PANDAS currently

elicits considerable debate. All of

the treatments that I discuss below

should be considered off-label. It is

advisable to work with a provider

who is knowledgeable about andexperienced in treating PANDAS prior

to starting any treatment regimen.

ANTIBIOTICS

Because of the link to GABHS, there

is at least an initial role for antibiotic

treatment in PANDAS. Once GABHS

is conhrmbd by laboratory doto or

there is a high index of suspicion basedon the medical history' or physical exatn, a course of antibiotics with

GABHS activity typically is initiated Patients with a history of PANDAS

report remissions of neuropsychiatric symptoms while on antibiotics. 13

A prospective study of PANDAS in patients with culture-positive

GABHS tonsillopharangitis showed that OCD symptoms promptly

disappeared with appropriate antibiotic treatment.26 While there

are several antibiotic options available, choosing an antibiotic thatalso has anti-inflammatory and/or neuroprotective potential seems toprovide more symptom relief than those that do not have these addedbenefits Initial antibiotic courses range from 3 to 4 weeks, dependingon symptom severity. If symptoms recur upon discontinuation of theantibiotic treatment, then the antibiotic is restarted.

Although the use of prophylactic antibiotics in PANDAS is

controversial, they are commonly used once acute symptom control is

achieved. Existing research supports the benefits of using prophylactic

antibiotics with another GABHS-related disease, rheumatic fever 25

In rheumatic fever, antibiotic prophylaxis not only decreased the risk

of recurrence but improved long-term prognosis. In PANDAS, daily

penicillin VK and weekly azithromycin have both been shown to

NC. - EIN : 16-1578255- EXPENDITURE RESPONSIBILITY STATFJIENT

decrease recurrent GABHS infections and reduce neuropsychiatricsymptom exacerbations.26 The effectiveness of azithromycm for thetreatment of GABHS" may have something to do with the fact thatit is a macrolide antibiotic. Macrolide antibiotics as a class haveshown immunomodulatory properties that help with inflammation 28Azithromycin has also demonstrated extended serum concentrations,which allows for the once weekly prophylactic dosing19 In addition,azithromycin can be used in penicillin-sensitive patients. For thesereasons, a single weekly dose of azithromyan is probably a morepractical choice than daily penicillin dosing.Augmentin® has been effective in treating PANDAS and may be

the most discussed antibiotic treatment. Augmentin© is amoxicillin

combined with clavulanic acid. The addition of clavulanic acid

(which itself has no antibiotic properties) creates an antibiotic with

o broader spectrum of bacterial coverage than that of amoxicillin

alone. Although the improved coverage benefits of Augmentin®

over amoxicillin are a sufficient reason to make it a more desirable

treatment for PANDAS, the benefits of Augmenhn® are not limited

to its improved GABHS coverage. Clavulamc acid has been found

to have its own CNS-rnodulating properties, which have reduced

anxiety levels in rats and primates 30

Clavulanic acid as a single agent hasalso shown potential neuroprotectiveeffects and is being investigated forpossible therapeutic use in otherinflammatory CNS disorders suchas Parkinson's and Alzheimer's

diiseases.31 Based on these findings,

the success of Augmentin® may

be due to its own direct neurologicbenefits

It should be noted that whereasazithromycin has an extended half-life that allows for one-time-per-day

dosing, Augmentm© does not havethe some extended half-life and

must be dosed two times per day. In

addition, because of the amoxicillm

component, Augmentm® cannot be

used in penicillin-allergic patients

An additional antibiotic that has

shown some neuroprotective properties in ischemic brain injury

and motor neuron degeneration is ceftriaxone.32 This antibiotic is

a cephalosponn, so it may not be able to be used in penicillin-

allergic patients. Ceftrioxone is given intravenously, which can be on

additional limiting factor.

Recently, research has shown that antibiotic-resistant streptococcalinfections are on the rise-" Because of this, initial antibiotic treatmentfailure is possible. Antibiotic treatments may need to be adjustedif the clinical response is poor. While the once daily dosing ofozithromycin can be easier to administer, the phormacokinetics ofAugmentin® may make it superior to azithromycin or other antibioticssuch as cepholosporins in terms of reducing the risk of resistance.

ANTI-INFLAMMATORI ESBecause PANDAS is strongly linked with neuronal autoimmunity andinflammation, similar to SC, treatments that are anti -inflammatory andimmunomodulatory have demonstrated success and may prove to beour best treatment options." If there are limited or no improvementsafter two weeks on the prescribed antibiotic treatment, additional

EXHIBIT KPage 29 ofr24-,gyp*W-M"A ,GeV T 40

THE HARRY T. MANGOBIAN, JR. FOUNDATION,2017 FORM 990-PF - PART VII-B, LINE 5c

treatments to address inflammation should be initiated. Anti-inflammatory treatment can be of great value for many autoimmune

conditions, and PANDAS is no exception In PANDAS, measures to

control the acute inflammatory response are often needed to reduce

symptoms and are used in addition to antibiotic treatment

Anti-inflammatory treatments range from nutritional supplements tosteroid protocols. One valuable adjunct to antibiotics is the use of

steroid pulse doses. A pulse dose is a 3-to-4-day 'burst' of steroids.Because of its abbreviated course, a pulse dose can be completed

without the need to taper the steroid. While its potential to reduce

inflammation is not as great as an extended tapering course, the

side effects are much better tolerated. To reduce side effects of daily

steroids, the full dose con be given in the morning with food. Because

cortisol naturally peaks in the morning and cascades down to lowerlevels through the day, a morning-only dose more closely mimics the

body's natural cortisol distribution, creating fewer side effects Dosesgiven later in the day may increase the risk of disrupting sleep

Steroid pulse doses may be repeated if necessary. However,if the benefits from a steroid pulse do not provide extended relief,other immunomodulatory treatment protocols should be consideredlonger tapering courses of steroids can be considered in patientswho improve with pulse dose steroid treatments but lose the benefit'sshortly after the pulse dose is completed. However, the side effects oflonger steroid doses limit their use.

If benefits are noted from a steroid pulse, additional anti-

inflammatory treatments may be beneficial in maintaining thesebenefits and reducing the frequency of repeat steroid pulses.Nutritional supplements with anti-inflammatory properties such as

boswellia,35,36 curcumin," or quercetin'e can be added to protectfrom inflammation recurrence Additional medications with anti-

inflammatory properties, used off-label, also may be of benefit.

Examples include spironolactoneJ",' and Singular@ 4' The use ofnonsteroidal anti-inflammatory drugs (NSAIDs) may also be useful to

help prevent and reduce inflammation recurrence. Though over-the-

counter, NSAID medications for PANDAS should be used only underthe close supervision of a medical professional

INTRAVENOUS IMMUNOGLOBULINIntravenous immunoglobulin (IVIG(, originally used to treat immune

dehcrehcy, has benefits in'several autoimmune diseases.42 IVIG has

also been shown to be effective in autism",and PANDAS.4° One of

the original research studies on possible treatments for PANDAS used

IVIG.46 A small study using IVIG on patients with PANDAS reduced

OCD symptom severity signihcantly.'s A follow-up National Institutes ofHealth (NIH) study is currently under way using IVIG as a treatment for

PANDAS Unfortunately, the study excludes patients with autism

IVIG is a pooled blood product and is screened for infectiouscontaminants in the some manner as other blood products. IVIG isgenerally considered safe for treating autoimmune disease." Priorto administering IVIG, patients must be screened for immunoglobulinA (IgA) deficiency. Severe I9A deficiency is a contraindication forIVIG use. When given by trained providers, the side effects of IVIGare usually mild and easily managed. Common side effects mayinclude (but are not limited to) headache, nausea, and vomiting. AposNransfusion reaction called aseptic meningitis may occur. Thiscondition is self-limiting, however, and can often be avoided by usingslower infusion rates and maintaining proper hydration.The high cost and limited insurance coverage for IVIG is often

a limiting factor for the use of this otherwise effective treatment.Currently, only one major insurance carrier recognizes IVIG as

INC. - EIN : 16-1578255- EXPENDITURE RESPONSIBILITY STATEMENT

proven for the treatment of PAN DAS Unfortunately, it is considered

investigational by other insurance companies

THERAPEUTIC PLASMA EXCHANGE (PEx)Therapeutic plasma exchange ( PEx) or plasmapheresis is used in thetreatment of several outoimmune conditions."'49 PEx is a procedurewhere antibodies ( including autoantibodies ) are removed fromthe blood by separating the cells from plasma and replacing the

plasma component PEx has also been studied as a possible therapy

for PANDAS and has been shown to be of particular benefit in

treating tics associated with PANDAS 45 Currently, it is difficult to find

providers and facilities that offer PEx treatment for PANDAS patients

PEx is also the most expensive and most invasive treatment used in

PANDAS

COGNITIVE BEHAVIORAL THERAPYIn traditional cases of OCD, the use of cognitive behavioral therapy

(CBTJ con be of great use . CBT teaches individuals to use concrete

tools to overcome OCD thought-patterns . Preliminary researchsuggests that CBT may also be of benefit in PANbAS.SO However,

CBT may be more difficult to provide in such cases, and its use inpatients with on additional diagnosis of autism may be limited

CLASSIC OCD MEDICATIONS

Because PANDAS is an autoimrnune condition that affects the

brain, immunomodulatory treatments should be considered before

resorting to traditional OCD medications such as selective serotonin

reuptake inhibitors (SSRIs( and tricyclic antidepressants (TCAs) such

as clomipramine. These classic OCD medications have large sideeffect profiles. In addition, SSRIs have been shown to exacerbate

behavioral symptoms in PANDAS when used at traditional OCD

doses 5' However, these medications may be a useful adjuncttreatment at doses lower than normally prescribed for OCD

TONSILLECTOMY

The use of elective tonsillectomy to treat PANDAS is quite

controversial and should not be routinely recommended Despite this,there have been published case studies where PANDAS patients

with recurrent tonsillitis have had some symptom improvement aftertonsillectomy.5LS3 Because GABHS infections are not limited to thetonsils , some patients have had tonsillectomies and no reduction in

symptoms

L-TAURINE

l-Taurine is a sulfur-based amino acid It con act as an inhibitory

neurotransmitter , a cell membrane stabilizer, and helps modulate

intercellular magnesium levels . L-Taurine may be of benefit in

PANDAS because it has been shown to decrease CoM kinase II

activation. 54

OTHER TREATMENTSPANDAS treatments can themselves cause secondary problems that

may lead to additional symptoms- This is particularly the case with

respect to the gastrointestinal (GI) tract and the gut flora, which can

be disrupted by the antibiotics and steroids used to treat PANDAS

The GI tract contains a disproportionately large amount of the human

immune system, which interacts with and is influenced by the flora

present Maintaining normal enteric flora con help with controlling

systemic inflammation.05'5' It is, therefore, important to keep the GI

tract as stable as possible. EXHIBIT K

Page 30 of 40

THE HARRY T. MANGURIAN , JR. FOUNDATION , INC. - EIN: 16-1578255

2017 FORM 990-PF - PART VII-B , LINE 5c - EXPENDITURE RESPONSIBILITY STATEMENT

Providers should have a high index ofsuspicion regarding PANDAS in autism patientswith acute behavioral changes. The initial presentation ofPANDAS in autism maybe slightly atypical and easily missed because ofsymptom overlap between the two

conditions. The long-term outcome ofpatients with this dual diagnosis greatly dependson provider recognition and appropriate intervention.

Numerous studies have documented that many autism patients

struggle with recurrent opportunistic infections within the GI tract

(dysbiosis) 57.38 Common opportunistic infections identified in autism

- CandidaS9 and clostridial60'61 species - can be exacerbated

by antibiotics and steroids. The use of additional antibiotic andontifungal treatments may be needed to help control clostridialand condidal overgrowth. Clostridial species are difficult totreat and have a high degree of recurrence.62 Vancomycin ormetronidazole may be needed to control clostridia populations. ForCandlda control, non-absorbable medications such as nystatin oramphotericin B should be tried first, although fluconazole or otherozole antifungals may be needed for Candlda overgrowths thatdo not respond to non-absorbable medications. Repeat testing ofstool or urinary organic acids should be done when using repeator prophylactic courses of antibiotics to identify and address theseopportunistic infections as they occur.

Probiotic use also is helpful in maintaining normal GI flora. Someprobiotics contain Streptococcus thermopolis, which may exacerbate

REFERENCES

1. Swedo SE, Leonard HI, Garvey M, Mutlemon B, AllenA(. Perimuaer S. Lougee I. Dow S. Zomkof J, Dubbert BK.Pediatric outoimmune neumpsycluamc disorders associatedwith strepiococcaf infections dimcol description of the tin 50cases Am J Psychiatry 1998 Feb, 155(21264-71

2. Bronze MS, Dole JB Epdopes of streptococcal M proteinsthat eroke antibodies that aosuead with human4ram. JLmmunof 1993 Sep,L51(5J 2820.8

3. Swedo SE, Leonard HL, Millemon BB, Allen AJ. Rapaport .11.Dow 5P, Kziier ME, Chapman F, Zabrakre J Idendicafron ofchildren with pediatric outoumnune neumpsyduatric disordersassociated with suepiococcol udedums by a mockerassociated with rhewt4c fever Am J Prycluooy 1997JaN154[l) 110.2

4, Lenglet C, Abosch A, Yocoub F. De Martina T, Sopno G,Horel N Compre eneve in vivo mopping of the humanbasal genglro rind thalamic cbnnedome In indmduols using7T MRI PLoS One. 2012.7[1) e29153

5. Tremblay L [Padwphryology of Parkinson s disease anupdate I [Article in French] Bug Aced Nod Med 2010Ocr,l94(7) 1321.31

6. Reiner A, Drogatsis I, Dietrich P Genetics andneuropathology of Hunti gton's disease. lit Rev Neurobiot201198 325,72

7. Coneo S, Hubbard E. Hassensiob J, Yip A. Vymozol J,Herynek V, Gledd J, Murphy Dl, Greenberg BD. Basal9onglo MR relawmetry in obsewne compulsne disorder T2depends upon age of symptom onset Brow Imaging Behav2010 Mor,4t 1 t 35-05

8. K'uron CA, Can CJ, Swede, SE. Cummighom MW Tubdn isa neuronal target of oeoor oodles in Sydenhorn's drama JImmunol 2007 Ju[ 1781 I I )7412-21

9. Singh VK, Rios WK Prevalence of serum arkbodies tocoudate nucleus in autistic children Neurosis Lee 2004

Jon.35511-2016

10. Singer H5. Mods CM, W$ams PN, Yoon DY, Hong

D, Zimmerman AW Antbrain antibodies in children wthautism and their urdfeded slbhngs. J Neurormrwncl 2008

Sep, 17811-21.14%55

symptoms in some individuals If a patient responds poorly to theirinitial probiotic, consider using a formula that is free of S. thermopohs.

SUMMARY

Providers should have a high index of suspicion regarding

PANDAS in autism patients with acute behavioral changes.

The initial presentation of PANDAS in autism may be slightly

atypical and easily missed because of symptom overlap between

the two conditions. The long-term outcome of patients with

this dual diagnosis greatly depends on provider recognition

and appropriate intervenhon. Because PANDAS is managed

rather than cured, it requires frequent monitoring and treatment

adjustments. Unfortunately, the available treatments can create

additional issues that require further attention. Nonetheless, in the

absence of a cure for PANDAS, every attempt should be made

to control acute exacerbations. Once acute control is achieved,

patients and providers should develop on individualized long-term

management plan.

11. Yaddonopudi K. Hornig M. Serge R. De MirandaJ. Boghbon A, Villas G. Lipkin WI Pasture taunter ofstreptoccocu duced antibodies reproduces behavioraldisturbances in a mouse model of pediatric outammuneneuropsychwtnc disorders associated with simpioccocollinfection. Mal Psydnatry. 2010 Jul,15(71712-26

12. Theoborides TC Autism spedncn disorders and miss ocytosis.Int J Immuwpmhol Phormoool. 2009 Od.0ec;22 (4( 85965

13. Theohartdes TC, Zhang B Neurolnflommahon, bbod-brombarrier, renames and outwit. J Neuranf ammanon 2011Nov-,8(l) 168

14. Kirvan CA, Swedo SE, Kuroham D, Cunningham MWStrepiocomd mimicry and onhbodymed aged cell signalingin the pathogenesis of Sydenham's chorea. Aubmunumy.2006 Feb-,3911121.9

15. Klrvon CA, Swedo SE, Snider I& Cunnhrghom MWAnnbodymedcied neuronal cell signaling in behovmf andmwemerri drsordea J Neurormmunol 2006 Od, 179(1-2)- 173.9

16. KatuzunoCzaphnsko J, Socha E. Rynkowskl J . Determinaflonof homovam'Pc cad and ronilylmandelic cod in urine ofouhstic children by gas chromasogroplry/moss spectroscopyMed So Mond 2010 Sep, 16(9) CR44550

17. Sun )E Yue J, Zheng C [Study of dopamtre transporterImaging on the bma of children with whirm ) Sheng Wu YiXue Gong Cheng Xue Zo Zhl 2008 Apr,2512 ) 327-30.

18. Scott U. Simon S Spoil ht on rispesdone in Irrltoblity,associated with oulsrc disorder in children and odolescmits.CNS Mugs . 2008,22(3(259 2.

19. Goedsa8-0e Groot LE Mkhel8ensmk N. Van Es8oonMM. Van Vomo All. Michel MF Comparison of the)Len of ASO. anisONase B, and antibodies againstthe group polysoccfwride of gtwp A streplwscd Inchildren with streptococcal Iniedions J C6 PathoL 1974Nor27(11) 891-6.

20. KYvon CA, Swedo SE, Heuset JS, Cenninglwn MW.Mmkry and whoa tibodyemedioted neunxwl cell signallingin Sydenhom chorea Not Med. 2003 Ju10(7t914.20

21. CengeLKriltUr SE, Cap E, Kam A, Cergat AB, Uhrdo AK,Unol F The relationship between group A beto hemo^ytlcsueplococcal infection and psychiatric symptoms. a pilotstudy Turk J Peddolr. 2009 JulAug,51(4( 317-24

22. Bernstein GA, Ybor AM, Pipol A). Williams KAComparison of clinical characteristics of pediatricoutoirnmune neurop iatric disorders associatedwith sheplococcal infecttioriii and childhood obsessne-compulsive disorder J Child Adolesc Psycoplrormocol2010 Aug,20(4) 33340

23. Murphy TK Slorch EA. Lewin AB, Edge PJ, GoodmanWK. Clinical factors associated whrh pediatric outounmuneneuropsychiatnc disorders associated with slreptococcdelectron J Pediatr 2012 Feb, 16012):314-9

24. Murphy Ml, Pidtkhero ME. ProsimmEve Identificationand treatment of children with pedioMC autmnununeneuropsyduorr c disorder associated with group Asueptococcal infection [PANDAS{ Arch Pell air AdolescMed 2002 Apr 156(4) 35661

23. Mossell BE Chute CG. Walker AM, Kurland G5 Penicillinand the marked deaease in mabidity and moms lhly fromrheumatic fever In the United States. N Engl J Med 1988Feb,318(5).280.6

26. Snider LA, Lougee I. Slattery M, Grant P 5wedo SEAntibiotic prophylaxis with anthromydn or penicillin fordWdhoodonset neuropsyddotric disorders Btol Psychiatry2005 Ap;57(7)788.92.

27. Ko©a T. Rlktrnoru T. Tokunago N. Higashi T, NakarnurcM, Iddkowo Y, Motsuo K. Evaluation of shomourn clinicalefficacy of 3doy therapy with ozBhnxrycn in comparisonwith Sday cefcopena-pnauyl for am" strepromccalootm9ophorang3s in primary care. J tided Chemodter2011 Aug: 1714) 499303.

28. Zansgouddls P. Poponos N, Kfoumis I, O.aizekl E,

Maltezos E. Zarogoulidis K. Moc olidec from in vitro anti

inflonunobry and lnmunomodulotory properties to clinical

practice in respiratory diseases. Run J do Phonnamt

2011 Nov 22 [Epub ahead of print]

EXHIBIT K

Page 31 of 40t36_Krtt^saft+^ plktui_ rxmsr+ore.cs.&o4.ArmwtmmrHt'rrW'J ----

'--+-^

THE HARRY T. MANGURIAN, JR. FOUNDATION, INC.EIN: 16-1578255

2017 FORK 990-PF - PART VII-B , LINE 5c - EXPENDITURE RESPONSIBILITY STATIIKENT

February 16, 2017

Mrs. BarbaraAA6 Ash PassOcala, Florida 34472

Dear Barbara,

Enclosed please find our Foundation' s Medical Emergency Financial Assistance GrantApplication- Please fill out sections 1 through 4 and return the completed sections to us in theenvelope provided. Also, please forward section 5 ofthe Application to Central Florida FunctionalMedicine with a note for them to complete and return same to our office (envelope also providedfor that).

Sincerely,


TI/. eth P PianaVice President - Finance

BPP:hs

Enclosures: As stated.

EXHIBIT K

Page 32 of 40

3696 NORTH FEDERAL HIGHWAY o SUITE 300 o FORT LAUDERDALE. FLORIDA 33308-6263

TELEPHONE: 954.491.1 722 o FAX: 954.772.7584

[email protected]

THE HARRY T. MANGDRIAN, JR. FOUNDATION, INC. - EIN: 16-1578255

2017 FORM 990-PP - PART VII-B, LINE 5c - EXPENDITURE RESPONSIBILITY STATEMENT

Scott M. Smith, P.A.

Central Florida Functional Medicine, PLLC

1395 N . Courtney Parkway

Suite 208

Merritt Island, Florida 32953

Telephone : 321-529-7300

March 15, 2017

To Whom It May Concern:

Thank you so much for your support of IVIG treatment for DelaneyA- We have

scheduled her for treatment on Tuesday March 29 and Wednesday March 30. Treatment will

last from 9:00 AM until 4:00 PM each day. Delaney will be attended by Mr. Smith and staff

members during that time.

The cost for these treatment is $10,520.00. This includes 82 grams of Gamunex.

Please call if there are any further questions.

Sincerely,

ott M. mith, PA.

SS:cjp

(Sent via e-mail to [email protected])

EXHIBIT K

Page 33 of 40


2017 FORM 990-PF - PART VII-B , LINE 5c - EXPENDITURE RESPONSIBILITY STATEMENT

March 16, 2017

All R Rezai, M.D.Director, Neuroscience ProgramStanley D. & Joan H. Ross Chair in NeuromodulationTHE OHIO STATE UNIVERSITYWexner Medical Center - S2044 Davis480 Medical Center DriveColumbus, Ohio 43210

Dear All,

I wanted to let you know how much your personal efforts are appreciated in connection with theDelaney A^issues. As you know, our principal recipients of grants are almost exclusivelylimited to I.R.C. Section 501(c)(3) organizations. There is an exception in the regulations whichprovided us with an opportunity to help a needy individual, providing certain conditions were met.In doing the required "due diligence," your efforts and those of the other doctors who assisted inreviewing her condition gave us the information needed to assist this family, notwithstanding thefact that the proposed treatment may not be successful. We had not previously encountered thistype of request, and as difficult as it was for us to observe the specifics of her condition, I'm sureit doesn't compare to what the family is going through.

We thank you, and please pass our appreciation on to Dr. Debabrata Ghosh at NationwideChildren's Hospital and the other doctors who provided their valuable time to us and the family.

Sincerely,

THE HARRY T. MANGURIAN, JR FOUNDATION, INC.

S en G. MehallisPresident

SGM:bpp

EXHIBIT K

Page 34 of 40


TELEPHONE: 954.491 1722 o FAX: 954.772.7584

[email protected]

EIN: 16-1578255THE HARRY T. MANGURIAN, JR. FOUNDATION, INC.2017 FORM 990-PF - PART VII-B, LINE 5c - EXPENDITURE RESPONSIBILITY STATEMENT

March 21, 2017

Scott M. Smith, P.A.CENTRAL FLORIDA FUNCTIONAL MEDICINE, LLC1395 North Courtney Parkway, Suite 208Merritt Island, Florida 32953

Dear Mr. Smith:

Pursuant to our agreement with Central Florida Functional Medicine, LLC (your letter datedMarch 15, 2017) and approval from the A' family, please find enclosed ourFoundation's check in the amount of $10,520.00 (Exactly Ten Thousand Five HundredTwenty and 00/100 Dollars), representing our funding of the WIG treatment (IntravenousImmunoglobulin therapy using 82 grams of Gamunex) for Delaney AJIMM scheduled forTuesday, March 29, 2017 and Wednesday, March 30, 2017, from 9:00 AM to 4:00 PM eachday, at the office of Central Florida Functional Medicine, LLC in Merritt Island, Florida.

We wish you every success with Delaney's treatment.

Sincerely,

THE HARRY , JR. FOUNDATION, INC.

"P . Diana, CP.AVice President - Finance

BPP:hs

Enclosure: As stated.

Cc: Mr. and Mrs . David C. Aj^

EXHIBIT K

Page 35 of 40

3696 NORTH FEDERAL HIGHWAY O SUITE 300 0 FORT LAUDERDALE. FLORIDA 33308-6263

TELEPHONE: 954.491.1 722 o FAX: 954.772.7584

[email protected]


2017 FORM 990-PF - PART VII-B, LINE 5c - EXPENDITURE RESPONSIBILI

STATQKENT

Scott M . Smith, P.A.


1395 N. Courtney Parkway

Suite 208

Merritt Island, Florida 32953

Telephone: 321-529-7300 --

April 6, 2017

Mr. Steve Mahallis


3696 North Federal Highway

Suite 300

Fort Lauderdale, Fl. 33308.6263

Dear Mr. Mahallis:

As you.may know, Delaney A%UQ received her IVIG treatments last week. I spoke with hermother today and she is showing improvements including less anxiety, improved focus and anincreased motivation towards school work.

Thank you and the Foundation for helping Delaney and her family. If I can ever be ofassistance, please feel free to contact me.

Sincerely,

Cco mith, P.A.

SS:cjp EXHIBIT K

Page 36 of 40


2017 FORM 990-PF - PART VII-B , LINE 5c - EXPENDITURERESPONSIBILITY

STATE! NT

Scott M. Smith, P.A. 64/



Suite 208Merritt Island, Florida 32953

Telephone: 321-529-7300

June 20, 2017

To: The Harry T. Mangurian, Jr., Foundation

Re: Ate! Delaney


Your Foundation graciously supported Delaney's treatment in March of this year. The resultswere dramatic and her parents reported an "80%" improvement in her condition. Her symptomswere greatly reduced and she was even able to participate in her sister's wedding. Sheexperienced 10 weeks of improvement after a several years spiral of increased symptoms anddecreased functioning.

However, 12 weeks after her initial treatment her symptoms have again increased. She is having

significant sleep disruption, a lack of impulse control and mood irritability and much anxiety. My

recommendation is that Delaney have another treatment using the higher dose medication of

108 gram of Gamunex over a period of 2 days.

This second- treatment may give Delaney an improved chance at being stabilized on less

complicated and expensive treatments. The cost of this 2-day protocol is $13,380.00.

I hope you can assist Delaney's family with this expense. If you need further information please

call.

Sincerely,


EXHIBIT K

Page 37 of 40

Opt

THE HARRY T. MANGITRIAN,JR. FOUNDATION, INC. - EIN: 16-1578255

2017 FORK 990-PF - PART VII-B, LINE Sc - EXPENDITURE RESPONSIBILITY STATEMM




Suite 208Merritt Island, Florida 32953Telephone: 321-529-7300

July 6, 2017


Thank you again for your support regarding Delaney AIWWs scheduled IVIG treatment.

Delaney is scheduled for her treatment on July 17 and 18. The treatments will last from 9:00 AM

until approximately 3:00 PM each day. Delaney will be attended by Mr. Smith and staff members

during this time.

The cost for this series is $13,380.00 and includes 108 grams of Gamunex.

Please let me know if you have any further questions.

Sincerely,


EXHIBIT K

Page 38 of 40



July 6, 2017

Scott M. Smith, P.A.CENTRAL FLORIDA FUNCTIONAL MEDICINE, PLLC1395 North Courtney Parkway, Suite 208Merritt Island, Florida 32953

Dear Mr. Smith:

Pursuant to our agreement with Central Florida Functional Medicine, PLLC (your letter

dated July 6, 2017) and approval from the AJIMM family, please find enclosed our

Foundation's check in the amount of$13,380.00 (Exactly Thirteen Thousand Three Hundred

Eighty and 00/100 Dollars), representing our funding of the second WIG treatment

(Intravenous Immunoglobulin therapy using 108 grams of Gamunex) for Delaney P10100

scheduled for Monday, July 17, 2017 and Tuesday, July 18, 2017, from 9:00 AM to 3:00

PM each day, at the office of Central Florida Functional Medicine, PLLC in Merritt Island,

Florida.

We wish you every success with Delaney' s treatment.

Sincerely,

THE T. GURIAN, JR. FOUNDATION, INC.

Pe^tffihlp. iana, CPAVice President - Finance

BPP:hs

Enclosure: As stated.

Cc: Mr. and Mrs. David C.AL

EXHIBIT K

Page 39 of 40


TELEPHONE: 954.491.1 722 O FAX: 954.772.7584

[email protected]

THE HARRY T. MANCURIAN, JR. FOUNDATION, INC. - EIN: 16-1578255





Suite 208Merritt Island, Florida 32953

Telephone: 321-529-7300

August 20, 2018

The Harry T. Mangurian , Jr. Foundation, Inc.3696 North Federal HighwaySuite300Fort Lauderdale, Florida 33080.6263

Re: Delaney A.

I am writing to provide feedback on the outcome of treatment that your foundation graciouslyfunded for Delaney.

Delaney initially presented with complaints of anxiety, OCD, intrusive and perseverative

thoughts, sleep disruption and an inability to concentrate and focus in school which resulted in

her being home schooled and spending most of her time in bed. Treatment was provided over

a 2-day period in March 2017 with good results. Her symptoms returned in June, approximately

12 weeks after her initial treatment, a not uncommon occurrence. A second round of IVIG was

given on July 17 and 18, 2017.

'Follow-up appointments reveal that Delaney had excellent results. She was able to return to

school in the fall of 2017 and was making A's and B's. She had joined the choir, was much less

anxious and*her sleep had improved dramatically. Our last follow-up in April 2018 showed she

continued to maintain these improvements.

Your foundation's assistance made a significant impact on this child's life. Thank you again for

your support.

Sincerely,

5S^cott M. Sith, P.A. EXHIBIT K

Page 40 of 40

29 49128600'904 - foundationcenter

Documents